; Mon Aug 10 14:08:52 PDT 2015
; 
;+ (version "3.4.5")
;+ (build "Build 585")

([Absence+of+Stage+D+HF] of  Diagnostic_Term_Metaclass

	(data_source clinical_assessment)
	(DiagnosticCriteria [KB_707214_Class0]))

([Acitve+prescription+for+ACE+and+ARB] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class250282]))

([Active+prescription+for+ACE+and+aldosterone+antagonists] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class100008]))

([Active+prescription+for+ARB+and+aldosterone+antagonist] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class100010]))

([AddisonsDisease] of  Medical_Conditions_Metaclass
)

([African+american+%28black%29+and+moderate+symptoms+and+using+ACE%2C+BB%2C+diuretic] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element clinical_assessment)
	(DiagnosticCriteria [ATHENA_HF_Class70151]))

([African_American_and_IF_moderate_or_severe_symptoms_and_using_ACEI_BB_diuretics] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class40000])
	(PrettyName "African American & (IF moderate symptoms) & using ACEI, BB, diuretics"))

([African_American_and_IF_moderate_or_severe_symptoms_and_using_ACEI_BBNot] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class40000]))

([African_American_and_IF_NYHA_ClassIII_IV_symptoms_and_ACEorARB_BB] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class110004]))

([African_American_and_NYHA_III_IV_symptoms_ACE_or_ARB_and_BB] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class110014])
	(PrettyName "African american & NYHA III IV & (ACE or ARB) & BB"))

([Angioedema+due+to+ADR+to+ACEI_OLD] of  Diagnostic_Term_Metaclass

	(controllable FALSE)
	(DiagnosticCriteria [library_Class120000])
	(PrettyName "Angioedema due to ADR to ACEI"))

([ATHENA_HF_Class0] of  Management_Guideline

	(clinical_algorithm [ATHENA_HF_Class1])
	(eligibility_criteria [KB_707214_Class0])
	(label "ATHENA Heart Failure Guideline"))

([ATHENA_HF_Class1] of  Management_Diagram

	(label "Athena Heart Failure clinical algorithm")
	(steps
		[ATHENA_HF_Class2]
		[ATHENA_HF_Class10003]
		[ATHENA_HF_Class10004]
		[ATHENA_HF_Class10005]
		[ATHENA_HF_Class30009]
		[ATHENA_HF_Class30017]
		[ATHENA_HF_Class50009]
		[ATHENA_HF_Class50087]
		[ATHENA_HF_Class50089]
		[ATHENA_HF_Class50097]
		[ATHENA_HF_Class60066]
		[ATHENA_HF_Class60068]
		[ATHENA_HF_Class60069])
	(transitions
		[ATHENA_HF_Class30016]
		[ATHENA_HF_Class20000]
		[ATHENA_HF_Class50014]
		[ATHENA_HF_Class50088]
		[ATHENA_HF_Class50090]
		[ATHENA_HF_Class50098]
		[ATHENA_HF_Class60067]
		[ATHENA_HF_Class60070]
		[ATHENA_HF_Class60071]))

([ATHENA_HF_Class10000] of  Drug_Usage

	(Absolute_Contraindications
		Pregnancy
		Angioedema+due+to+ADR+to+ACEI
		Angioedema_due_to_ADR_to_ARB
		K%3E5)
	(collateral_actions
		[ATHENA_HF_Class110378]
		[ATHENA_HF_Class170010]
		[ATHENA_HF_Class170013]
		[ATHENA_HF_Class170009])
	(Compelling_Indications
		Myocardial_Infarction
		LVEF%3C%3D40+and+no+HF+symptoms
		HF+%28ICD9+or+symptoms%29+and+LVEF%3C%3D40)
	(Drug_Class_Name ACE_Inhibitors)
	(formulary_preferred_drug_in_class
		[ATHENA_HF_Class10001]
		[ATHENA_HF_Class50040]
		[ATHENA_HF_Class50042])
	(label "Ace_Inhibitor")
	(Relative_Contraindications Active+prescription+for+ARB+and+aldosterone+antagonist)
	(Relative_Indications
		HTN+and+LVH
		High+Risk+for+HF+and+DM%2C+HTN%2C+or+atherosclerotic+vascular+disease))

([ATHENA_HF_Class100000] of  Management_Guideline

	(label "HF Performance Measures Outpatient"))

([ATHENA_HF_Class100002] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class100853]
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50018])
	(label "HF (HF global ICD or NYHA Symptoms) and LVEF<=40 and no MI")
	(operator AND))

([ATHENA_HF_Class100004] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class100853]
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50011])
	(label "HF (ICD or Symptoms) and LVEF<=40 and MI")
	(operator AND))

([ATHENA_HF_Class100006] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00016]
		[ATHENA_HF_Class50026])
	(label "Active prescription for ACE OR ARB")
	(operator OR))

([ATHENA_HF_Class100008] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00016]
		[ATHENA_HF_Class110825])
	(label "Active prescription for ACE and aldosterone antagonists")
	(operator AND))

([ATHENA_HF_Class10001] of  Guideline_Drug

	(dose_level_ranges [ATHENA_HF_Class10002])
	(dose_strength_unit mg_per_mL)
	(generic_drug captopril)
	(label "Captopril old")
	(max_recommended_dose_level Low_Dose%28high%2Flow%29)
	(rule_in [ATHENA_HF_Class50011])
	(starting_dose 18.75))

([ATHENA_HF_Class100010] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50026]
		[ATHENA_HF_Class110825])
	(label "Active prescription for ARB and aldosterone antagonist")
	(operator AND))

([ATHENA_HF_Class100013] of  Presence_Criterion

	(domain_term Stage+D+Heart+Failure)
	(entry_type Note_Entry)
	(label "Stage D HF (refractory end stage HF)")
	(presence TRUE))

([ATHENA_HF_Class100014] of  Conditional_On_Screen_Message

	(description "Fluid management if using diuretics")
	(label "Fluid management if using diuretics")
	(message "Continue to manage diuretics and salt restriction for optimal volume control.  (Level of Evidence: C)")
	(message_type Class+I)
	(references
		[ATHENA_HF_Class110381]
		[ATHENA_HF_Class110389])
	(rule_in_condition [ATHENA_HF_Class70169]))

([ATHENA_HF_Class100015] of  Conditional_On_Screen_Message

	(description "fluid management NOT on diuretics")
	(label "fluid management NOT on diuretics")
	(message "Diuretics and salt restriction are indicated if there is evidence of fluid retention. (Level of Evidence: C)")
	(message_type Class+I)
	(references [ATHENA_HF_Class110381])
	(rule_in_condition [ATHENA_HF_Class100016]))

([ATHENA_HF_Class100016] of  Presence_Criterion

	(domain_term Diuretics)
	(entry_type Medication)
	(label "absence of diuretics")
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class10002] of  Range_Mapping_Entry

	(abstract_value Low_Dose%28high%2Flow%29)
	(lower_limit 18.75)
	(upper_limit 150.0))

([ATHENA_HF_Class10003] of  Scenario

	(consultation_template [ATHENA_HF_Class50000])
	(followed_by [ATHENA_HF_Class30009])
	(label "Stage B HF")
	(new_encounter TRUE)
	(precondition [ATHENA_HF_Class60053]))

([ATHENA_HF_Class10004] of  Scenario

	(consultation_template [ATHENA_HF_Class50074])
	(followed_by [ATHENA_HF_Class50087])
	(label "Stage C HF")
	(new_encounter TRUE)
	(precondition [ATHENA_HF_Class110175]))

([ATHENA_HF_Class10005] of  Scenario

	(followed_by [ATHENA_HF_Class60066])
	(label "Stage D HF")
	(new_encounter FALSE)
	(precondition [ATHENA_HF_Class100013]))

([ATHENA_HF_Class10006] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50031]
		[ATHENA_DM_Eye_Instance_40003])
	(label "High risk for developing heart failure")
	(operator OR))

([ATHENA_HF_Class10007] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class20005]
		[ATHENA_HF_Class20006]
		[ATHENA_HF_Class70628]
		[ATHENA_HF_Class50011]
		[ATHENA_HF_Class60044])
	(label "Structural Heart Disease")
	(operator OR))

([ATHENA_HF_Class10008] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class60088]
		[ATHENA_HF_Class10006]
		[ATHENA_HF_Class20008]
		[ATHENA_HF_Class60054])
	(label "Criteria for Stage A HF")
	(operator AND))

([ATHENA_HF_Class100223] of  N_ary_Criterion

	(criteria
		[athena_hypertension_203766]
		[ATHENA_HF_Class60012]
		[ATHENA_HF_Class60015]
		[ATHENA_HF_Class60016]
		[ATHENA_HF_Class460015])
	(label "ACE or ARB intolerance: ADR, hypotension, renal insuficiency")
	(operator OR))

([ATHENA_HF_Class100224] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class100223]
		[KB_886846_Class0])
	(label "HF and LVEF<=40 and intolerance to ACE/ARB")
	(operator AND))

([ATHENA_HF_Class100394] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50024]
		[ATHENA_HF_Class70168]
		[ATHENA_HF_Class70002]
		[ATHENA_HF_Class270266]
		[ATHENA_HF_Class240003])
	(label "HF with persistent symptoms and LVEF<=40 and treated with conventional therapy")
	(operator AND))

([ATHENA_HF_Class100434] of  N_ary_Criterion

	(criteria [ATHENA_HF_Class70145])
	(label "MI at least 40d old OR non ischemic dilated cardiomyopathy")
	(operator OR))

([ATHENA_HF_Class100847] of  Conditional_On_Screen_Message

	(description "rec cardiac resynchronization therapy")
	(label "rec cardiac resynchronization therapy")
	(message "Patients with LVEF of less than or equal to 35%, sinus rhythm, and NYHA functional class III ambulatory class IV symptoms\ndespite recommended optimal medical therapy and who have cardiac dyssynchrony, which is currently defined as a QRS duration greater than or equal to 0.12 seconds, should receive cardiac resynchronization therapy, with or without an ICD, unless contraindicated (203–218). (Level of Evidence: A)")
	(message_type Class+I)
	(rule_in_condition [ATHENA_HF_Class100848]))

([ATHENA_HF_Class100848] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class100849]
		[ATHENA_HF_Class50049]
		[ATHENA_HF_Class70195])
	(label "LVEF<=35 & QRS >=0.12 & sinus rhythm & NYHA functional class III ambulatory class IV symptoms")
	(operator AND))

([ATHENA_HF_Class100849] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70192]
		[ATHENA_HF_Class100850])
	(label "cardiac dyssynchrony OR QRS>= 0.12")
	(operator OR))

([ATHENA_HF_Class100850] of  Presence_Criterion

	(domain_term cardiac+dyssynchrony)
	(entry_type Note_Entry)
	(label "presence of cardiac dyssynchrony")
	(presence TRUE))

([ATHENA_HF_Class100851] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70156]
		[ATHENA_HF_Class70186])
	(label "presence of moderate or severe symptoms")
	(operator OR))

([ATHENA_HF_Class100852] of  N_ary_Criterion

	(criteria [ATHENA_HF_Class70198])
	(label "HF symptoms/HF and LVEF<=40")
	(operator AND))

([ATHENA_HF_Class100853] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class60072]
		[ATHENA_HF_Class390977])
	(label "HF global OR HF symptoms")
	(operator OR))

([ATHENA_HF_Class101051] of  Evaluate_Start_Activity

	(alternatives
		[ATHENA_HF_Class240006]
		[ATHENA_HF_Class180005]
		[ATHENA_HF_Class260000]
		[ATHENA_HF_Class340000]
		[KB_412386_Class5]
		[KB_412386_Class6])
	(label "Stage C drug recs Astronaut"))

([ATHENA_HF_Class102530] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00016]
		[athena_hypertension_INSTANCE_00017]
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class70002])
	(label "LVEF<=40 & using ACE & using BB & persistent HF symptoms")
	(operator AND))

([ATHENA_HF_Class110000] of  Management_Guideline

	(label "HF Performance Measures Inpatient"))

([ATHENA_HF_Class110004] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70168]
		[athena_hypertension_360026]
		[ATHENA_HF_Class110005]
		[ATHENA_HF_Class50025])
	(label "African American & (IF NYHA Class III-IV symtoms) & using (ACE or ARB)  & BB")
	(operator AND))

([ATHENA_HF_Class110005] of  Presence_Criterion

	(domain_term IF_NYHA_class_III_IV_symptoms)
	(entry_type Note_Entry)
	(label "IF NYHA class III-IV symptoms")
	(presence TRUE))

([ATHENA_HF_Class110014] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class220005]
		[KB_056864_Class7]
		[KB_490421_Class0]
		[ATHENA_HF_Class210009])
	(label "African american & NYHA III IV & (ACE or ARB) & BB")
	(operator AND))

([ATHENA_HF_Class110015] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class110016]
		[ATHENA_HF_Class110017])
	(label "NYHA class III or class IV")
	(operator OR))

([ATHENA_HF_Class110016] of  Presence_Criterion

	(domain_term NYHA+functional+class+III)
	(entry_type Note_Entry)
	(label "Presence of NYHA class III symptoms")
	(presence TRUE))

([ATHENA_HF_Class110017] of  Presence_Criterion

	(domain_term NYHA_functional_class_IV)
	(entry_type Note_Entry)
	(label "Presence of NYHA class IV symptoms")
	(presence TRUE))

([ATHENA_HF_Class110018] of  Drug_Usage

	(collateral_actions [KB_899077_Class9])
	(Compelling_Indications
		African_American_and_NYHA_III_IV_symptoms_ACE_or_ARB_and_BB
		LVEF%3C%3D40_and_NYHA_Class_IIi_or_IV_and_ACE_intolerance)
	(Drug_Class_Name Hydralazine_and_nitrates)
	(label "Hydralazine and nitrates Astronaut II")
	(Relative_Indications LVEF%3C%3D40+and+contraindications+to+ACE%2FARB+%28hypotension%2C+renal+insufficiency+or+drug+intolerance%29))

([ATHENA_HF_Class110175] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[KB_886846_Class0])
	(label "HF (ICD or signs/symptoms) and LVEF<=40")
	(operator AND))

([ATHENA_HF_Class110348] of  Conditional_On_Screen_Message

	(description "LVEF<30")
	(label "LVEF<30")
	(message "Most recent LVEF <30, patient should have a cardiac evaluation.")
	(message_type Recommendation)
	(references
		[ATHENA_HF_Class110364]
		[ATHENA_HF_Class110365])
	(rule_in_condition [ATHENA_HF_Class110349]))

([ATHENA_HF_Class110349] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "LVEF<30")
	(numeric_domain_term Left+Ventricular+Ejection+fraction)
	(operator %3C)
	(value 30.0))

([ATHENA_HF_Class110350] of  Conditional_On_Screen_Message

	(description "30<=LVEF<40")
	(label "30<=LVEF<40")
	(message "Patient has a low LVEF, consider cardiac evaluation or repeat left ventricular ejection fraction in about 3 months.")
	(message_type Recommendation)
	(references
		[ATHENA_HF_Class110365]
		[ATHENA_HF_Class110364])
	(rule_in_condition [ATHENA_HF_Class110351]))

([ATHENA_HF_Class110351] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class20004]
		[ATHENA_HF_Class110352])
	(label "30<=LVEF<40")
	(operator AND))

([ATHENA_HF_Class110352] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "LVEF>=30")
	(numeric_domain_term Left+Ventricular+Ejection+fraction)
	(operator %3E%3D)
	(value 30.0))

([ATHENA_HF_Class110353] of  Conditional_On_Screen_Message

	(description "PM rec add AA and using ACE")
	(label "PM rec add AA and using ACE")
	(message "Patient has active prescription for ACE inhibitor. Potassium and kidney function should be measured within 3 days of starting aldosterone antagonists, at 1 week, then every 4 weeks for the first 12 weeks, then every 3 months thereafter.")
	(message_type Primary_Recommendation)
	(references [ATHENA_HF_Class110381])
	(rule_in_condition [athena_hypertension_INSTANCE_00016]))

([ATHENA_HF_Class110354] of  Collateral_Action

	(actions [ATHENA_HF_Class110355])
	(mood Authorized))

([ATHENA_HF_Class110355] of  On_Screen_Message

	(description "meet target dose, not max dose lisinopril")
	(label "meet target dose, not max dose lisinopril")
	(message "The target dose for lisinopril in heart failure management is 20mg/day. There were no demonstrated benefits using higher doses.")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110362]))

([ATHENA_HF_Class110356] of  Collateral_Action

	(actions [ATHENA_HF_Class110357])
	(mood Authorized))

([ATHENA_HF_Class110357] of  On_Screen_Message

	(description "target dose enalapril")
	(label "target dose enalapril")
	(message "The target dose for enalapril in heart failure management is 20mg/day. There were no demonstrated benefits using higher doses.")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110362]))

([ATHENA_HF_Class110358] of  Collateral_Action

	(actions [ATHENA_HF_Class110357])
	(mood Recommend_Increase))

([ATHENA_HF_Class110359] of  Collateral_Action

	(actions [ATHENA_HF_Class110355])
	(mood Recommend_Increase))

([ATHENA_HF_Class110360] of  Collateral_Action

	(actions [ATHENA_HF_Class110361])
	(mood Recommend_Add))

([ATHENA_HF_Class110361] of  Conditional_On_Screen_Message

	(description "add bb before inc dose ace")
	(label "add bb before inc dose ace")
	(message "In clinical trial, adding a beta blocker showed greater improvement in heart failure symptoms and outcomes versus increasing dose of ACE inhibitor.")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110362])
	(rule_in_condition [athena_runtime_00103]))

([ATHENA_HF_Class110362] of  Supporting_Material

	(label "Elaine furmaga - consensus document"))

([ATHENA_HF_Class110363] of  Conditional_On_Screen_Message

	(description "ICD info to discuss with patient")
	(label "ICD info to discuss with patient")
	(message "Discussion should clarify in simple words exactly what an ICD does and doesn’t do.\nOf every 100 patients like yourself, during the next 5 years 7-8 will live longer because of device but:    \n- 28-30 will die anyway\n- Most (>50%) will never use their device but we have no sure way to know who they are\n- 8-10 will have an inappropriate shock which may increase the risk of dying \n- 4-10 will have other complications, some of which will be fatal\n- Your heart failure is more likely to worsen\n- Someday you may wish to have the defibrillation feature inactivated")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110364])
	(rule_in_condition [ATHENA_HF_Class70141]))

([ATHENA_HF_Class110364] of  Supporting_Material

	(label "Barry Massey- consensus document"))

([ATHENA_HF_Class110365] of  Supporting_Material

	(label "Paul Heindenrich - consensus document"))

([ATHENA_HF_Class110366] of  Conditional_On_Screen_Message

	(label "expectation of survival")
	(message "When evaluating expectation of survival with a good functional status, it is important that this estimation be based on non-cardiac survival.")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110365])
	(rule_in_condition [ATHENA_HF_Class70141]))

([ATHENA_HF_Class110367] of  Order_TestProcedure

	(label "order ecg")
	(test_or_procedure EKG)
	(when [ATHENA_DM_Eye_Instance_100018]))

([ATHENA_HF_Class110368] of  Conditional_On_Screen_Message

	(description "order ecg")
	(label "order ecg")
	(message "Order ECG to determine QRS duration and candidacy for a CRT.")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110365])
	(rule_in_condition [ATHENA_HF_Class110369]))

([ATHENA_HF_Class110369] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class70195])
	(label "LVEF<=35 and NYHA class 3 or 4")
	(operator AND))

([ATHENA_HF_Class110370] of  Collateral_Action

	(actions
		[ATHENA_HF_Class110371]
		[ATHENA_HF_Class110375]
		[ATHENA_HF_Class132286])
	(mood Recommend_Add))

([ATHENA_HF_Class110371] of  Conditional_On_Screen_Message

	(label "inital dose recommendation digoxin when age>70, egfr<30 or lean body mass.")
	(message "Initial recommended dose of digoxin is 0.125mcg daily (or every other day).")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110362])
	(rule_in_condition [ATHENA_HF_Class110372]))

([ATHENA_HF_Class110372] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class110373]
		[ATHENA_HF_Class110374])
	(label "age>70, egfr<30 or low lean body mass")
	(operator OR))

([ATHENA_HF_Class110373] of  Numeric_Term_Criterion

	(entry_type Numeric_Entry)
	(label "age >70")
	(numeric_domain_term Age)
	(operator %3E)
	(value 70.0))

([ATHENA_HF_Class110374] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "egfr < 30")
	(numeric_domain_term eGFR)
	(operator %3C)
	(value 30.0))

([ATHENA_HF_Class110375] of  Parameterized_Message

	(label "parameterized message: dig dose if age>70, egfr<30 or lean body mass")
	(message_type Recommendation)
	(parameterized_message [ATHENA_HF_Class110376])
	(references [ATHENA_HF_Class110362]))

([ATHENA_HF_Class110376] of  Parameterized_String

	(variables [ATHENA_HF_Class110377]))

([ATHENA_HF_Class110377] of  Variable
)

([ATHENA_HF_Class110378] of  Collateral_Action

	(actions
		[ATHENA_HF_Class110379]
		[ATHENA_HF_Class110380])
	(mood Recommend_Add))

([ATHENA_HF_Class110379] of  On_Screen_Message

	(description "rec add ace: dose adjustent based on kidney function")
	(label "rec add ace: dose adjustent based on kidney functio")
	(message "Refer to specific ACE Inhibitor dose adjustments based on kidney function.")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110362]))

([ATHENA_HF_Class110380] of  On_Screen_Message

	(description "monitoring renal function and K for ACEI")
	(label "monitoring renal function and K for ACEI")
	(message "Renal function and\nserum potassium should be assessed within 1 to 2 weeks of\ninitiation of therapy and periodically thereafter, especially in\npatients with preexisting hypotension, hyponatremia, diabetes\nmellitus, or azotemia or in those taking potassium\nsupplements.")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110381]))

([ATHENA_HF_Class110381] of  Supporting_Material

	(label "ACC/AHA 2009"))

([ATHENA_HF_Class110382] of  Collateral_Action

	(actions
		[ATHENA_HF_Class110383]
		[ATHENA_HF_Class240016])
	(mood Recommend_Add))

([ATHENA_HF_Class110383] of  On_Screen_Message

	(description "rec add hydralazine and nitrates- dose suggsetions")
	(label "rec add hydralazine and nitrates- dose suggsetions")
	(message "Recommend starting with hydralazine 25mg tid and nitrates 10mg tid. Would not go much above hydralazine 50mg tid and nitrates 40mg tid. Titrate after a month. Beta blockers can avoid the tachycardia caused by hydralazine and nitrates.")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110364]))

([ATHENA_HF_Class110384] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class110388])
	(label "Age>70: dose adjsutment may be necessary"))

([ATHENA_HF_Class110386] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class110384]))

([ATHENA_HF_Class110387] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class50084]))

([ATHENA_HF_Class110388] of  Conditional_On_Screen_Message

	(description "age > 70, dose adjustments may be necessary")
	(label "age > 70, dose adjustments may be necessary")
	(message "For patients older than 70 years be alert of the possible need for dose adjustment based on eGFR.")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110389])
	(rule_in_condition [KB_155357_Class53]))

([ATHENA_HF_Class110389] of  Supporting_Material

	(label "Mary Goldstein - consensus"))

([ATHENA_HF_Class110390] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class110392])
	(label "BNP monitoring"))

([ATHENA_HF_Class110391] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class110390]))

([ATHENA_HF_Class110392] of  On_Screen_Message

	(description "BNP monitoring")
	(label "BNP monitoring")
	(message "There is somewhat more evidence, and home self bnp monitoring is in development.   While I don’t do it, I think that it wouldn’t be bad to get a baseline BNP on a newly diagnosed patient.  Very high ones mean something and woulde make me more aggressive.  I prefer history and PE, but there may be value for PCP who may have less time for history and less skill with PE.")
	(message_type Recommendation))

([ATHENA_HF_Class110411] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class110414])
	(label "not use nutritional supplements")
	(rule_in [criterion_INSTANCE_00001])
	(rule_out [ATHENA_HF_Class50043]))

([ATHENA_HF_Class110413] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50001])
	(%3ATO [ATHENA_HF_Class110411]))

([ATHENA_HF_Class110414] of  On_Screen_Message

	(description "not use nutritional supplements")
	(label "not use nutritional supplements")
	(message "Routine use of nutritional supplements solely to prevent the development of structural heart disease should not be recommended for patients at high risk for developing HF. (Level of\nEvidence: C)")
	(message_type Class+III))

([ATHENA_HF_Class110823] of  Conditional_On_Screen_Message

	(description "Combined use ACEI, ARB and aldosterone antagonist not rec")
	(label "Combined use ACEI, ARB and aldosterone antagonist not rec")
	(message "Routine combined use of an ACEI, ARB, and aldosterone antagonist is NOT RECOMMENDED for patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: C)")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class110824]))

([ATHENA_HF_Class110824] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50024]
		[ATHENA_HF_Class50026]
		[ATHENA_HF_Class110825])
	(label "On ACEI, ARB and aldosterone antagonist")
	(operator AND))

([ATHENA_HF_Class110825] of  Presence_Criterion

	(domain_term aldosterone+antagonist)
	(entry_type Medication)
	(label "presence of aldosterone antagonist")
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class120000] of  Management_Guideline

	(clinical_algorithm [ATHENA_HF_Class130000])
	(drug_usages
		[ATHENA_HF_Class260000]
		[ATHENA_HF_Class240006]
		[ATHENA_HF_Class180005]
		[ATHENA_HF_Class340000]
		[KB_412386_Class5]
		[KB_412386_Class6])
	(eligibility_criteria
		[KB_707214_Class0]
		[KB_886846_Class0]
		[KB_412386_Class3]
		[KB_412386_Class2])
	(guideline_drugs
		[ATHENA_HF_Class50094]
		[ATHENA_HF_Class50093]
		[ATHENA_HF_Class50092]
		[ATHENA_HF_Class50042]
		[KB_234689_Class3]
		[KB_443299_Class0]
		[KB_443299_Class1]
		[athena_hypertension_00040]
		[athena_hypertension_00044]
		[KB_126607_Class0]
		[KB_412412_Class0])
	(label "ATHENA HF Astronaut"))

([ATHENA_HF_Class120002] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "LVEF<40")
	(numeric_domain_term Left+Ventricular+Ejection+fraction)
	(operator %3C)
	(valid_window [ATHENA_DM_Eye_Instance_80016])
	(value 40.0))

([ATHENA_HF_Class120005] of  Presence_Criterion

	(entry_type Note_Entry)
	(label "Presence HF PM Outpatient")
	(presence TRUE))

([ATHENA_HF_Class120883] of  Conditional_On_Screen_Message

	(description "Acute MI, use contemporary guidelines")
	(label "Acute MI, use contemporary guidelines")
	(message "Patients who have not developed HF symptoms should be treated according to contemporary guidelines after an acute MI. (Level of Evidence: C).")
	(message_type Class+I)
	(rule_in_condition [ATHENA_HF_Class90385]))

([ATHENA_HF_Class121650] of  Presence_Criterion

	(domain_term structural+heart+disease)
	(entry_type Note_Entry)
	(label "presence of structural heart disease")
	(presence TRUE))

([ATHENA_HF_Class122379] of  Presence_Criterion

	(domain_term NYHA+class+I)
	(entry_type Note_Entry)
	(label "presence of NYHA functional class I")
	(presence TRUE))

([ATHENA_HF_Class124161] of  Presence_Criterion

	(domain_term nonsteroidal+anti-inflammatory+drugs)
	(entry_type Medication)
	(label "presence of NSAIDs")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class124162] of  Presence_Criterion

	(domain_term calcium+channel+blockers+with+negative+inotropic+effects)
	(entry_type Medication)
	(label "presence of cardiotoxic CCB")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class124163] of  Presence_Criterion

	(domain_term antiarrhythmic+drugs)
	(entry_type Medication)
	(label "presence of cardiotoxic antiarrhythmic drugs")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class124167] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class124162]
		[ATHENA_HF_Class124163]
		[ATHENA_HF_Class170002]
		[ATHENA_HF_Class260070])
	(label "presence of drugs that adversely effect HF")
	(operator OR))

([ATHENA_HF_Class124168] of  Conditional_On_Screen_Message

	(description "Use of drugs adversely affect HF status")
	(label "Use of drugs adversely affect HF status")
	(message "Drugs known to adversely affect the clinical status of patients with current or prior symptoms of HF and reduced LVEF should be avoided or withdrawn whenever possible (e.g., nonsteroidal anti-inflammatory drugs, most antiarrhythmic drugs, and most\ncalcium channel blocking drugs). (Level of Evidence: B)")
	(message_type Class+I)
	(rule_in_condition [ATHENA_HF_Class124167]))

([ATHENA_HF_Class130000] of  Management_Diagram

	(label "ATHENA HF Astronaut algorithm")
	(steps
		[ATHENA_HF_Class130001]
		[ATHENA_HF_Class130002]
		[ATHENA_HF_Class250000]
		[ATHENA_HF_Class270000]
		[ATHENA_HF_Class130004]
		[ATHENA_HF_Class330002]
		[ATHENA_HF_Class340249]
		[ATHENA_HF_Class340250]
		[KB_243202_Class0]
		[KB_261275_Class11]
		[KB_048666_Class4]
		[ATHENA_HF_Class360004]
		[KB_486502_Class1]
		[KB_335875_Class1]
		[ATHENA_HF_Class370001]
		[ATHENA_HF_Class370003]
		[ATHENA_HF_Class370005]
		[ATHENA_HF_Class390010]
		[KB_261275_Class11])
	(transitions
		[ATHENA_HF_Class130003]
		[ATHENA_HF_Class260001]
		[ATHENA_HF_Class310000]
		[ATHENA_HF_Class330001]
		[ATHENA_HF_Class330004]
		[ATHENA_HF_Class350555]
		[KB_243202_Class2]
		[KB_261275_Class14]
		[ATHENA_HF_Class360001]
		[ATHENA_HF_Class360002]
		[ATHENA_HF_Class360003]
		[ATHENA_HF_Class360005]
		[KB_486502_Class20]
		[KB_810954_Class1]
		[KB_335875_Class2]
		[KB_335875_Class3]
		[KB_335875_Class4]
		[KB_335875_Class5]
		[ATHENA_HF_Class370007]
		[ATHENA_HF_Class370008]
		[ATHENA_HF_Class370009]
		[ATHENA_HF_Class370010]
		[ATHENA_HF_Class370011]
		[ATHENA_HF_Class370012]
		[ATHENA_HF_Class390014]))

([ATHENA_HF_Class130001] of  Scenario

	(consultation_template [ATHENA_HF_Class170005])
	(followed_by [ATHENA_HF_Class130002])
	(label "Stage C HF (ICD or sugns/symptoms and EF<=40)")
	(new_encounter TRUE)
	(precondition [ATHENA_HF_Class110175]))

([ATHENA_HF_Class130002] of  Choice_Step

	(branches
		[ATHENA_HF_Class250000]
		[ATHENA_HF_Class270000]
		[ATHENA_HF_Class130004]
		[ATHENA_HF_Class330002]
		[KB_261275_Class11]
		[KB_486502_Class1]
		[ATHENA_HF_Class370001]
		[ATHENA_HF_Class370003]
		[ATHENA_HF_Class370005]
		[ATHENA_HF_Class390010])
	(label "Stage C HF branches"))

([ATHENA_HF_Class130003] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130001])
	(%3ATO [ATHENA_HF_Class130002]))

([ATHENA_HF_Class130004] of  Action_Choice

	(actions [ATHENA_HF_Class101051])
	(followed_by [KB_335875_Class1])
	(label "Stage C HF rec LVEF <= 40 AND SBP>=110 AND ( NOT angioedema ACEi) AND (NOT angioedema ARB) AND ( NOT 20% increase creatinine post ACEi/ARB)")
	(strict_rule_in_condition [ATHENA_HF_Class280000]))

([ATHENA_HF_Class130006] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class130004]))

([ATHENA_HF_Class130007] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00377]
		[ATHENA_HF_Class133534]
		[ATHENA_HF_Class100851]
		[ATHENA_HF_Class70142])
	(label "LVEF <=35 & HF & (moderate or severe symptoms) & creatinine low & K<5")
	(operator AND))

([ATHENA_HF_Class132286] of  On_Screen_Message

	(description "Digoxin StageC Class IIA 4")
	(label "Digoxin StageC Class IIA 4")
	(message "Digitalis can be beneficial in patients with current or prior symptoms of HF and reduced LVEF to decrease hospitalizations for HF (Level of Evidence: B).  ADD ADDL INFO from HF experts to help guide choice of when to add dig")
	(message_type Recommendation)
	(references [ATHENA_HF_Class110381]))

([ATHENA_HF_Class133534] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class133535]
		[ATHENA_HF_Class133536])
	(label "(creatinine <=2.5 males OR <=2 females) and K<5")
	(operator AND))

([ATHENA_HF_Class133535] of  Numeric_Term_Criterion

	(entry_type Numeric_Entry)
	(label "K<5")
	(numeric_domain_term Potassium)
	(operator %3C)
	(value 5.0))

([ATHENA_HF_Class133536] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class133537]
		[ATHENA_HF_Class133539])
	(label "creatinine <=2.5 males OR  <=2 females")
	(operator OR))

([ATHENA_HF_Class133537] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00102]
		[ATHENA_HF_Class133538])
	(label "male and creatinine <=2.5")
	(operator AND))

([ATHENA_HF_Class133538] of  Numeric_Term_Criterion

	(entry_type Numeric_Entry)
	(label "creatinine <=2.5")
	(numeric_domain_term Creatinine)
	(operator %3C%3D)
	(value 2.5))

([ATHENA_HF_Class133539] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00100]
		[ATHENA_HF_Class133540])
	(label "female and creatinine<=2")
	(operator AND))

([ATHENA_HF_Class133540] of  Numeric_Term_Criterion

	(entry_type Numeric_Entry)
	(label "creatinine <=2")
	(numeric_domain_term Creatinine)
	(operator %3C%3D)
	(value 2.0))

([ATHENA_HF_Class140000] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "Presence of angioedema due to ADR to ACEI")
	(%3APAL-RANGE "(defrange ?reaction :FRAME Adverse_Reaction)")
	(%3APAL-STATEMENT "(exists ?reaction \n        (and (= (patient_id ?reaction) $patient_id) \n             (or (= (substance ?reaction) \"ACE_Inhibitors\")\n                 (and (is-class (substance ?reaction))( subclass-of (coerce-to-class (substance ?reaction)) ACE_Inhibitors)))\n             (or (= (domain_term ?reaction) \"Angioedema\"))\n        )\n)"))

([ATHENA_HF_Class140004] of  Conditional_Goal
)

([ATHENA_HF_Class140006] of  Numeric_Term_Criterion

	(entry_type Numeric_Entry)
	(label "Age >=21")
	(numeric_domain_term Age)
	(operator %3E%3D)
	(value 21.0))

([ATHENA_HF_Class140007] of  Presence_Criterion

	(domain_term Outpatient_Encounter)
	(entry_type Note_Entry)
	(label "Outpatient encounter in past 12m")
	(period [ATHENA_DM_Eye_Instance_30019])
	(presence TRUE))

([ATHENA_HF_Class140008] of  N_ary_Criterion

	(label "Joint HF exclusions")
	(operator OR))

([ATHENA_HF_Class140009] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class140010]
		[ATHENA_HF_Class140011]
		[ATHENA_HF_Class140012])
	(label "Prescription for carvedilol OR bisoprolol OR sustained release metoprolol succinate")
	(operator OR))

([ATHENA_HF_Class140010] of  Presence_Criterion

	(domain_term carvedilol)
	(entry_type Medication)
	(label "prescription for carvedilol in past year")
	(mood Authorized)
	(period [ATHENA_DM_Eye_Instance_30019])
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class140011] of  Presence_Criterion

	(domain_term bisoprolol)
	(entry_type Medication)
	(label "prescription for bisoprolol in past year")
	(mood Authorized)
	(period [ATHENA_DM_Eye_Instance_30019])
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class140012] of  Presence_Criterion

	(domain_term sustained+release+metoprolol+succinate)
	(entry_type Medication)
	(label "prescription for sustained release metoprolol succinate")
	(mood Authorized)
	(period [ATHENA_DM_Eye_Instance_30019])
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class140013] of  N_ary_Criterion

	(criteria
		[athena_hypertension_203766]
		[ATHENA_HF_Class140014])
	(label "ACE AND ARB ADR/allergy")
	(operator AND))

([ATHENA_HF_Class140014] of  Presence_Criterion

	(domain_term Angiotensin_II_receptor_blockers)
	(entry_type Adverse_Reaction)
	(label "ADR ARB")
	(presence TRUE))

([ATHENA_HF_Class140015] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "most recent K >=5.5")
	(numeric_domain_term Potassium)
	(operator %3E%3D)
	(value 5.5))

([ATHENA_HF_Class144252] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70036]
		[ATHENA_HF_Class60088])
	(label "No HF AND (DM or HTN or atherosclerotic vascular diseas)")
	(operator AND))

([ATHENA_HF_Class150000] of  Action_Choice

	(actions [ATHENA_HF_Class70140])
	(label "ICD primary prevention")
	(strict_rule_in_condition [ATHENA_HF_Class50043]))

([ATHENA_HF_Class150001] of  Drug_Usage

	(Absolute_Contraindications
		Female+and+most+recent+creatinine++%3E2
		Male+and+most+recent+creatinine%3E2.5
		Acitve+prescription+for+ACE+and+ARB
		Renal_Insufficiency)
	(collateral_actions [ATHENA_HF_Class70166])
	(Compelling_Indications HF_and_+LVEF%3C%3D35_and_IF_NYHA_Class_III_or__IV_or_II_and_elevated_BNP)
	(Drug_Class_Name aldosterone+antagonist)
	(label "Aldosterone antagonist Astronaut"))

([ATHENA_HF_Class150003] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00377]
		[ATHENA_HF_Class150004]
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class133536]
		[athena_hypertension_360026])
	(label "LVEF <=35 & HF & (IF moderate or severe symptoms) & creatinine low & K<5")
	(operator AND))

([ATHENA_HF_Class150004] of  Presence_Criterion

	(domain_term If_moderate_or_severe_symptoms_are_present)
	(entry_type Note_Entry)
	(label "If moderate or severe symptoms are present")
	(presence TRUE))

([ATHENA_HF_Class150007] of  Drug_Usage

	(collateral_actions [ATHENA_HF_Class110382])
	(Compelling_Indications African_American_and_IF_NYHA_ClassIII_IV_symptoms_and_ACEorARB_BB)
	(Drug_Class_Name Hydralazine_and_nitrates)
	(label "Hydralazine and nitrates Astronaut")
	(Relative_Indications
		LVEF%3C%3D40+%26+using+ACE+%26+using+BB+%26+HF+symptoms
		LVEF%3C%3D40+and+contraindications+to+ACE%2FARB+%28hypotension%2C+renal+insufficiency+or+drug+intolerance%29))

([ATHENA_HF_Class150009] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50024]
		[ATHENA_HF_Class70169]
		[ATHENA_HF_Class70168]
		[ATHENA_HF_Class150004]
		[athena_hypertension_360026])
	(label "African American & (IF moderate or severe symptoms) & using ACE & BB & diuretics")
	(operator AND))

([ATHENA_HF_Class150011] of  Presence_Criterion

	(domain_term If_moderate_symptoms_+are_present)
	(entry_type Note_Entry)
	(label "If moderate symptoms are present")
	(presence TRUE))

([ATHENA_HF_Class160000] of  On_Screen_Message

	(fine-grain_priority 9)
	(label "NYHA classification")
	(message "Functional Capacity .....................................................Objective Assessment\nClass I. Patients with cardiac disease but without resulting limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea, or anginal pain.	A. No objective evidence of cardiovascular disease.\nClass II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain.	B. Objective evidence of minimal cardiovascular disease.\nClass III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or anginal pain.	C. Objective evidence of moderately severe cardiovascular disease.\nClass IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.	D. Objective evidence of severe cardiovascular disease.")
	(message_type Recommendation))

([ATHENA_HF_Class160001] of  Conditional_On_Screen_Message

	(fine-grain_priority 9)
	(label "CRT NYHA classification Astronaut")
	(message "Functional Capacity .....................................................Objective Assessment\nClass I. Patients with cardiac disease but without resulting limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea, or anginal pain.	A. No objective evidence of cardiovascular disease.\nClass II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain.	B. Objective evidence of minimal cardiovascular disease.\nClass III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or anginal pain.	C. Objective evidence of moderately severe cardiovascular disease.\nClass IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.	D. Objective evidence of severe cardiovascular disease.")
	(message_type Recommendation)
	(rule_in_condition [ATHENA_HF_Class70189]))

([ATHENA_HF_Class160002] of  Conditional_On_Screen_Message

	(fine-grain_priority 9)
	(label "NYHA classification")
	(message "NYHA Class I...............................Patients with cardiac disease but without resulting limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea, or anginal pain.	/A. No objective evidence of cardiovascular disease.\n\nNYHA Class II............................. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain.	/	B. Objective evidence of minimal cardiovascular disease.\n\nNYHA Class III. .............................Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or anginal pain.	/C. Objective evidence of moderately severe cardiovascular disease.\n\nNYHA Class IV. ...........................Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.		/D. Objective evidence of severe cardiovascular disease.")
	(message_type Recommendation)
	(rule_in_condition [criterion_INSTANCE_00001]))

([ATHENA_HF_Class160325] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class150000]))

([ATHENA_HF_Class160433] of  Conditional_On_Screen_Message

	(label "ICD primary prev rec Stage C Astronaut")
	(message "Class I:  Implantable cardioverter-defibrillator therapy is recommended for primary prevention of sudden cardiac death to reduce total mortality in patients with non-ischemic dilated cardiomyopathy or ischemic heart disease at least 40 days post-MI, a LVEF less than or equal to 35%, and ASSUMING NYHA functional class II or III symptoms while receiving chronic optimal medical therapy, and who have reasonable expectation of survival with a good functional status for more than 1 year. (Level of Evidence: A).  PRESENCE OF HF SYMPTOMS DATA IS NOT AVAILABLE AND IS ASSUMED TO BE PRESENT.")
	(message_type Class+I)
	(rule_in_condition [ATHENA_HF_Class170331]))

([ATHENA_HF_Class161507] of  Presence_Criterion

	(domain_term Myocardial_Infarction)
	(entry_type Note_Entry)
	(label "Presence of MI at least 40 days old")
	(period [ATHENA_HF_Class50057])
	(presence TRUE))

([ATHENA_HF_Class161508] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70145]
		[ATHENA_HF_Class161615])
	(label "Presence of MI at least 40 days old or nonischemic dilated cardiomyopathy")
	(operator OR))

([ATHENA_HF_Class161615] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class161616]
		[ATHENA_HF_Class50011])
	(label "Presence of MI gt 40 days old")
	(operator AND))

([ATHENA_HF_Class161616] of  Presence_Criterion

	(domain_term Myocardial_Infarction)
	(entry_type Note_Entry)
	(label "Absence of MI within 41 days")
	(period [ATHENA_HF_Class50057])
	(presence FALSE))

([ATHENA_HF_Class170000] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class133536]
		[athena_hypertension_477393])
	(label "(Creatinine<=2.5 and male or creatinine <=2.0 and female) or eGFR>30")
	(operator OR))

([ATHENA_HF_Class170001] of  Presence_Criterion

	(domain_term aspirin)
	(entry_type Medication)
	(label "Absence of aspirin")
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class170002] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class124161]
		[ATHENA_HF_Class170001])
	(label "Presence of NSAID and Absence of aspirin")
	(operator AND))

([ATHENA_HF_Class170003] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class260070]
		[KB_783525_Class5])
	(label "presence of drugs that adversely effect HF Astrpnaut")
	(operator OR))

([ATHENA_HF_Class170004] of  Conditional_On_Screen_Message

	(description "Use of drugs adversely affect HF status Astronaut")
	(label "Use of drugs adversely affect HF status Astronaut")
	(message "Drugs known to adversely affect the clinical status of patients with current or prior symptoms of HF and reduced LVEF should be avoided or withdrawn whenever possible (e.g., nonsteroidal anti-inflammatory drugs (not aspirin), most antiarrhythmic drugs,  most\ncalcium channel blocking drugs (except amlodipine) and thiazolidinediones). (Level of Evidence: B)")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class170003]))

([ATHENA_HF_Class170005] of  Consultation_Guideline

	(first_step [ATHENA_HF_Class170006])
	(label "Stage C consultation template Astronaut")
	(steps
		[ATHENA_HF_Class170006]
		[KB_313397_Class3]
		[KB_234689_Class1])
	(transitions
		[KB_313397_Class4]
		[KB_234689_Class2]))

([ATHENA_HF_Class170006] of  Consultation_Branch_Step

	(branches
		[KB_313397_Class3]
		[KB_234689_Class1])
	(label "Stage C HF Astronaut")
	(selection_method all_of))

([ATHENA_HF_Class170007] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class170004])
	(label "Drugs to avoid in HF")
	(rule_in [ATHENA_HF_Class170003]))

([ATHENA_HF_Class170008] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class170006])
	(%3ATO [ATHENA_HF_Class170007]))

([ATHENA_HF_Class170009] of  Collateral_Action

	(actions [ATHENA_HF_Class170020])
	(mood Recommend_Add))

([ATHENA_HF_Class170010] of  Collateral_Action

	(actions [ATHENA_HF_Class170011])
	(mood Recommend_Add))

([ATHENA_HF_Class170011] of  Conditional_On_Screen_Message

	(description "Use of ACE inhibitor and NSAID Astronaut")
	(label "Use of ACE inhibitor and NSAID Astronaut")
	(message "Nonsteroidal anti-inflammatory drugs(except aspirin) can cause sodium retention and peripheral vasoconstriction and can attenuate the efficacy and enhance the toxicity of diuretics and ACEIs")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class170012]))

([ATHENA_HF_Class170012] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00016]
		[ATHENA_HF_Class170002])
	(label "Presence of ACE inhibitor and NSAID not aspirin")
	(operator AND))

([ATHENA_HF_Class170013] of  Collateral_Action

	(actions [ATHENA_HF_Class170016])
	(mood Recommend_Add))

([ATHENA_HF_Class170016] of  Conditional_On_Screen_Message

	(label "Add ACE inhibitor while on NSAID not aspirin primary message")
	(message "Presence of NSAID detected.  Warning:  Nonsteroidal anti-inflammatory drugs(except aspirin) can cause sodium retention and peripheral vasoconstriction and can attenuate the efficacy and enhance the toxicity of diuretics and ACEIs")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class170002]))

([ATHENA_HF_Class170017] of  Consultation_Action_Step

	(label "NSAID general collateral message"))

([ATHENA_HF_Class170018] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class170006])
	(%3ATO [ATHENA_HF_Class170017]))

([ATHENA_HF_Class170019] of  Presence_Criterion

	(domain_term nonsteroidal+anti-inflammatory+drugs)
	(entry_type Medication)
	(label "Absence of NSAID")
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class170020] of  Conditional_On_Screen_Message

	(description "Presence of NSAID HF collateral message Astronaut")
	(label "Presence of NSAID HF collateral message Astronaut")
	(message "Nonsteroidal anti-inflammatory drugs(except aspirin) can cause sodium retention and peripheral vasoconstriction and can attenuate the efficacy and enhance the toxicity of diuretics and ACEIs")
	(message_type Recommendation)
	(rule_in_condition [ATHENA_HF_Class170002]))

([ATHENA_HF_Class170329] of  On_Screen_Message

	(label "rec add hyralazine_nitrates IF symptoms")
	(message "Class I Recommendation for hydralazine and nitrates for patients who are African American, have an active prescription of an ACE inhibitor and beta blocker and diuretics and an ASSUMMPTION that patient is experiencing moderate or severe HF symptoms.  Presence/absence of HF symptoms data not available for this recommendation")
	(message_type Class+I))

([ATHENA_HF_Class170330] of  On_Screen_Message

	(label "rec add aldosterone antagonist IF symptoms")
	(message "Class I recommendation for aldosterone antagonist for patietst with HF, LVEF<=35, (creatinine <=2.5 and male) or (creatine <=2 and femalel) and an ASSUMPTiON that  patient is experiencing moderate or severe HF symptoms.  Presence/absence of HF symptoms data not available for this recommendation.")
	(message_type Class+I))

([ATHENA_HF_Class170331] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class161508]
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class170335])
	(label "(MI 40 days old OR non-ischemid dilated cardiomyopathy) & LVEF le 35 & IF symptoms")
	(operator AND))

([ATHENA_HF_Class170334] of  Presence_Criterion

	(domain_term IF_NYHA_functional_class_III_or+_mbulatory_class_IV_heart_failure_symptoms)
	(entry_type Note_Entry)
	(label "IF NYHA functional class III or ambulatory class IV heart failure symptoms")
	(presence TRUE))

([ATHENA_HF_Class170335] of  Presence_Criterion

	(domain_term IF_NYHA_functional_class_II_o_+III_symptoms)
	(entry_type Note_Entry)
	(label "IF NYHA functional class II or III symptoms")
	(presence TRUE))

([ATHENA_HF_Class170336] of  Conditional_On_Screen_Message

	(label "CRT when LVEF<=35% and QRS>=0.12s and atrial fibrillation Astronaut")
	(message "Class IIa:  For patients who have LVEF less than or equal to 35%, a QRS duration of greater than or equal to 0.12 seconds, and atrial fibrillation (AF), CRT with or without an ICD is reasonable for the treatment of those patients with NYHA functional class III or ambulatory class IV heart failure symptoms on optimal recommended medical therapy. (Level of Evidence: B).  PRESENCE OF HF SYMPTOMS DATA IS NOT AVAILABLE AND IS ASSUMED TO BE PRESENT.")
	(message_type Class+II+a)
	(rule_in_condition [ATHENA_HF_Class70189]))

([ATHENA_HF_Class180000] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "BNP>250")
	(numeric_domain_term BNP)
	(operator %3E%3D)
	(unit "pg/ml")
	(value 250.0))

([ATHENA_HF_Class180001] of  Presence_Criterion

	(domain_term IF_NYHA_Class_II_III_IV_symptoms)
	(entry_type Note_Entry)
	(label "IF NHYA Class II or Class III or Class IV symptoms")
	(presence TRUE))

([ATHENA_HF_Class180002] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00377]
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class180001]
		[ATHENA_HF_Class133535]
		[ATHENA_HF_Class170000])
	(label "LVEF <=35 & HF & (IF NYHA Class II or III or IV symptoms) & (creatinine low or egfr>30) & K<5")
	(operator AND))

([ATHENA_HF_Class180005] of  Drug_Usage

	(Absolute_Contraindications
		AddisonsDisease
		CKDstage4_5_eGFRlte30_highcreatinine)
	(collateral_actions [ATHENA_HF_Class250001])
	(Compelling_Indications
		HF_and_LVEF%3C%3D35_and_NYHA_Class_III_IV_or_Class_II_and_elevated_BNP
		HF_and_LVEF_le_40_and_NYHA_II_III_IIV_or_DM)
	(Do_Not_Start_Conditions absenceKpastmonth)
	(Drug_Class_Name aldosterone+antagonist)
	(formulary_preferred_drug_in_class
		[KB_412412_Class0]
		[KB_126607_Class0])
	(label "Aldosterone antagonist Astronaut II")
	(Relative_Contraindications
		CKDstage3_30gt_eGFR_lte60
		On_Potassium+supplements
		Prescription_Ksparingdiuretic
		Prescription_heparin
		Prescription_cholestyramine
		Prescription_NSAID))

([ATHENA_HF_Class190000] of  On_Screen_Message

	(label "elevated BNP")
	(message "Although lower values of BNP or NT-proBNP exclude the presence of HF and higher values have\nreasonably high positive predictive value to diagnose HF, elevated plasma levels\nfor both natriuretic peptides have been associated with a wide variety of cardiac (ACS, heart muscle disease, valvular heart disease, pericardial disease, atrial fibrilation, myocarditis, cardiac surgery, cardioverion) and noncardiac causes (advancing age, anemia, renal failure, obstuctive sleep apnea, severe pnemonia, pumonary hypertension, critical illness, bacterial sepsis, severe burns, toxic-metablic insults, including cancer chemotherapy and envenomation)..")
	(message_type Recommendation))

([ATHENA_HF_Class190001] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "NT pro BNP >=500")
	(numeric_domain_term NT_proBNP)
	(operator %3E%3D)
	(value 500.0))

([ATHENA_HF_Class190002] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "NT pro BNP>=750")
	(numeric_domain_term NT_proBNP)
	(operator %3E%3D)
	(unit "pg/ml")
	(value 750.0))

([ATHENA_HF_Class190003] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class190001]
		[ATHENA_CKD_Instance_70005])
	(label "NT proBNP >=500 and male")
	(operator AND))

([ATHENA_HF_Class190004] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class190002]
		[ATHENA_CKD_Instance_40003])
	(label "NT proBNP>750 and female")
	(operator AND))

([ATHENA_HF_Class190005] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class190003]
		[ATHENA_HF_Class190004])
	(label "NT proBNP>=750 & female or NT proBNP>=500 & male")
	(operator OR))

([ATHENA_HF_Class190006] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class110005]
		[ATHENA_HF_Class200006]
		[ATHENA_HF_Class190010])
	(label "(IF NYHA Class III or IV) or (IF NYHA Class II and BNP elevated)")
	(operator OR))

([ATHENA_HF_Class190008] of  Presence_Criterion

	(domain_term IF_NHYA_Class_II_symptoms)
	(entry_type Note_Entry)
	(label "IF NYHA Class II symptoms")
	(presence TRUE))

([ATHENA_HF_Class190009] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class180000]
		[ATHENA_HF_Class190005])
	(label "BNP elevated or proBNP elevated")
	(operator OR))

([ATHENA_HF_Class190010] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class190008]
		[ATHENA_HF_Class190009])
	(label "IF NYHA Class II symptoms and (BNP or NTproBNP elevated)")
	(operator AND))

([ATHENA_HF_Class190011] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00377]
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class133535]
		[ATHENA_HF_Class170000]
		[ATHENA_HF_Class200010])
	(label "LVEF <=35 & HF & (IF NYHA Class III or IV symptoms or (NYHA II and elevated BNP)) & (creatinine low or egfr>30) & K<5")
	(operator AND))

([ATHENA_HF_Class190013] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class133535]
		[ATHENA_HF_Class170000]
		[KB_056864_Class9]
		[KB_886846_Class0]
		[ATHENA_HF_Class220005]
		[ATHENA_HF_Class200001])
	(label "LVEF <=35 & HF & (NYHA Class III or IV symptoms or (NYHA II and elevated BNP)) & (creatinine low or egfr>30) & K<5")
	(operator AND))

([ATHENA_HF_Class190014] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class190009]
		[ATHENA_HF_Class190015])
	(label "NYHA Class II and (BNP or NTproBNP elevated)")
	(operator AND))

([ATHENA_HF_Class190015] of  Presence_Criterion

	(domain_term NYHA+functional+class+II)
	(entry_type Note_Entry)
	(label "Presence of NYHA Class II symptoms")
	(presence TRUE))

([ATHENA_HF_Class190017] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class110015]
		[ATHENA_HF_Class190014])
	(label "(NYHA Class III or IV) or (Class II and elevated BNP or NTproBNP)")
	(operator OR))

([ATHENA_HF_Class2] of  Scenario

	(consultation_template [ATHENA_HF_Class50000])
	(followed_by [ATHENA_HF_Class60068])
	(label "Stage A HF")
	(new_encounter TRUE)
	(precondition [ATHENA_HF_Class10008]))

([ATHENA_HF_Class20000] of  Followed_By

	(%3AFROM [ATHENA_HF_Class2])
	(%3ATO [ATHENA_HF_Class60068]))

([ATHENA_HF_Class200000] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "ACE Inhibitor contraindicated")
	(PAL_constraint [ATHENA_HF_Class200017]))

([ATHENA_HF_Class200001] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50024]
		[ATHENA_HF_Class460015])
	(label "ACE-I or contraindication to ACE I")
	(operator OR))

([ATHENA_HF_Class200002] of  Presence_Criterion

	(domain_term prior_cardiovascular_hospitalization)
	(entry_type Note_Entry)
	(label "Presence of prior cardiovascular hospitalization")
	(presence TRUE))

([ATHENA_HF_Class200003] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class190009]
		[ATHENA_HF_Class200002])
	(label "Prior cardiovascular hospitalization OR elevated BNP or elevated NTproBNP")
	(operator OR))

([ATHENA_HF_Class200004] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class110015]
		[ATHENA_HF_Class200005])
	(label "(NYHA Class III or IV) or (Class II and elevated BNP or NTproBNP or prior cardiovascular hospitalization)")
	(operator OR))

([ATHENA_HF_Class200005] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class190015]
		[ATHENA_HF_Class200003])
	(label "NYHA Class II and (BNP or NTproBNP elevated or prior cardiovascular hospitalization)")
	(operator AND))

([ATHENA_HF_Class200006] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class190008]
		[ATHENA_HF_Class200003])
	(label "IF NYHA Class II symptoms and (BNP or NTproBNP elevated or prior cardiovascular hospitalization)")
	(operator AND))

([ATHENA_HF_Class200007] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00377]
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class133535]
		[ATHENA_HF_Class170000]
		[ATHENA_HF_Class200004])
	(label "LVEF <=35 & HF & (NYHA Class III or IV symptoms or (NYHA II and (elevated BNP or cardiovas hosptilaization)) & (creatinine low or egfr>30) & K<5")
	(operator AND))

([ATHENA_HF_Class200008] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00377]
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class133535]
		[ATHENA_HF_Class170000]
		[ATHENA_HF_Class190006])
	(label "LVEF <=35 & HF & (IF NYHA Class III or IV symptoms or (NYHA II and elevated BNP or prior cardiovas hosp)) & (creatinine low or egfr>30) & K<5")
	(operator AND))

([ATHENA_HF_Class20001] of  N_ary_Criterion

	(criteria [ATHENA_HF_Class40003])
	(label "Not_on_ACEI_ARB or BB")
	(operator OR))

([ATHENA_HF_Class200010] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class110005]
		[ATHENA_HF_Class200006])
	(label "(IF NYHA Class III or IV) or (IF NYHA Class II and BNP elevated or prior cardiocascular hospitalizaiton)")
	(operator OR))

([ATHENA_HF_Class200011] of  Consultation_Action_Step

	(actions
		[ATHENA_HF_Class200016]
		[ATHENA_HF_Class360828]
		[KB_063169_Class0])
	(label "BNP lab?")
	(rule_in [ATHENA_HF_Class200015]))

([ATHENA_HF_Class200013] of  Presence_Criterion

	(domain_term BNP)
	(entry_type Numeric_Entry)
	(label "Absence of BNP lab in past 6 months")
	(period [library_Class30029])
	(presence FALSE))

([ATHENA_HF_Class200014] of  Presence_Criterion

	(domain_term NT_proBNP)
	(entry_type Numeric_Entry)
	(label "Absence of NT-ProBNP lab in past 6 months")
	(period [library_Class30029])
	(presence FALSE))

([ATHENA_HF_Class200015] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class200013]
		[ATHENA_HF_Class200014])
	(label "Absence of BNP and Absence of NTproBNP in last 6 months")
	(operator AND))

([ATHENA_HF_Class200016] of  On_Screen_Message

	(label "Order BNP or NTproBNP lab")
	(message "BNP and NTproBNP lab values absent.  Either of these measurements is useful in clinical decision making in HF.  Please order BNP or NTproBNP. [Level of Evidence A]")
	(message_type Recommendation))

([ATHENA_HF_Class200017] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "ACE Inhibitor contraindicated")
	(%3APAL-RANGE "(defrange ?condition :FRAME Note_Entry)\n(defrange ?problem :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(forall ?drug_usage\n        (=> (Drug_Class_Name ?drug_usage ACE_Inhibitors)\n            (or (exists ?condition \n                        (and (patient_id ?condition $patient_id)\n                             (exists ?problem \n                                     (and (Absolute_Contraindications ?drug_usage ?problem)\n                                          (is-class (domain_term ?condition))\n                                          (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                              (equal-or-subclass-of (coerce-to-class (domain_term ?condition)) ?problem )) \n                                     ))))\n                (exists  ?derived_problem \n                         (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                              (is-derivable ?derived_problem))))\n        )\n)\n "))

([ATHENA_HF_Class20004] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "LVEF < 40")
	(numeric_domain_term Left+Ventricular+Ejection+fraction)
	(operator %3C)
	(value 40.0))

([ATHENA_HF_Class20005] of  Presence_Criterion

	(domain_term Prior_Myocardial_Infarction)
	(entry_type Note_Entry)
	(label "Prior Myocardial_Infarction")
	(presence TRUE))

([ATHENA_HF_Class20006] of  Presence_Criterion

	(domain_term Severe_LVH)
	(entry_type Note_Entry)
	(label "Severe LVH")
	(presence TRUE))

([ATHENA_HF_Class20008] of  N_ary_Criterion

	(criteria [ATHENA_HF_Class10007])
	(label "Not Structural Heart Disease")
	(operator NOT))

([ATHENA_HF_Class210000] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "BB Stage C with MI contraindicated")
	(PAL_constraint [ATHENA_HF_Class210010]))

([ATHENA_HF_Class210001] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "BB Stage C no MI contraindicated")
	(PAL_constraint [ATHENA_HF_Class210011]))

([ATHENA_HF_Class210002] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "ARB contraindicated")
	(%3APAL-RANGE "(defrange ?condition :FRAME Note_Entry)\n(defrange ?problem :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(forall ?drug_usage\n        (=> (Drug_Class_Name ?drug_usage Angiotensin_II_receptor_blockers)\n            (or (exists ?condition \n                        (and (patient_id ?condition $patient_id)\n                             (exists ?problem \n                                     (and (Absolute_Contraindications ?drug_usage ?problem)\n                                          (is-class (domain_term ?condition))\n                                          (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                              (subclass-of (coerce-to-class (domain_term ?condition)) ?problem )) \n                                     ))))\n                (exists  ?derived_problem \n                         (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                              (is-derivable ?derived_problem))))\n        )\n)\n "))

([ATHENA_HF_Class210003] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "ARB contraindicated")
	(PAL_constraint [ATHENA_HF_Class210002]))

([ATHENA_HF_Class210004] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50026]
		[ATHENA_HF_Class460008])
	(label "ARB or ARB contraindicated")
	(operator OR))

([ATHENA_HF_Class210005] of  Presence_Criterion

	(domain_term ACE_Inhibitors)
	(entry_type Medication)
	(label "Absence of ACE Inhibitor")
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class210006] of  Presence_Criterion

	(domain_term Angiotensin_II_receptor_blockers)
	(entry_type Medication)
	(label "Absence of ARB")
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class210007] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class210005]
		[ATHENA_HF_Class210006])
	(label "Absence of ACE-I or Absence of ARB")
	(operator OR))

([ATHENA_HF_Class210008] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class220006]
		[ATHENA_HF_Class220005])
	(label "ACE or ARB or contraindication and not both AND BB or contra to BB")
	(operator AND))

([ATHENA_HF_Class210009] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class200001]
		[ATHENA_HF_Class210004])
	(label "ACE or ARB or contraindication")
	(operator OR))

([ATHENA_HF_Class210010] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "BB Stage C w MI contraindicated")
	(%3APAL-RANGE "(defrange ?condition :FRAME Note_Entry)\n(defrange ?problem :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(forall ?drug_usage\n        (=> (Drug_Class_Name ?drug_usage carvedilol)\n            (or (exists ?condition \n                        (and (patient_id ?condition $patient_id)\n                             (is-class (domain_term ?condition))\n                             (exists ?problem \n                                     (and (Absolute_Contraindications ?drug_usage ?problem)\n                                          (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                              (subclass-of (coerce-to-class (domain_term ?condition)) ?problem )) \n                                     ))))\n                (exists  ?derived_problem \n                         (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                              (is-derivable ?derived_problem))))\n        )\n)\n "))

([ATHENA_HF_Class210011] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "BB Stage C no MI contraindicated")
	(%3APAL-RANGE "(defrange ?condition :FRAME Note_Entry)\n(defrange ?problem :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(forall ?drug_usage\n        (=> (Drug_Class_Name ?drug_usage 'Beta_Blocker Stage C Heart Failure')\n            (or (exists ?condition \n                        (and (patient_id ?condition $patient_id)\n                             (exists ?problem \n                                     (and (Absolute_Contraindications ?drug_usage ?problem)\n                                          (is-class (domain_term ?condition))\n                                          (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                              (subclass-of (coerce-to-class (domain_term ?condition)) ?problem )) \n                                     ))))\n                (exists  ?derived_problem \n                         (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                              (is-derivable ?derived_problem))))\n        )\n)"))

([ATHENA_HF_Class220000] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class210001]
		[ATHENA_HF_Class210000])
	(label "BB Stage C contraindicated")
	(operator OR))

([ATHENA_HF_Class220002] of  Presence_Criterion

	(domain_term Beta_Blocker+Stage+C+Heart+Failure)
	(entry_type Medication)
	(label "Presence of Stage C BB no MI")
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class220003] of  Presence_Criterion

	(domain_term carvedilol)
	(entry_type Medication)
	(label "Presence of Stage C BB w MI")
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class220004] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class220002]
		[ATHENA_HF_Class220003]
		[KB_165290_Class0])
	(label "Presence of Stage C BB")
	(operator OR))

([ATHENA_HF_Class220005] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class220004]
		[ATHENA_HF_Class460023])
	(label "Presence of Stage C BB or contraindication to BB")
	(operator OR))

([ATHENA_HF_Class220006] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class210009]
		[athena_hypertension_359489])
	(label "DO NOT USEACE or ARB or contraindication")
	(operator AND))

([ATHENA_HF_Class220007] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "Aldosterone_antagonist_contraindicated")
	(%3APAL-RANGE "(defrange ?condition :FRAME Note_Entry)\n(defrange ?problem :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(forall ?drug_usage\n        (=> (Drug_Class_Name ?drug_usage 'aldosterone antagonist')\n            (or (exists ?condition \n                        (and (patient_id ?condition $patient_id)\n                                          (is-class (domain_term ?condition))\n                             (exists ?problem \n                                     (and (Absolute_Contraindications ?drug_usage ?problem)\n                                          (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                              (subclass-of (coerce-to-class (domain_term ?condition)) ?problem )) \n                                     ))))\n                (exists  ?derived_problem \n                         (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                              (is-derivable ?derived_problem))))\n        )\n)"))

([ATHENA_HF_Class220008] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "hydralazine and nitrates contraindicated")
	(%3APAL-RANGE "(defrange ?condition :FRAME Note_Entry)\n(defrange ?problem :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(forall ?drug_usage\n        (=> (Drug_Class_Name ?drug_usage Hydralazine_and_nitrates)\n            (or (exists ?condition \n                        (and (patient_id ?condition $patient_id)\n                                           (isa-classname (domain_term ?condition))\n                            (exists ?problem \n                                     (and (Absolute_Contraindications ?drug_usage ?problem)\n                                          (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                              (subclass-of (coerce-to-class (domain_term ?condition)) ?problem )) \n                                     ))))\n                (exists  ?derived_problem \n                         (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                              (is-derivable ?derived_problem))))\n        )\n)\n "))

([ATHENA_HF_Class220009] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "Aldosterone antagonist contraindicated")
	(PAL_constraint [ATHENA_HF_Class220007]))

([ATHENA_HF_Class220010] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "hydralazine and nitrates contraindicated")
	(PAL_constraint [ATHENA_HF_Class220008]))

([ATHENA_HF_Class220011] of  Presence_Criterion

	(domain_term Hydralazine_and_nitrates)
	(entry_type Medication)
	(label "Presence of hydralazine and nitrates")
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class220012] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class110825]
		[ATHENA_HF_Class460021])
	(label "Aldosterone antagonist or contraindication to aldosterone antagonist")
	(operator OR))

([ATHENA_HF_Class220013] of  N_ary_Criterion

	(criteria [KB_149589_Class14])
	(label "Hydralazine_and_nitrates or contraindication to hydralazine_and_nitrates")
	(operator AND))

([ATHENA_HF_Class220014] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class190015]
		[ATHENA_HF_Class110016]
		[ATHENA_HF_Class110017])
	(label "Presence of NYHA Class II III or IV symptoms")
	(operator OR))

([ATHENA_HF_Class220015] of  N_ary_Criterion

	(criteria [ATHENA_HF_Class220014])
	(label "NOT Presence of NYHA II III IV symptoms")
	(operator NOT))

([ATHENA_HF_Class220016] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class220012]
		[ATHENA_HF_Class220013]
		[ATHENA_HF_Class220015]
		[ATHENA_HF_Class122379]
		[ATHENA_HF_Class220022])
	(label "AA or contra OR hydralazine & nitrates or contra OR Loop diuretics or contra OR Absence class II III IV symptoms OR Presence NYHA class I symptoms")
	(operator OR))

([ATHENA_HF_Class220017] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class210008]
		[ATHENA_HF_Class220012]
		[KB_240498_Class2])
	(label "GDMT")
	(operator AND))

([ATHENA_HF_Class220018] of  Drug_Usage

	(Drug_Class_Name Loop_diuretics)
	(label "Loop diuretic Astronaut"))

([ATHENA_HF_Class220019] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "Loop_diuretic_contraindicated")
	(%3APAL-RANGE "(defrange ?condition :FRAME Note_Entry)\n(defrange ?problem :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(forall ?drug_usage\n        (=> (Drug_Class_Name ?drug_usage Loop_diuretics)\n            (or (exists ?condition \n                        (and (patient_id ?condition $patient_id)\n                                         (isa-classname (domain_term ?condition))\n                             (exists ?problem \n                                     (and (Absolute_Contraindications ?drug_usage ?problem)\n                                           (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                              (subclass-of (coerce-to-class (domain_term ?condition)) ?problem )) \n                                     ))))\n                (exists  ?derived_problem \n                         (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                              (is-derivable ?derived_problem))))\n        )\n)"))

([ATHENA_HF_Class220020] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "Loop diuretic contraindicated")
	(PAL_constraint [ATHENA_HF_Class220019]))

([ATHENA_HF_Class220021] of  Presence_Criterion

	(domain_term Loop_diuretics)
	(entry_type Medication)
	(label "Presence of loop_diuretics")
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class220022] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class220021]
		[ATHENA_HF_Class220020])
	(label "Presence of loop diuretic or contraindication to loop diuretic")
	(operator OR))

([ATHENA_HF_Class230000] of  Presence_Criterion

	(domain_term Left_Bundle_Branch_Block)
	(entry_type Note_Entry)
	(label "Presence of LBBB")
	(presence TRUE))

([ATHENA_HF_Class230001] of  Conditional_On_Screen_Message

	(label "ICD primary prev rec Stage C Astronaut II")
	(message "ICD therapy is recommended for primary prevention of SCD to reduce total mortality in selected patients with nonischemic DCM or ischemic heart disease at least 40 days post-MI with LVEF of 35% or less and NYHA class II or III symptoms on chronic GDMT, who have reasonable expectation of meaningful survival for more than 1 year (355, 593). (Level of Evidence:  A)")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class230002]))

([ATHENA_HF_Class230002] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class220017]
		[KB_104117_Class6]
		[KB_247253_Class0]
		[ATHENA_HF_Class400732]
		[ATHENA_HF_Class161615])
	(label "MI 40 days old & LVEF le 35 & II III symptoms & GDMT & no palliative care")
	(operator AND))

([ATHENA_HF_Class230003] of  Conditional_On_Screen_Message

	(label "ICD primary prev rec Stage C stage I Astronaut II")
	(message "ICD therapy is recommended for primary prevention of SCD to reduce total mortality in selected patients at least 40 days post-MI with LVEF of30% or less, and NYHA class I symptoms while receiving GDMT, who have reasonable expectation of meaningful survival for more than 1 year (362, 597, 598). (Level of Evidence:  B)*")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class230004]))

([ATHENA_HF_Class230004] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class220017]
		[KB_056864_Class0]
		[KB_104117_Class6]
		[ATHENA_HF_Class50054]
		[KB_240498_Class16]
		[ATHENA_HF_Class400732])
	(label "(MI 40 days old) AND LVEF<=30 AND NYHA I symptoms AND GDMT")
	(operator AND))

([ATHENA_HF_Class230005] of  Conditional_On_Screen_Message

	(label "CRT when LVEF<=35% and QRS>=0.15s and LBBB Astronaut II")
	(message "CRT is indicated for patients who have LVEF of 35% or less, sinus rhythm, left bundle-branch block (LBBB) with a QRS duration of 150 ms or greater, and NYHA class II, III, or ambulatory IV symptoms on GDMT. (Level of Evidence: A for NYHA class III/IV; Level of Evidence: B for NYHA class II).  ALERT:  we assumed the presence of sinus rhythm, LBBB with QRS duration of >150ms.  If these assumptions are incorrect, a CRT is not indicated.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_899077_Class0]))

([ATHENA_HF_Class230006] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class50049]
		[ATHENA_HF_Class220017]
		[ATHENA_HF_Class230009]
		[ATHENA_HF_Class240001])
	(label "LVEF<=35 & QRS >=0.15 & sinus rhythm & LBBB & NYHA functional class II or III or ambulatory class IV symptoms & GDMT")
	(operator AND))

([ATHENA_HF_Class230007] of  Numeric_Term_Criterion

	(entry_type Numeric_Entry)
	(label "QRS >= .15")
	(numeric_domain_term QRS)
	(operator %3E%3D)
	(unit "s")
	(value 0.15))

([ATHENA_HF_Class230009] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class190015]
		[ATHENA_HF_Class110016]
		[ATHENA_HF_Class230010])
	(label "Presence of NYHA II III or ambulatory IV")
	(operator OR))

([ATHENA_HF_Class230010] of  Presence_Criterion

	(domain_term NYHA_functional_class_IV_ambulatory)
	(entry_type Note_Entry)
	(label "Presence NYHA IV ambulatory symptoms")
	(presence TRUE))

([ATHENA_HF_Class230011] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class110016]
		[ATHENA_HF_Class230010])
	(label "Presencoe of NYHA III or ambulatory IV symptoms")
	(operator OR))

([ATHENA_HF_Class240000] of  On_Screen_Message

	(label "test")
	(message "test")
	(message_type Recommendation))

([ATHENA_HF_Class240001] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class230000]
		[ATHENA_HF_Class230007])
	(label "LBBB and QRS>=.15")
	(operator AND))

([ATHENA_HF_Class240002] of  Drug_Usage

	(collateral_actions [KB_899077_Class8])
	(Compelling_Indications HF+%28HF+global+ICD+or+Symptoms%29+and+LVEF%3C%3D40+and+no+MI)
	(Drug_Class_Name Beta_Blocker+Stage+C+Heart+Failure)
	(Drug_Partners_To_Avoid sotalol)
	(formulary_preferred_drug_in_class
		[ATHENA_HF_Class50094]
		[ATHENA_HF_Class50092]
		[ATHENA_HF_Class50093])
	(label "DO NOT USE Beta blocker Stage C HF no MI Astronaut II")
	(Relative_Contraindications
		Asthma
		Aortic_stenosis
		Prescription_betablocker_notstageC_HF
		Pulse_lt_60
		Most+recent+SBP%3C110
		Prescription_diltiazem
		Prescription_verapamil
		Prescription_betablocker_notstageC_HF
		prescription_sotalol))

([ATHENA_HF_Class240003] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50068]
		[KB_886846_Class0])
	(label "Stage C HF or ICD9 HF")
	(operator OR))

([ATHENA_HF_Class240004] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class240003]
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50036]
		[KB_056864_Class5])
	(label "Stage C or ICD9 HF AND EF<=40 AND symptoms AND ADR ACE")
	(operator AND))

([ATHENA_HF_Class240006] of  Drug_Usage

	(Absolute_Contraindications
		Angioedema_due_to_ADR_to_ARB
		K%3E5)
	(collateral_actions [KB_899077_Class3])
	(Compelling_Indications LVEF%3C%3D40+and+intolerant+ACE)
	(Do_Not_Intensify_Conditions
		absenceKpastmonth
		K%3E5.0)
	(Do_Not_Start_Conditions
		DecisionCreatinine
		absenceKpastmonth
		K%3E5.0)
	(Drug_Class_Name Angiotensin_II_receptor_blockers)
	(Drug_Partners_To_Avoid ACE_Inhibitors)
	(formulary_preferred_drug_in_class
		[athena_hypertension_00040]
		[athena_hypertension_00044])
	(label "ARB Astronaut II")
	(Relative_Contraindications
		CKD_Stage3or4_15eGFR_gt60
		Prescription_Aliskiren
		Prescription_Ksparingdiuretic
		Aortic_stenosis
		Renal_artery_stenosis
		Hypertrophic_cardiomyopathy
		Active+prescription+for+ACE+and+aldosterone+antagonists))

([ATHENA_HF_Class240007] of  Presence_Criterion

	(domain_term Myocardial_Infarction)
	(entry_type Note_Entry)
	(label "Presence of MI within last 6 mo")
	(period [ATHENA_HF_Class240008])
	(presence TRUE))

([ATHENA_HF_Class240008] of  Relative_Time_Interval_Definite

	(how_many "6")
	(label "6 months before today")
	(polarity Before)
	(relative_time_point [time%3AINSTANCE_1])
	(time_unit month))

([ATHENA_HF_Class240009] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class240007]
		[ATHENA_HF_Class50019]
		[KB_056864_Class10]
		[KB_886846_Class0]
		[ATHENA_HF_Class133535]
		[ATHENA_HF_Class220005]
		[ATHENA_HF_Class220006])
	(label "MI in last 6 months AND HF AND LVEF<=40 AND NYHA II III IV symptoms or DM")
	(operator AND))

([ATHENA_HF_Class240010] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class220014]
		[KB_341641_Class2])
	(label "NYHA II III IV or DM")
	(operator OR))

([ATHENA_HF_Class240011] of  Presence_Criterion

	(domain_term Diabetes_Mellitus)
	(entry_type Note_Entry)
	(label "Presence of DM")
	(presence TRUE))

([ATHENA_HF_Class240015] of  Collateral_Action

	(actions
		[ATHENA_HF_Class170329]
		[ATHENA_HF_Class110383])
	(mood Recommend_Add))

([ATHENA_HF_Class240016] of  On_Screen_Message

	(label "rec add hyralazine_nitrates Astronaut II")
	(message "The combination of hydralazine and isosorbide dinitrate is recommended to reduce morbidity and mortality for patients self-described as African Americans with NYHA class III or IIV HFrEF receiving optimal therapy with ACE inhibitors and beta blockers, unless contraindicated (423, 424). (Level of Evidence: A)")
	(message_type Class+I))

([ATHENA_HF_Class250000] of  Action_Choice

	(actions
		[ATHENA_HF_Class110823]
		[ATHENA_HF_Class170004]
		[KB_783525_Class4])
	(label "Harmful to HF")
	(strict_rule_in_condition [ATHENA_HF_Class260002]))

([ATHENA_HF_Class250001] of  Collateral_Action

	(actions
		[ATHENA_HF_Class70167]
		[KB_899077_Class5])
	(mood Recommend_Add))

([ATHENA_HF_Class250282] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50026]
		[ATHENA_HF_Class50024])
	(label "Active prescription for ACE AND ARB")
	(operator AND))

([ATHENA_HF_Class260000] of  Drug_Usage

	(Absolute_Contraindications Angioedema+due+to+ADR+to+ACEI)
	(collateral_actions
		[ATHENA_HF_Class170009]
		[KB_899077_Class1])
	(Compelling_Indications LVEF%3C%3D40)
	(Do_Not_Intensify_Conditions
		K%3E5.0
		absenceKpastmonth)
	(Do_Not_Start_Conditions
		K%3E5.0
		absenceKpastmonth
		Decision_eGFR)
	(Drug_Class_Name ACE_Inhibitors)
	(Drug_Partners_To_Avoid Angiotensin_II_receptor_blockers)
	(drug_relations [KB_219746_Class0])
	(formulary_preferred_drug_in_class
		[ATHENA_HF_Class50042]
		[KB_234689_Class3]
		[KB_443299_Class0]
		[KB_443299_Class1])
	(label "Ace_Inhibitor Astronaut II")
	(Relative_Contraindications
		Active+prescription+for+ARB+and+aldosterone+antagonist
		Aortic_stenosis
		Hypertrophic_cardiomyopathy
		Renal_artery_stenosis
		Prescription_Aliskiren
		Prescription_Ksparingdiuretic
		CKD_Stage3or4_15eGFR_gt60))

([ATHENA_HF_Class260001] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class250000]))

([ATHENA_HF_Class260002] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class110824]
		[ATHENA_HF_Class170003])
	(label "Harmful drugs criteria")
	(operator OR))

([ATHENA_HF_Class260070] of  Presence_Criterion

	(domain_term THIAZOLIDINEDIONES)
	(entry_type Medication)
	(label "Presence of thiazolidinedione")
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class270000] of  Action_Choice

	(actions
		[ATHENA_HF_Class300008]
		[ATHENA_HF_Class230003]
		[ATHENA_HF_Class230005]
		[ATHENA_HF_Class230001])
	(followed_by [KB_335875_Class1])
	(label "LCEF <=40 AND SBP>=110 AND ((decision eGFR<30 or creat>=2.5male, 2.3 female) OR CKD stage 4/5) OR angioedema to ARB/ACEi OR 20% increase creat after ACEi/ARB)")
	(strict_rule_in_condition [ATHENA_HF_Class300006]))

([ATHENA_HF_Class270001] of  Presence_Criterion

	(domain_term Acute_Coronary_Syndrome)
	(entry_type Note_Entry)
	(label "History of ACS")
	(presence TRUE))

([ATHENA_HF_Class270002] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50011]
		[ATHENA_HF_Class270001])
	(label "Presence of MI or ACS")
	(operator OR))

([ATHENA_HF_Class270003] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class270002]
		[ATHENA_HF_Class60053]
		[ATHENA_HF_Class50019])
	(label "LVEF<=40 and MI or ACS Stage B")
	(operator AND))

([ATHENA_HF_Class270266] of  Presence_Criterion

	(domain_term aldosterone+antagonist)
	(entry_type Medication)
	(label "Absence of aldosterone antagonist")
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class280000] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class300001]
		[KB_978532_Class0]
		[KB_978532_Class1]
		[KB_810954_Class5]
		[ATHENA_HF_Class490000])
	(label "LVEF<=40 and SBP>=110 AND NOT angioedema ARB AND NOT angioedema ACE AND NOT (20% increase creat after ARB/ACE)")
	(operator AND))

([ATHENA_HF_Class280001] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "Angioedema due to ADR to ARB")
	(PAL_constraint [ATHENA_HF_Class280002]))

([ATHENA_HF_Class280002] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "Presence of angioedema due to ADR to ARB")
	(%3APAL-RANGE "(defrange ?reaction :FRAME Adverse_Reaction)")
	(%3APAL-STATEMENT "(exists ?reaction \n        (and (= (patient_id ?reaction) $patient_id) \n             (or (= (substance ?reaction) \"Angiotensin_II_receptor_blockers\")\n                (and (is-class (substance ?reaction)) ( subclass-of (coerce-to-class (substance ?reaction) ) Angiotensin_II_receptor_blockers)))\n             (or (= (domain_term ?reaction) \"angioedema\"))\n        )\n)"))

([ATHENA_HF_Class290000] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "There exists a contraindicated current med w no complicating factor")
	(PAL_constraint [eon2_Class40000]))

([ATHENA_HF_Class290001] of  N_ary_Criterion

	(criteria
		[library_Class70000]
		[KB_810954_Class10]
		[KB_155357_Class38])
	(label "(Creatinine>=2.5 (men) 2.3(women) OR CKD stage 4 OR 5) OR angioedema as ADR to ARB OR 20% increase creatinine after start ACE")
	(operator OR))

([ATHENA_HF_Class290002] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class290003]
		[ATHENA_HF_Class290005])
	(label "most recent creatinine>=2.5 (men) or >=2.3 (women)")
	(operator OR))

([ATHENA_HF_Class290003] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00100]
		[ATHENA_HF_Class290004])
	(label "most recent creatinine >=2.3 and female")
	(operator AND))

([ATHENA_HF_Class290004] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "most recent creatinine >=2.3")
	(numeric_domain_term Creatinine)
	(operator %3E%3D)
	(value 2.3))

([ATHENA_HF_Class290005] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00102]
		[ATHENA_HF_Class290006])
	(label "most recent creatinine >=2.5 and male")
	(operator AND))

([ATHENA_HF_Class290006] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "most recent creatinine >=2.5")
	(numeric_domain_term Creatinine)
	(operator %3E%3D)
	(value 2.5))

([ATHENA_HF_Class30000] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class30001]
		[ATHENA_HF_Class10007])
	(label "Criteria for Stage C HF")
	(operator AND))

([ATHENA_HF_Class300000] of  Action_Choice

	(actions
		[ATHENA_HF_Class300008]
		[ATHENA_HF_Class160000]
		[ATHENA_HF_Class230003]
		[ATHENA_HF_Class230005]
		[ATHENA_HF_Class230001])
	(label "no contraindic med and LCEF <=40 AND (SBP<110 OR high creatinine)")
	(strict_rule_in_condition [ATHENA_HF_Class310003]))

([ATHENA_HF_Class300001] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "most recent SBP>=110")
	(numeric_domain_term Treatment_Systolic_BP)
	(operator %3E%3D)
	(value 110.0))

([ATHENA_HF_Class300002] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class300003]
		[ATHENA_HF_Class300004])
	(label "creatinine <2.5 (men) OR <2.3 (women)")
	(operator OR))

([ATHENA_HF_Class300003] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00102]
		[athena_hypertension_INSTANCE_00559])
	(label "most recent creatinine <2.5 and male")
	(operator AND))

([ATHENA_HF_Class300004] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00100]
		[ATHENA_HF_Class300005])
	(label "most recent creatinine <2.3 and female")
	(operator AND))

([ATHENA_HF_Class300005] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "most recent creatinine <2.3")
	(numeric_domain_term Creatinine)
	(operator %3C)
	(value 2.3))

([ATHENA_HF_Class300006] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class370352]
		[ATHENA_HF_Class300001])
	(label "LVEF <=40 AND SBP>=110 AND ((decision eGFR<30 or creat>=2.5male, 2.3 female) OR CKD stage 4/5) OR (angioedema as ADR to ARB and using ACEI) or (angioedema to ACEI and using ARB) or (20% increase in creatinine after ACEI/ARB)")
	(operator AND))

([ATHENA_HF_Class300007] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class270000]))

([ATHENA_HF_Class300008] of  Evaluate_Start_Activity

	(alternatives
		[ATHENA_HF_Class340000]
		[KB_412386_Class5]
		[KB_412386_Class6]
		[ATHENA_HF_Class180005])
	(label "Evaluate start activity LVEF <=40 AND SBP>=110 AND (kidney failure OR angioedema ACEi/ARB or 20%increase creat after ACEi/ARB)"))

([ATHENA_HF_Class30001] of  N_ary_Criterion

	(criteria [ATHENA_HF_Class60072])
	(label "Symptoms of HF")
	(operator OR))

([ATHENA_HF_Class30002] of  Presence_Criterion

	(domain_term Beta-Blockers)
	(entry_type Medication)
	(label "Not_on_betablocker")
	(mood Authorized)
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class30004] of  Presence_Criterion

	(domain_term Heart_Failure)
	(entry_type Note_Entry)
	(label "Heart_Failure HTN")
	(presence TRUE))

([ATHENA_HF_Class30005] of  Presence_Criterion

	(domain_term Heart_Failure)
	(entry_type Note_Entry)
	(label "Absence_Heart_Failure")
	(presence FALSE))

([ATHENA_HF_Class30009] of  Choice_Step

	(branches [ATHENA_HF_Class50009])
	(label "Secondary prevention"))

([ATHENA_HF_Class30016] of  Followed_By

	(%3AFROM [ATHENA_HF_Class10003])
	(%3ATO [ATHENA_HF_Class30009]))

([ATHENA_HF_Class30017] of  Action_Choice

	(actions [ATHENA_HF_Class70037])
	(label "stage A drug choices")
	(strict_rule_in_condition [ATHENA_HF_Class70036]))

([ATHENA_HF_Class30018] of  Drug_Usage

	(Compelling_Indications
		Stage+C+and+LVEF%3C%3D40+and+ADR+ACE
		No+HF%2C+MI%2C++LVEF%3C%3D40+and+ADR+ACE)
	(Drug_Class_Name Angiotensin_II_receptor_blockers)
	(label "ARB")
	(Relative_Contraindications Active+prescription+for+ACE+and+aldosterone+antagonists)
	(Relative_Indications
		HTN+and+LVH
		Stage+B+and+LVEF%3C%3D40+and+ADR+ACE
		Mild-moderate+HF+symptoms+and+LVEF%3C%3D+40+and+ACE+intolerant
		High+Risk+for+HF+and+DM%2C+HTN%2C+or+atherosclerotic+vascular+disease
		HF+with+persistent+symptoms+and+LVEF%3C%3D40+and+treated+with+conventional+therapy))

([ATHENA_HF_Class310000] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class270000]))

([ATHENA_HF_Class310001] of  N_ary_Criterion

	(criteria [ATHENA_HF_Class290000])
	(label "NOT There exists a contraindicated current med w no complicating factor")
	(operator NOT))

([ATHENA_HF_Class310002] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class300001]
		[ATHENA_HF_Class300002]
		[ATHENA_HF_Class310001])
	(label "no contraindic med and LVEF<=40 and SBP>110 and creatinine<2.5 (men) and 2.3 (women)")
	(operator AND))

([ATHENA_HF_Class310003] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class290001]
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class310001])
	(label "no contraindc med and LCEF <=40 AND (SBP<110 OR high creatinine)")
	(operator AND))

([ATHENA_HF_Class320000] of  PAL-QUERY

	(%3APAL-NAME "query for contraindicated current med in guideline drug usage class")
	(%3APAL-RANGE "(defrange ?current_med :FRAME Medication)\n(defrange ?problem :FRAME Note_Entry)\n(defrange ?med_class :FRAME Drug_Usage)\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_contraindication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)\n")
	(%3APAL-STATEMENT "(findall ?current_med\n         (and (or (not (own-slot-not-null mood ?current_med ))\n                  (mood ?current_med Authorized))\n              (patient_id ?current_med $patient_id)\n              (is-class (drug_name ?current_med))\n              (exists ?med_class\n                      (and (equal-or-subclass-of (coerce-to-class (drug_name ?current_med)) (Drug_Class_Name ?med_class ))\n                           			(exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")(drug_usages ?guideline ?med_class)))\n                           (or (exists ?contraindication\n                                       (and  (Absolute_Contraindications ?med_class ?contraindication)\n                                             (exists ?problem\n                                                     (and (patient_id ?problem $patient_id)\n                                                          (is-class (domain_term ?problem) )\n                                                          (equal-or-subclass-of  (coerce-to-class (domain_term ?problem))\n                                                                                 ?contraindication)\n                                                     ))))\n                               (exists ?derived_contraindication                           \n                                       (and (Absolute_Contraindications ?med_class ?derived_contraindication)\n                                            		(is-derivable ?derived_contraindication)\n                                       )))))))\n"))

([ATHENA_HF_Class320001] of  Action_Choice

	(actions
		[ATHENA_HF_Class101051]
		[ATHENA_HF_Class160002]
		[ATHENA_HF_Class230001]
		[ATHENA_HF_Class230003]
		[ATHENA_HF_Class230005])
	(label "Stage C HF rec LVEF <= 40 and no contraindic cur med")
	(strict_rule_in_condition [ATHENA_HF_Class310003]))

([ATHENA_HF_Class320002] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class300000]))

([ATHENA_HF_Class320003] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class320001]))

([ATHENA_HF_Class330000] of  Presence_Criterion

	(domain_term Left+Ventricular+Ejection+fraction)
	(entry_type Numeric_Entry)
	(label "Absence of LVEF")
	(presence FALSE))

([ATHENA_HF_Class330001] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class130004]))

([ATHENA_HF_Class330002] of  Action_Choice

	(actions [ATHENA_HF_Class330003])
	(label "Presence of contraindication, Stop")
	(strict_rule_in_condition [ATHENA_HF_Class430002]))

([ATHENA_HF_Class330003] of  Evaluate_Stop_Activity

	(activity_class "Medication")
	(activity_spec Drug_Usage)
	(activity_spec_key [Drug_Class_Name])
	(activity_to_stop [ATHENA_HF_Class450004])
	(domain_term Anti-Hypertensive_Drugs_Inclusive)
	(label "Stop contraindicated drug"))

([ATHENA_HF_Class330004] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class330002]))

([ATHENA_HF_Class340000] of  Drug_Usage

	(collateral_actions [KB_899077_Class8])
	(Compelling_Indications HF+%28ICD9+or+symptoms%29+and+LVEF%3C%3D40)
	(Drug_Class_Name Beta_Blocker+Stage+C+Heart+Failure)
	(Drug_Partners_To_Avoid sotalol)
	(formulary_preferred_drug_in_class
		[ATHENA_HF_Class50092]
		[ATHENA_HF_Class50093]
		[ATHENA_HF_Class50094])
	(label "Beta Blocker Astronaut II")
	(Relative_Contraindications
		Aortic_stenosis
		Asthma
		Pulse_lt_60
		Most+recent+SBP%3C110
		Prescription_diltiazem
		Prescription_verapamil
		prescription_sotalol
		Prescription_betablocker_notstageC_HF))

([ATHENA_HF_Class340001] of  PAL_Query

	(case_variable "$patient_id")
	(key_slot [drug_name])
	(label "query for contraindicated current med in guideline drug_usage class")
	(PAL_query [ATHENA_HF_Class320000]))

([ATHENA_HF_Class340248] of  Action_Choice

	(actions
		[ATHENA_HF_Class340251]
		[KB_899077_Class2]
		[ATHENA_HF_Class360366])
	(label "Absence of ACE-I, add ACE-I")
	(strict_rule_in_condition [ATHENA_HF_Class210005]))

([ATHENA_HF_Class340249] of  Scenario

	(consultation_template [ATHENA_HF_Class170005])
	(followed_by [ATHENA_HF_Class340250])
	(label "No LVEF or LVEF > 40")
	(new_encounter TRUE)
	(precondition [ATHENA_HF_Class350002]))

([ATHENA_HF_Class340250] of  Choice_Step

	(branches [KB_243202_Class0])
	(label " "))

([ATHENA_HF_Class340251] of  On_Screen_Message

	(label "Absence of ACE-I, add ACE-I")
	(message "Patient is not taking ACE-I; add ACE-I.")
	(message_type Primary_Recommendation))

([ATHENA_HF_Class350000] of  Choice_Step

	(branches [KB_048666_Class4])
	(label " "))

([ATHENA_HF_Class350001] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "LVEF>40")
	(numeric_domain_term Left+Ventricular+Ejection+fraction)
	(operator %3E)
	(value 40.0))

([ATHENA_HF_Class350002] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class330000]
		[ATHENA_HF_Class350001])
	(label "Absence of LVEFor LVEF>40")
	(operator OR))

([ATHENA_HF_Class350181] of  General_Comparison_Criterion

	(aggregation_operator exists)
	(domain_term fatigue)
	(entry_type Note_Entry)
	(label "fatigue = yes")
	(operator eq)
	(value [ATHENA_HF_Class350182]))

([ATHENA_HF_Class350182] of  Qualitative_Constant

	(label "yes")
	(value "yes"))

([ATHENA_HF_Class350555] of  Followed_By

	(%3AFROM [ATHENA_HF_Class340249])
	(%3ATO [ATHENA_HF_Class340250]))

([ATHENA_HF_Class350556] of  Followed_By

	(%3AFROM [ATHENA_HF_Class340250])
	(%3ATO [ATHENA_HF_Class340248]))

([ATHENA_HF_Class360000] of  Variable

	(derivation_expression [library_Class70000])
	(label "Creatinine > 20%")
	(string_name "?creat"))

([ATHENA_HF_Class360001] of  Followed_By

	(%3AFROM [KB_918681_Class2])
	(%3ATO [ATHENA_HF_Class350000]))

([ATHENA_HF_Class360002] of  Followed_By

	(%3AFROM [ATHENA_HF_Class350000])
	(%3ATO [KB_048666_Class4]))

([ATHENA_HF_Class360003] of  Followed_By

	(%3AFROM [ATHENA_HF_Class350000])
	(%3ATO [KB_048666_Class4]))

([ATHENA_HF_Class360004] of  Choice_Step

	(branches [KB_048666_Class4])
	(label "PMs after generating recs"))

([ATHENA_HF_Class360005] of  Followed_By

	(%3AFROM [ATHENA_HF_Class360004])
	(%3ATO [KB_048666_Class4]))

([ATHENA_HF_Class360006] of  Followed_By

	(%3AFROM [KB_918681_Class2])
	(%3ATO [ATHENA_HF_Class360004]))

([ATHENA_HF_Class360366] of  Start_Activity

	(activity [ATHENA_HF_Class260000])
	(label "start ACE-I Astronaut II"))

([ATHENA_HF_Class360828] of  Order_TestProcedure

	(label "Order BNP")
	(test_or_procedure BNP))

([ATHENA_HF_Class370000] of  Order_TestProcedure

	(label "Order CRT")
	(subsidiary_message "CRT is indicated for patients who have LVEF of 35% or less, sinus rhythm, left bundle-branch block (LBBB) with a QRS duration of 150 ms or greater, and NYHA class II, III, or ambulatory IV symptoms on GDMT. (Level of Evidence: A for NYHA class III/IV; Level of Evidence: B for NYHA class II).  ALERT:  we assumed the presence of sinus rhythm, LBBB with QRS duration of >150ms.  If these assumptions are incorrect, a CRT is not indicated.")
	(test_or_procedure Cardiac_resynchronization_therapy))

([ATHENA_HF_Class370001] of  Action_Choice

	(actions [ATHENA_HF_Class410000])
	(followed_by [KB_335875_Class1])
	(label "ICD primary prev rec Stage C Astronaut II")
	(strict_rule_in_condition [ATHENA_HF_Class230002])
	(strict_rule_out_condition [KB_155357_Class77]))

([ATHENA_HF_Class370002] of  On_Screen_Message

	(label "ICD primary prev rec Stage C Astronaut II msg")
	(message "ICD therapy is recommended for primary prevention of SCD to reduce total mortality in selected patients with nonischemic DCM or ischemic heart disease at least 40 days post-MI with LVEF of 35% or less and NYHA class II or III symptoms on chronic GDMT, who have reasonable expectation of meaningful survival for more than 1 year (355, 593). (Level of Evidence:  A)")
	(message_type Primary_Recommendation))

([ATHENA_HF_Class370003] of  Action_Choice

	(actions [ATHENA_HF_Class410001])
	(followed_by [KB_335875_Class1])
	(label "ICD primary prev rec Stage C stage I Astronaut II")
	(strict_rule_in_condition [ATHENA_HF_Class230004])
	(strict_rule_out_condition [KB_155357_Class77]))

([ATHENA_HF_Class370004] of  On_Screen_Message

	(label "ICD primary prev rec Stage C stage I Astronaut II msg")
	(message "ICD therapy is recommended for primary prevention of SCD to reduce total mortality in selected patients at least 40 days post-MI with LVEF of30% or less, and NYHA class I symptoms while receiving GDMT, who have reasonable expectation of meaningful survival for more than 1 year (362, 597, 598). (Level of Evidence:  B)*")
	(message_type Primary_Recommendation))

([ATHENA_HF_Class370005] of  Action_Choice

	(actions [ATHENA_HF_Class410002])
	(followed_by [KB_335875_Class1])
	(label "CRT when LVEF<=35% and NYHA Calss II III IV Astronaut II")
	(strict_rule_in_condition [KB_899077_Class0]))

([ATHENA_HF_Class370006] of  On_Screen_Message

	(label "CRT Astronaut II msg")
	(message "CRT is indicated for patients who have LVEF of 35% or less, sinus rhythm, left bundle-branch block (LBBB) with a QRS duration of 150 ms or greater, and NYHA class II, III, or ambulatory IV symptoms on GDMT. (Level of Evidence: A for NYHA class III/IV; Level of Evidence: B for NYHA class II).  ALERT:  we assumed the presence of sinus rhythm, LBBB with QRS duration of >150ms.  If these assumptions are incorrect, a CRT is not indicated.")
	(message_type Primary_Recommendation))

([ATHENA_HF_Class370007] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class370001]))

([ATHENA_HF_Class370008] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class370003]))

([ATHENA_HF_Class370009] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class370005]))

([ATHENA_HF_Class370010] of  Followed_By

	(%3AFROM [ATHENA_HF_Class370001])
	(%3ATO [KB_335875_Class1]))

([ATHENA_HF_Class370011] of  Followed_By

	(%3AFROM [ATHENA_HF_Class370005])
	(%3ATO [KB_335875_Class1]))

([ATHENA_HF_Class370012] of  Followed_By

	(%3AFROM [ATHENA_HF_Class370003])
	(%3ATO [KB_335875_Class1]))

([ATHENA_HF_Class370352] of  N_ary_Criterion

	(criteria
		[KB_567743_Class0]
		[library_Class70000]
		[library_Class70001]
		[library_Class70004])
	(label "((decision eGFR<30 or creat>=2.5male, 2.3 female) OR CKD stage 4/5) OR (angioedema as ADR to ARB) or (angioedema to ACEI) or (20% increase in creatinine after ACEI/ARB)")
	(operator OR))

([ATHENA_HF_Class370648] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class300002]
		[KB_155357_Class42]
		[KB_335875_Class24])
	(label "(creat<2.5(men) or <2.3(women) OR CKD stage 3 OR eGFR>=30")
	(operator OR))

([ATHENA_HF_Class371546] of  Conditional_On_Screen_Message

	(description "PM ARB (add or on) and pregnancy warning")
	(label "PM ARB (add or on) and pregnancy warning")
	(message "Angiotensin receptor blocker is contraindicated in pregnant women; assess pregnancy status.")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class371549]))

([ATHENA_HF_Class371547] of  Supporting_Material
)

([ATHENA_HF_Class371548] of  N_ary_Criterion

	(criteria
		[athena_hypertension_141022]
		[athena_hypertension_305979])
	(label "rec add or has active prescription for ARB")
	(operator OR))

([ATHENA_HF_Class371549] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class372081]
		[ATHENA_HF_Class372082])
	(label "women<=50 and add ARB or using ARB pregnancy warning")
	(operator OR))

([ATHENA_HF_Class372081] of  N_ary_Criterion

	(criteria
		[athena_hypertension_305979]
		[KB_502940_Class9])
	(label "women<=50 and rec ADD ARB")
	(operator AND))

([ATHENA_HF_Class372082] of  N_ary_Criterion

	(criteria
		[KB_502940_Class9]
		[athena_hypertension_141022])
	(label "women <=50 and using ARB")
	(operator AND))

([ATHENA_HF_Class380000] of  Order_TestProcedure

	(label "Order ICD Class I")
	(subsidiary_message "ICD therapy is recommended for primary prevention of SCD to reduce total mortality in selected patients at least 40 days post-MI with LVEF of30% or less, and NYHA class I symptoms while receiving GDMT, who have reasonable expectation of meaningful survival for more than 1 year (362, 597, 598). (Level of Evidence:  B)*")
	(test_or_procedure Implantable_cardioverter_defibrillator))

([ATHENA_HF_Class380470] of  Conditional_On_Screen_Message

	(description "PM Rec BB stage C HF and on other BB")
	(label "PM Rec BB stage C HF and on other BB")
	(message "Patient already has active prescription for a different beta blocker. Consider appropriateness of change to the recommended beta blocker.")
	(message_type Recommendation)
	(rule_in_condition [ATHENA_HF_Class380471]))

([ATHENA_HF_Class380471] of  N_ary_Criterion

	(criteria
		[KB_155357_Class71]
		[KB_261275_Class10])
	(label "PM Rec BB stage C HF and on other BB")
	(operator AND))

([ATHENA_HF_Class380598] of  Presence_Criterion

	(domain_term Beta_Blocker+Stage+C+Heart+Failure)
	(entry_type Medication)
	(label "Rec ADD BB stage C HF")
	(mood Recommend_Add)
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class380817] of  Conditional_On_Screen_Message

	(description "PM on nitrates and hydralazine and phosphodiesterase inhibitors")
	(label "PM on nitrates and  hydralazine and phosphodiesterase inhibitors")
	(message "Patient has active prescriptions for hydralazine, a nitrate and a phosphodiesterase inhibitor. Must discontinue either nitrate or phsophodiesterase inhibitor.")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class380818]))

([ATHENA_HF_Class380818] of  N_ary_Criterion

	(criteria
		[KB_149589_Class16]
		[library_Class40006]
		[athena_hypertension_504685])
	(label "on nitrates and  hydralazine and phosphodiesterase inhibitors")
	(operator AND))

([ATHENA_HF_Class390000] of  Conditional_On_Screen_Message

	(description "Active prescription for ACEi and 80<=SBP<110")
	(label "PM Active prescription for ACEi and 80<=SBP<110")
	(message "Patient's most recent SBP is between 80 and 110, evaluate continuing prescription for ACE inhibitor.")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class390001]))

([ATHENA_HF_Class390001] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00016]
		[library_Class30020]
		[ATHENA_HF_Class390002])
	(label "Active prescription for ACEi and 80<=SBP<110")
	(operator AND))

([ATHENA_HF_Class390002] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "SBP >= 80")
	(numeric_domain_term Systolic_BP)
	(operator %3E%3D)
	(status "active")
	(value 80.0))

([ATHENA_HF_Class390004] of  Conditional_On_Screen_Message

	(description "PM active prescription ACE inhibitor and SBP<80")
	(label ".PM active prescription ACE inhibitor and SBP<80")
	(message "Patient's most recent SBP<80, consider STOPPING ACE inhibitor.")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class390005]))

([ATHENA_HF_Class390005] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00016]
		[ATHENA_HF_Class390006])
	(label "PM active prescription ACE inhibitor and SBP<80")
	(operator AND))

([ATHENA_HF_Class390006] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "most recent SBP<80")
	(numeric_domain_term Systolic_BP)
	(operator %3C)
	(status "active")
	(value 80.0))

([ATHENA_HF_Class390007] of  Presence_Criterion

	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class390008] of  Numeric_Term_Criterion

	(aggregation_operator count)
	(entry_type Medication)
	(label "Count of BB >= 2")
	(mood Authorized)
	(numeric_domain_term Beta-Blockers)
	(operator %3E%3D)
	(status "active")
	(value 2.0))

([ATHENA_HF_Class390009] of  Numeric_Term_Criterion

	(status "active"))

([ATHENA_HF_Class390010] of  Action_Choice

	(actions [ATHENA_HF_Class390138])
	(label "presence >1 BB and one is not stage C BB")
	(strict_rule_in_condition [ATHENA_HF_Class390012]))

([ATHENA_HF_Class390012] of  N_ary_Criterion

	(criteria
		[athena_hypertension_510452]
		[KB_261275_Class10]
		[ATHENA_HF_Class390013])
	(label "presence >1 BB and one is not stage C BB")
	(operator AND))

([ATHENA_HF_Class390013] of  Presence_Criterion

	(domain_term Beta_Blocker+Stage+C+Heart+Failure)
	(entry_type Medication)
	(label "presence stage C HF BB")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class390014] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [ATHENA_HF_Class390010]))

([ATHENA_HF_Class390015] of  Conditional_On_Screen_Message

	(label "Absence labs will not rec ACEi")
	(message "Patient does not have creatinine, eGFR and/or potassium in past year. ACE could have been recommended if labs existed. Please order labs.")
	(message_type Recommendation)
	(rule_in_condition [ATHENA_HF_Class390016]))

([ATHENA_HF_Class390016] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class390017]
		[ATHENA_HF_Class390020])
	(label "absence of (creatinine or eGFR) AND K in past year")
	(operator AND))

([ATHENA_HF_Class390017] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class390018]
		[ATHENA_HF_Class390019])
	(label "absence of Creatinine and eGFR in past year")
	(operator AND))

([ATHENA_HF_Class390018] of  Presence_Criterion

	(domain_term Creatinine)
	(entry_type Numeric_Entry)
	(label "absence creatinine past year")
	(period [ATHENA_DM_Eye_Instance_30019])
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class390019] of  Presence_Criterion

	(domain_term eGFR)
	(entry_type Numeric_Entry)
	(label "absence eGFR in past year")
	(period [ATHENA_DM_Eye_Instance_30019])
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class390020] of  Presence_Criterion

	(domain_term Potassium)
	(entry_type Numeric_Entry)
	(label "absence K in past year")
	(period [ATHENA_DM_Eye_Instance_30019])
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class390136] of  PAL-QUERY

	(%3APAL-NAME "Patient is taking BB not Stage C")
	(%3APAL-RANGE "(defrange ?med :FRAME Medication)")
	(%3APAL-STATEMENT "(findall ?med (and (patient_id ?med $patient_id)\n                   (is-class (drug_name ?med))\n                   (or (not (own-slot-not-null mood ?med))\n                       (mood ?med Authorized))\n                   (subclass-of (coerce-to-class (drug_name ?med))(coerce-to-class \"Beta_blocker_not_StageC_HF\")))\n)"))

([ATHENA_HF_Class390137] of  PAL_Query

	(case_variable "$patient_id")
	(key_slot [drug_name])
	(label "patient is taking BB not stage C")
	(PAL_query [ATHENA_HF_Class390136]))

([ATHENA_HF_Class390138] of  Evaluate_Stop_Activity

	(activity_class "Medication")
	(activity_spec Drug_Usage)
	(activity_spec_key [Drug_Class_Name])
	(activity_to_stop [ATHENA_HF_Class450000])
	(label "Evalaute Stop BB not stage C"))

([ATHENA_HF_Class390139] of  Drug_Usage

	(Drug_Class_Name Beta_blocker_not_StageC_HF)
	(label "BB not Stage C HF"))

([ATHENA_HF_Class390277] of  Stop_Activity

	(activity_to_stop [ATHENA_HF_Class450000])
	(label "Stop BB not Stage C"))

([ATHENA_HF_Class390605] of  Conditional_On_Screen_Message

	(description "Add hydralazine SBP<110")
	(label "Add hydralazine SBP<110")
	(message "Would recommend add hydralazine but SBP is less than 110mmHg. Evaluate clinical significance")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class390606]))

([ATHENA_HF_Class390606] of  N_ary_Criterion

	(criteria
		[library_Class30020]
		[KB_240498_Class14]
		[ATHENA_HF_Class390607])
	(label "SBP<110, absence hydralazine and compelling indication for hydralazine")
	(operator AND))

([ATHENA_HF_Class390607] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class110014]
		[KB_261275_Class3])
	(label "compelling indications for hydralazine")
	(operator OR))

([ATHENA_HF_Class390608] of  Parameterized_Message

	(label "PM most recent SBP<110 and on hydralazine")
	(message_type Recommendation)
	(parameterized_message [ATHENA_HF_Class390610])
	(rule_in_condition [ATHENA_HF_Class390609]))

([ATHENA_HF_Class390609] of  N_ary_Criterion

	(criteria
		[library_Class40006]
		[library_Class30020])
	(label "SBP<110 and on hydralazine")
	(operator AND))

([ATHENA_HF_Class390610] of  Parameterized_String

	(label "most recent SBP<110 and on hydralazine")
	(value "Patient's most recent SBP (date ?date) was less than 110mmHg. Consider evaluating dose of hydralazine.")
	(variables [KB_212231_Class3]))

([ATHENA_HF_Class390977] of  Presence_Criterion

	(domain_term Heart_Failure_Global)
	(entry_type Note_Entry)
	(label "Presence HF global")
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class40000] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50024]
		[ATHENA_HF_Class70168]
		[ATHENA_HF_Class150004]
		[ATHENA_HF_Class70152])
	(label "African American (black) & (IF moderate or severe symptoms) & using ACE & BB")
	(operator AND))

([ATHENA_HF_Class400000] of  N_ary_Criterion

	(criteria
		[KB_155357_Class67]
		[KB_911127_Class0])
	(label "presence bb not stage C HF and absence bb stage C HF")
	(operator AND))

([ATHENA_HF_Class400001] of  N_ary_Criterion

	(criteria
		[KB_978532_Class1]
		[KB_810954_Class5]
		[KB_978532_Class0]
		[ATHENA_HF_Class300001]
		[ATHENA_HF_Class390017])
	(label "SBP>=110 AND NOT angioedema AECi AND NOT angioedema ARB and NOT 20% increase creatinine after starting ACEi/ARB")
	(operator AND))

([ATHENA_HF_Class400002] of  On_Screen_Message

	(description "Missing creatinine/eGFR might rec ACEi/ARB")
	(label "Missing creatinine/eGFR might rec ACEi/ARB")
	(message "ATHENA Heart Failure CDS may have recommended ACE inhibitor/ARB but lab values for creatinine/eGFR are missing. Please order creatinine.")
	(message_type Primary_Recommendation))

([ATHENA_HF_Class40002] of  Presence_Criterion

	(domain_term fatigue)
	(entry_type Note_Entry)
	(label "Presence of fatigue")
	(presence TRUE))

([ATHENA_HF_Class40003] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class40005]
		[ATHENA_HF_Class50004])
	(label "Not on ACEI or ARB")
	(operator OR))

([ATHENA_HF_Class40005] of  Presence_Criterion

	(domain_term ACE_Inhibitors)
	(entry_type Medication)
	(label "Not_on_ACEI")
	(mood Authorized)
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class40006] of  Start_Activity

	(activity [ATHENA_HF_Class10000])
	(label "Prescribe_ACEI"))

([ATHENA_HF_Class400732] of  Presence_Criterion

	(domain_term Palliative_care)
	(entry_type Note_Entry)
	(label "Absence of palliative care")
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class400733] of  Order_TestProcedure

	(label "Order ICD Class II III")
	(subsidiary_message "ICD therapy is recommended for primary prevention of SCD to reduce total mortality in selected patients with nonischemic DCM or ischemic heart disease at least 40 days post-MI with LVEF of 35% or less and NYHA class II or III symptoms on chronic GDMT, who have reasonable expectation of meaningful survival for more than 1 year (355, 593). (Level of Evidence:  A)")
	(test_or_procedure Implantable_cardioverter_defibrillator))

([ATHENA_HF_Class401702] of  Conditional_On_Screen_Message

	(description "add nitrates age>=70")
	(label "add nitrates age>=70")
	(message "Isosorbide dinitrate  may be eliminated more slowly in elderly patients. Initiate therapy at the low end of the dosing range.")
	(message_type Recommendation)
	(rule_in_condition [KB_155357_Class53]))

([ATHENA_HF_Class401845] of  Conditional_On_Screen_Message

	(description "add hydralazine age>=70")
	(label "add hydralazine age>=70")
	(message "Hidralazine may be eliminated more slowly in elderly patients. Initiate therapy at the low end of the dosing range.")
	(message_type Recommendation)
	(rule_in_condition [KB_155357_Class53]))

([ATHENA_HF_Class401988] of  Collateral_Action

	(actions [ATHENA_HF_Class401702])
	(mood Recommend_Add))

([ATHENA_HF_Class401990] of  Collateral_Action

	(actions [ATHENA_HF_Class401845])
	(mood Recommend_Add))

([ATHENA_HF_Class401993] of  Conditional_On_Screen_Message

	(description "PM CKD stage 4 ICD")
	(label "PM CKD stage 4 ICD")
	(message "Patient has a diagnosis of CKD stage 4. Evaluate clinical significance.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_261275_Class0]))

([ATHENA_HF_Class410000] of  Referral

	(label "Refer cardiologist ICD Class II III")
	(subsidiary_message "ICD therapy is recommended for primary prevention of SCD to reduce total mortality in selected patients with nonischemic DCM or ischemic heart disease at least 40 days post-MI with LVEF of 35% or less and NYHA class II or III symptoms on chronic GDMT, who have reasonable expectation of meaningful survival for more than 1 year (355, 593). (Level of Evidence:  A)"))

([ATHENA_HF_Class410001] of  Referral

	(label "Refer to cardiologist ICD Class I")
	(subsidiary_message "ICD therapy is recommended for primary prevention of SCD to reduce total mortality in selected patients at least 40 days post-MI with LVEF of30% or less, and NYHA class I symptoms while receiving GDMT, who have reasonable expectation of meaningful survival for more than 1 year (362, 597, 598). (Level of Evidence:  B)*"))

([ATHENA_HF_Class410002] of  Referral

	(label "Refer cardiologist CRT")
	(subsidiary_message "CRT is indicated for patients who have LVEF of 35% or less, sinus rhythm, left bundle-branch block (LBBB) with a QRS duration of 150 ms or greater, and NYHA class II, III, or ambulatory IV symptoms on GDMT. (Level of Evidence: A for NYHA class III/IV; Level of Evidence: B for NYHA class II).  ALERT:  we assumed the presence of sinus rhythm, LBBB with QRS duration of >150ms.  If these assumptions are incorrect, a CRT is not indicated."))

([ATHENA_HF_Class412268] of  N_ary_Criterion

	(criteria
		[KB_155357_Class53]
		[library_Class40006])
	(label "age>=70 and on hydralazine")
	(operator AND))

([ATHENA_HF_Class420000] of  N_ary_Criterion
)

([ATHENA_HF_Class430000] of  Presence_Criterion

	(domain_term diltiazem)
	(entry_type Medication)
	(label "diltiazem being used")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class430001] of  Presence_Criterion

	(domain_term verapamil)
	(entry_type Medication)
	(label "Presence of verapamil")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class430002] of  Query_Result_Criterion

	(label "There exists a contraindicated current med")
	(presence TRUE)
	(query [ATHENA_HF_Class430003]))

([ATHENA_HF_Class430003] of  Structured_Query

	(attribute [drug_name])
	(label "Query for contraindicated med")
	(type Medication)
	(where_restriction [ATHENA_HF_Class430004]))

([ATHENA_HF_Class430004] of  Comparison_Filter

	(attribute [drug_name])
	(label "drug name member of contraindicated drug usage")
	(operator member_of)
	(value_expression [ATHENA_HF_Class430005]))

([ATHENA_HF_Class430005] of  Structured_Query

	(attribute [Drug_Class_Name])
	(label "Drug class name of contraindicated drug usage")
	(type Drug_Usage)
	(where_restriction
		[eon2_Class60001]
		[ATHENA_HF_Class460011]))

([ATHENA_HF_Class440000] of  Presence_Criterion

	(domain_term Potassium)
	(entry_type Numeric_Entry)
	(label "absence K in past month")
	(period [ATHENA_DM_Eye_Instance_100003])
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class440002] of  Conditional_On_Screen_Message

	(description "PM: active prescription ACE Inhibitor and most recent K.5")
	(label "PM: most recent K >5")
	(message "Patient has active prescription for ACE Inhibitor and most recent K greater than 5. Monitor closely.")
	(message_type Primary_Recommendation)
	(rule_in_condition [ATHENA_HF_Class440003]))

([ATHENA_HF_Class440003] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00016]
		[library_Class30019])
	(label "active prescription ACE Inhibitor and most recent K.5")
	(operator AND))

([ATHENA_HF_Class440004] of  Conditional_On_Screen_Message

	(description "PM: On ARB and K>5")
	(label "PM: On ARB and K>5")
	(message "Patient has active prescription for and ARB and most recent K greater than 5. Monitor closely.")
	(message_type Recommendation)
	(rule_in_condition [ATHENA_HF_Class440005]))

([ATHENA_HF_Class440005] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50026]
		[library_Class30019])
	(label "active prescription for ARB and most recent K.5")
	(operator AND))

([ATHENA_HF_Class440006] of  Parameterized_Message

	(label "Most recent SBP<80 and on ARB")
	(message_type Recommendation)
	(parameterized_message [ATHENA_HF_Class440007])
	(rule_in_condition [ATHENA_HF_Class480001]))

([ATHENA_HF_Class440007] of  Parameterized_String

	(label "SBP<80 and on ARB")
	(value "Patient's most recent SBP (date ?date) was less than 80mmHg. Consider evaluating dose of angiotensin receptor blocker.")
	(variables [KB_212231_Class3]))

([ATHENA_HF_Class440008] of  Parameterized_Message

	(message_type Recommendation))

([ATHENA_HF_Class450000] of  Structured_Query

	(attribute [drug_name])
	(label "Structured Query: Patient is taking BB not stage C")
	(type Medication)
	(where_restriction [ATHENA_HF_Class450001]))

([ATHENA_HF_Class450001] of  Comparison_Filter

	(attribute [drug_name])
	(label "drug name subclass of \"BB not stage C\"")
	(operator subclass_of)
	(value_expression [Beta_blocker_not_StageC_HF]))

([ATHENA_HF_Class450002] of  Structured_Query

	(attribute [drug_name])
	(label "Structured Query: Patient taking drugs harmful to HF")
	(type Medication)
	(where_restriction [ATHENA_HF_Class450003]))

([ATHENA_HF_Class450003] of  Comparison_Filter

	(attribute [drug_name])
	(label "drug harmful to HF")
	(operator subclass_of)
	(value_expression [Harmful_to_HF]))

([ATHENA_HF_Class450004] of  Structured_Query

	(attribute [drug_name])
	(label "Query for contraindicated med in guideline")
	(type Medication)
	(where_restriction [ATHENA_HF_Class450005]))

([ATHENA_HF_Class450005] of  Comparison_Filter

	(attribute [drug_name])
	(label "drug_name member of contraindicated guideline drug usage")
	(operator member_of)
	(value_expression [ATHENA_HF_Class450006]))

([ATHENA_HF_Class450006] of  Structured_Query

	(attribute [Drug_Class_Name])
	(label "contraindicated guideline drug usage")
	(type Drug_Usage)
	(where_restriction
		[eon2_Class60001]
		[ATHENA_HF_Class450007]))

([ATHENA_HF_Class450007] of  Comparison_Filter

	(label "drug usage member of guideline drug usages")
	(operator member_of)
	(value_expression [ATHENA_HF_Class450008]))

([ATHENA_HF_Class450008] of  Structured_Query

	(attribute [drug_usages])
	(label "drug usages of \"astronaut\" HF guideline")
	(type Management_Guideline)
	(where_restriction [ATHENA_HF_Class450009]))

([ATHENA_HF_Class450009] of  Comparison_Filter

	(attribute [label])
	(label "guideline label = \"astronaut\" HF guideline")
	(operator eq)
	(value_expression [ATHENA_HF_Class450010]))

([ATHENA_HF_Class450010] of  Qualitative_Constant

	(label "ATHENA HF Astronaut")
	(value "ATHENA HF Astronaut"))

([ATHENA_HF_Class460000] of  Query_Result_Criterion

	(label "lupus as ADR to hydralazine or ACE-I")
	(presence TRUE)
	(query [ATHENA_HF_Class460001]))

([ATHENA_HF_Class460001] of  Structured_Query

	(label "lupus as ADR to hydralazine or ACE-I")
	(type Adverse_Reaction)
	(where_restriction
		[ATHENA_HF_Class460002]
		[ATHENA_HF_Class460004]))

([ATHENA_HF_Class460002] of  Comparison_Filter

	(attribute [domain_term])
	(label "domain term is Lupus")
	(operator eq)
	(value_expression [ATHENA_HF_Class460003]))

([ATHENA_HF_Class460003] of  Qualitative_Constant

	(label "Lupus")
	(value "Lupus"))

([ATHENA_HF_Class460004] of  N_aryFilter

	(filters
		[ATHENA_HF_Class460005]
		[library_Class130001])
	(label "substance is hydralazine or an ACE-I")
	(operator OR))

([ATHENA_HF_Class460005] of  Comparison_Filter

	(attribute [substance])
	(label "substance is hydralazine")
	(operator eq)
	(value_expression [ATHENA_HF_Class460006]))

([ATHENA_HF_Class460006] of  Qualitative_Constant

	(label "hydralazine")
	(value "hydralazine"))

([ATHENA_HF_Class460008] of  Query_Result_Criterion

	(label "ARB in guideline contraindicated")
	(presence TRUE)
	(query [ATHENA_HF_Class460009]))

([ATHENA_HF_Class460009] of  Structured_Query

	(label "ARB in guideline contraindicated")
	(type Drug_Usage)
	(where_restriction
		[ATHENA_HF_Class460010]
		[ATHENA_HF_Class460011]
		[eon2_Class60001]))

([ATHENA_HF_Class460010] of  Comparison_Filter

	(attribute [Drug_Class_Name])
	(label "Drug class name is ARB")
	(operator subclass_of)
	(value_expression [Angiotensin_II_receptor_blockers]))

([ATHENA_HF_Class460011] of  Comparison_Filter

	(label "Instance is a member of guideline drug usage")
	(operator member_of)
	(value_expression [ATHENA_HF_Class460012]))

([ATHENA_HF_Class460012] of  Structured_Query

	(attribute [drug_usages])
	(label "Guideline is ATHENA HF Astronaut")
	(type Management_Guideline)
	(where_restriction [ATHENA_HF_Class460013]))

([ATHENA_HF_Class460013] of  Comparison_Filter

	(attribute [label])
	(label "ATHENA HF Astronaut")
	(operator eq)
	(value_expression [ATHENA_HF_Class460014]))

([ATHENA_HF_Class460014] of  Qualitative_Constant

	(label "ATHENA HF Astronaut")
	(value "ATHENA HF Astronaut"))

([ATHENA_HF_Class460015] of  Query_Result_Criterion

	(label "ACE Inhibitor in guideline contraindicated")
	(presence TRUE)
	(query [ATHENA_HF_Class460016]))

([ATHENA_HF_Class460016] of  Structured_Query

	(label "ACE Inhibitor in guideline contraindicated")
	(type Drug_Usage)
	(where_restriction
		[ATHENA_HF_Class460017]
		[eon2_Class60001]
		[ATHENA_HF_Class460011]))

([ATHENA_HF_Class460017] of  Comparison_Filter

	(attribute [Drug_Class_Name])
	(label "Drug class name is or a subclass of ACE-I")
	(operator subclass_of)
	(value_expression [ACE_Inhibitors]))

([ATHENA_HF_Class460018] of  Query_Result_Criterion

	(label "Isosorbide dinitrate in guideline contraindicated")
	(presence TRUE)
	(query [ATHENA_HF_Class460019]))

([ATHENA_HF_Class460019] of  Structured_Query

	(label "Isosorbide dinitrate in guideline contraindicated")
	(type Drug_Usage)
	(where_restriction
		[eon2_Class60001]
		[ATHENA_HF_Class460011]
		[ATHENA_HF_Class460020]))

([ATHENA_HF_Class460020] of  Comparison_Filter

	(attribute [Drug_Class_Name])
	(label "Drug class name is Isosorbide dinitrate")
	(operator subclass_of)
	(value_expression [Isosorbide_dinitrate]))

([ATHENA_HF_Class460021] of  Query_Result_Criterion

	(label "Aldosterone antagonist in guideline contraindicated")
	(presence TRUE)
	(query [ATHENA_HF_Class460024]))

([ATHENA_HF_Class460022] of  Query_Result_Criterion

	(label "Hydralazine in guideline contraindicated")
	(presence TRUE)
	(query [ATHENA_HF_Class460026]))

([ATHENA_HF_Class460023] of  Query_Result_Criterion

	(label "BB Stage C in guideline contraindicated")
	(presence TRUE)
	(query [ATHENA_HF_Class460025]))

([ATHENA_HF_Class460024] of  Structured_Query

	(label "Aldosterone antagonist in guideline contraindicated")
	(type Drug_Usage)
	(where_restriction
		[eon2_Class60001]
		[ATHENA_HF_Class460011]
		[ATHENA_HF_Class460027]))

([ATHENA_HF_Class460025] of  Structured_Query

	(label "BB Stage C in guideline contraindicated")
	(type Drug_Usage)
	(where_restriction
		[ATHENA_HF_Class460017]
		[eon2_Class60001]
		[ATHENA_HF_Class460011]
		[ATHENA_HF_Class460028]))

([ATHENA_HF_Class460026] of  Structured_Query

	(label "Hydralazine in guideline contraindicated")
	(type Drug_Usage)
	(where_restriction
		[eon2_Class60001]
		[ATHENA_HF_Class460011]
		[ATHENA_HF_Class460029]))

([ATHENA_HF_Class460027] of  Comparison_Filter

	(attribute [Drug_Class_Name])
	(label "Drug class name is or a subclass of Aldosterone antagonist")
	(operator subclass_of)
	(value_expression [aldosterone+antagonist]))

([ATHENA_HF_Class460028] of  Comparison_Filter

	(attribute [Drug_Class_Name])
	(label "Drug class name is BB Stage C")
	(operator subclass_of)
	(value_expression [Beta_Blocker+Stage+C+Heart+Failure]))

([ATHENA_HF_Class460029] of  Comparison_Filter

	(attribute [Drug_Class_Name])
	(label "Drug class name is Hydralazine")
	(operator subclass_of)
	(value_expression [hydralazine]))

([ATHENA_HF_Class470000] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class210005]
		[athena_runtime_15046]
		[KB_261275_Class2])
	(label "Absence ACEI AND ARB AND CKD stage 4/5 or eGFR<30)")
	(operator AND))

([ATHENA_HF_Class470001] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class210005]
		[athena_runtime_15046]
		[library_Class30020])
	(label "Absence ACE AND ARB AND SBP<110")
	(operator AND))

([ATHENA_HF_Class470002] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class210005]
		[athena_runtime_15046]
		[ATHENA_HF_Class140014]
		[athena_hypertension_203766])
	(label "Absence ACEI AND ARB AND ADR ACEI AND ADR ARB")
	(operator AND))

([ATHENA_HF_Class470407] of  Variable

	(derivation_expression [ATHENA_HF_Class460016])
	(label "Drug usage ACE contraindicated")
	(string_name "ACE_contraindicated"))

([ATHENA_HF_Class470408] of  Variable

	(derivation_expression [ATHENA_HF_Class460008])
	(label "Drug usage ARB contraindicated")
	(string_name "ARB_contraindicated"))

([ATHENA_HF_Class470409] of  Variable

	(derivation_expression [ATHENA_HF_Class460021])
	(label "Drug usage Aldosterone contraindicated")
	(string_name "Aldosterone_contraindicated"))

([ATHENA_HF_Class470410] of  Variable

	(derivation_expression [ATHENA_HF_Class460022])
	(label "Drug usage Hydralazine contraindicated")
	(string_name "Hydralazine_contraindicated"))

([ATHENA_HF_Class470411] of  Variable

	(derivation_expression [ATHENA_HF_Class460023])
	(label "Drug usage BB Stage C contraindicated")
	(string_name "BBStageC_contraindicated"))

([ATHENA_HF_Class470412] of  Variable

	(derivation_expression [library_Class120000])
	(label "Angio to ACE")
	(string_name "AngioACE"))

([ATHENA_HF_Class470413] of  Variable

	(derivation_expression [library_Class140004])
	(label "Angio to ARB")
	(string_name "AngioARB"))

([ATHENA_HF_Class470414] of  Variable

	(derivation_expression [ATHENA_HF_Class460000])
	(label "LupusToHydralazine")
	(string_name "LupusToHydralazine"))

([ATHENA_HF_Class470929] of  Variable

	(derivation_expression [ATHENA_HF_Class430003])
	(label "Constraindicated meds")
	(string_name "Contraindicated meds"))

([ATHENA_HF_Class480000] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "SBP<80")
	(numeric_domain_term Systolic_BP)
	(operator %3C)
	(value 80.0))

([ATHENA_HF_Class480001] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class480000]
		[ATHENA_HF_Class50026])
	(label "on ARB and SBP<80")
	(operator AND))

([ATHENA_HF_Class480002] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00016]
		[ATHENA_HF_Class280001])
	(label "angioedema ARB and active prescription ACEI")
	(operator AND))

([ATHENA_HF_Class490000] of  N_ary_Criterion

	(criteria
		[library_Class100000]
		[ATHENA_HF_Class490001])
	(label "Decision eGFR present & >30")
	(operator AND))

([ATHENA_HF_Class490001] of  Expression_Comparison_Criterion

	(expression [library_Class110008])
	(label "Most recent \"decision\"  eGFR  > 30")
	(operator %3E)
	(variable [library_Class110007]))

([ATHENA_HF_Class50000] of  Consultation_Guideline

	(first_step [ATHENA_HF_Class50001])
	(label "Stage A consultation messages")
	(steps
		[ATHENA_HF_Class50001]
		[ATHENA_HF_Class50002]
		[ATHENA_HF_Class50003]
		[ATHENA_HF_Class60006]
		[ATHENA_HF_Class60007]
		[ATHENA_HF_Class70008]
		[ATHENA_HF_Class70009]
		[ATHENA_HF_Class70010]
		[ATHENA_HF_Class70011]
		[ATHENA_HF_Class70012]
		[ATHENA_HF_Class110411])
	(transitions
		[ATHENA_HF_Class60004]
		[ATHENA_HF_Class60005]
		[ATHENA_HF_Class70013]
		[ATHENA_HF_Class70014]
		[ATHENA_HF_Class70015]
		[ATHENA_HF_Class70016]
		[ATHENA_HF_Class70017]
		[ATHENA_HF_Class70018]
		[ATHENA_HF_Class70019]
		[ATHENA_HF_Class110413]))

([ATHENA_HF_Class500000] of  N_ary_Criterion

	(criteria
		[library_Class70001]
		[ATHENA_HF_Class50026])
	(label "angioedema to ACEI and active prescription ARB")
	(operator AND))

([ATHENA_HF_Class50001] of  Consultation_Branch_Step

	(branches
		[ATHENA_HF_Class50002]
		[ATHENA_HF_Class50003]
		[ATHENA_HF_Class70009]
		[ATHENA_HF_Class60006]
		[ATHENA_HF_Class70008]
		[ATHENA_HF_Class60007]
		[ATHENA_HF_Class70010]
		[ATHENA_HF_Class70012]
		[ATHENA_HF_Class70011]
		[ATHENA_HF_Class110411])
	(label "Stage A messages")
	(selection_method all_of))

([ATHENA_HF_Class50002] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class70020])
	(label "Hypertension control")
	(rule_in [criterion_INSTANCE_00001])
	(rule_out [ATHENA_HF_Class50043]))

([ATHENA_HF_Class50003] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class70021])
	(label "Lipid disorder control")
	(rule_in [criterion_INSTANCE_00001])
	(rule_out [ATHENA_HF_Class50043]))

([ATHENA_HF_Class50004] of  Presence_Criterion

	(domain_term Angiotensin_II_receptor_blockers)
	(entry_type Medication)
	(label "Not on ARB")
	(mood Authorized)
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class50007] of  Evaluate_Start_Activity

	(label "Add Beta Blocker"))

([ATHENA_HF_Class50008] of  Start_Activity

	(label "Add Beta blocker"))

([ATHENA_HF_Class50009] of  Action_Choice

	(actions
		[ATHENA_HF_Class50051]
		[ATHENA_HF_Class50061]
		[ATHENA_HF_Class50052]
		[ATHENA_HF_Class50058]
		[ATHENA_HF_Class50062]
		[ATHENA_HF_Class50065]
		[ATHENA_HF_Class120883]
		[ATHENA_HF_Class110348]
		[ATHENA_HF_Class110350])
	(label "Stage B HF action")
	(strict_rule_in_condition [criterion_INSTANCE_00001]))

([ATHENA_HF_Class50011] of  Presence_Criterion

	(domain_term Myocardial_Infarction)
	(entry_type Note_Entry)
	(label "Presence of MI")
	(presence TRUE))

([ATHENA_HF_Class50012] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50011]
		[ATHENA_HF_Class40003])
	(label "Previous MI and no ACEI (or ARB)")
	(operator AND))

([ATHENA_HF_Class50013] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50011]
		[ATHENA_HF_Class30002])
	(label "Previous MI and no beta blocker")
	(operator AND))

([ATHENA_HF_Class50014] of  Followed_By

	(%3AFROM [ATHENA_HF_Class30009])
	(%3ATO [ATHENA_HF_Class50009]))

([ATHENA_HF_Class50017] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50018]
		[ATHENA_HF_Class50019])
	(label "LVEF < 35 (?) and no MI")
	(operator AND))

([ATHENA_HF_Class50018] of  Presence_Criterion

	(domain_term Myocardial_Infarction)
	(entry_type Note_Entry)
	(label "Absence of MI")
	(presence FALSE))

([ATHENA_HF_Class50019] of  Numeric_Term_Criterion

	(entry_type Numeric_Entry)
	(label "LVEF <= 40")
	(numeric_domain_term Left+Ventricular+Ejection+fraction)
	(operator %3C%3D)
	(value 40.0))

([ATHENA_HF_Class50020] of  Presence_Criterion

	(domain_term Beta-Blockers)
	(entry_type Medication)
	(label "Absence of beta blocker")
	(mood Authorized)
	(presence FALSE)
	(status "active"))

([ATHENA_HF_Class50024] of  Presence_Criterion

	(domain_term ACE_Inhibitors)
	(entry_type Medication)
	(label "Presence of ACE Inhibitor")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class50025] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50024]
		[ATHENA_HF_Class50026])
	(label "Presence of ACEI or ARB")
	(operator OR))

([ATHENA_HF_Class50026] of  Presence_Criterion

	(domain_term Angiotensin_II_receptor_blockers)
	(entry_type Medication)
	(label "Presence of ARB")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class50030] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50031]
		[ATHENA_HF_Class50032])
	(label "HTN and LVH")
	(operator AND))

([ATHENA_HF_Class50031] of  Presence_Criterion

	(domain_term Hypertension_Inclusive)
	(entry_type Note_Entry)
	(label "Presence of hypertension")
	(presence TRUE))

([ATHENA_HF_Class50032] of  Presence_Criterion

	(domain_term LVH)
	(entry_type Note_Entry)
	(label "Presence of LVH")
	(presence TRUE))

([ATHENA_HF_Class50035] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50011]
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50036]
		[ATHENA_HF_Class60088]
		[ATHENA_HF_Class60054]
		[KB_412386_Class1])
	(label "NO HF, MI, LVEF<=40 and ADR ACE")
	(operator AND))

([ATHENA_HF_Class50036] of  Presence_Criterion

	(domain_term ACE_Inhibitors)
	(entry_type Adverse_Reaction)
	(label "Adverse Reaction to ACEI")
	(presence TRUE))

([ATHENA_HF_Class50037] of  Drug_Usage

	(collateral_actions [ATHENA_HF_Class110360])
	(Compelling_Indications
		Myocardial_Infarction
		LVEF%3C%3D40+and+no+HF+symptoms
		HF+%28ICD9+or+symptoms%29+and+LVEF%3C%3D40)
	(Drug_Class_Name Beta-Blockers)
	(formulary_preferred_drug_in_class
		[ATHENA_HF_Class50092]
		[ATHENA_HF_Class50093]
		[ATHENA_HF_Class50094])
	(label "Beta Blocker"))

([ATHENA_HF_Class50039] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50036]
		[ATHENA_HF_Class210005])
	(label "LVEF <=40 and intolerant ACE")
	(operator AND))

([ATHENA_HF_Class50040] of  Guideline_Drug

	(collateral_actions
		[ATHENA_HF_Class110354]
		[ATHENA_HF_Class110359])
	(dose_level_ranges [ATHENA_HF_Class50041])
	(drug_usage [ATHENA_HF_Class10000])
	(generic_drug lisinopril)
	(label "Lisinopril old")
	(max_recommended_dose_level High_Dose%28high%2Flow%29)
	(rule_in [ATHENA_HF_Class50011])
	(starting_dose 2.5))

([ATHENA_HF_Class50041] of  Range_Mapping_Entry

	(abstract_value High_Dose%28high%2Flow%29)
	(lower_limit 2.5)
	(upper_limit 20.0))

([ATHENA_HF_Class50042] of  Guideline_Drug

	(collateral_actions
		[ATHENA_HF_Class110356]
		[ATHENA_HF_Class110358])
	(dose_level_ranges [ATHENA_HF_Class50044])
	(generic_drug enalapril)
	(label "Enalapril")
	(max_recommended_dose_level High_Dose%28high%2Flow%29)
	(rule_in [ATHENA_HF_Class50043])
	(starting_dose 5.0))

([ATHENA_HF_Class50043] of  Presence_Criterion

	(domain_term Heart_Failure)
	(entry_type Note_Entry)
	(label "Presence of HF HTN")
	(presence TRUE))

([ATHENA_HF_Class50044] of  Range_Mapping_Entry

	(abstract_value High_Dose%28high%2Flow%29)
	(lower_limit 5.0)
	(upper_limit 20.0))

([ATHENA_HF_Class50045] of  Drug_Usage

	(Absolute_Contraindications
		Heart_Failure
		LVEF%3C%3D40+and+no+HF+symptoms
		Myocardial_Infarction
		HF+%28ICD9+or+symptoms%29+and+LVEF%3C%3D40)
	(Drug_Class_Name Non-Dihydropyridines)
	(label "NDHP CCB"))

([ATHENA_HF_Class50046] of  Drug_Usage

	(Absolute_Contraindications LVEF%3C%3D40+and+sinus+rhythm+and+Stage+B+and+absence+HF+symptoms)
	(collateral_actions [ATHENA_HF_Class110370])
	(Drug_Class_Name digoxin)
	(label "Digoxin")
	(Relative_Indications HF+%28ICD9+or+symptoms%29+and+LVEF%3C%3D40))

([ATHENA_HF_Class50048] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50049]
		[ATHENA_HF_Class10007]
		[ATHENA_HF_Class60054]
		[ATHENA_HF_Class60088])
	(label "LVEF<=40 and sinus shythm and Stage B and absence HF symptoms")
	(operator AND))

([ATHENA_HF_Class50049] of  Presence_Criterion

	(domain_term sinus+rhythm)
	(entry_type Note_Entry)
	(label "sinus rhythm")
	(presence TRUE))

([ATHENA_HF_Class50050] of  Presence_Criterion

	(domain_term Stage+B+Heart+Failure)
	(entry_type Note_Entry)
	(label "Stage B HF")
	(presence TRUE))

([ATHENA_HF_Class50051] of  Evaluate_Start_Activity

	(alternatives
		[ATHENA_HF_Class10000]
		[ATHENA_HF_Class30018]
		[ATHENA_HF_Class50046]
		[ATHENA_HF_Class50045]
		[ATHENA_HF_Class70001]
		[ATHENA_HF_Class80000])
	(label "Evaluate drugs for stage B HF"))

([ATHENA_HF_Class50052] of  Conditional_On_Screen_Message

	(label "Refer cardiology for ICD (ischemic cardiomyopathy)")
	(message "Placement of an ICD is reasonable in patients with ischemic cardiomyopathy who are at least 40 days post-MI, have an LVEF of 30% or less, are NYHA functional class I on chronic optimal medical therapy, and have reasonable expectation of survival with a good functional status for more than 1 year. \nIf this is the case, refer to cardiology.")
	(message_type Class+II+a)
	(rule_in_condition [ATHENA_HF_Class50053]))

([ATHENA_HF_Class50053] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50054]
		[ATHENA_HF_Class50055]
		[ATHENA_HF_Class90384]
		[ATHENA_HF_Class122379]
		[ATHENA_HF_Class50011])
	(label "ischemic heart disease and LVEF<=30 and >40d postMI and NYHA functional class I")
	(operator AND))

([ATHENA_HF_Class50054] of  Numeric_Term_Criterion

	(entry_type Numeric_Entry)
	(label "LVEF<=30")
	(numeric_domain_term Left+Ventricular+Ejection+fraction)
	(operator %3C%3D)
	(value 30.0))

([ATHENA_HF_Class50055] of  Presence_Criterion

	(domain_term Ischemic+Heart+Disease)
	(entry_type Note_Entry)
	(label "presence of ischemic heart disease")
	(presence TRUE))

([ATHENA_HF_Class50057] of  Relative_Time_Interval_Definite

	(how_many "41")
	(label "41days before today")
	(polarity Before)
	(relative_time_point [time%3AINSTANCE_1])
	(time_unit day))

([ATHENA_HF_Class50058] of  Conditional_On_Screen_Message

	(label "Refer cardiology for ICD (non-ischemic cardiomyopathy)")
	(message "Placement of an ICD might be considered in patients without HF who have nonischemic cardiomyopathy and an LVEF less than or equal to 30% who are in NYHA functional class I with chronic optimal medical therapy and have a reasonable expectation of survival with good functional status for more than 1 year.\nIf this is the case refer to cardiology.")
	(message_type Class+II+b)
	(rule_in_condition [ATHENA_HF_Class50059]))

([ATHENA_HF_Class50059] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50054]
		[ATHENA_HF_Class50060])
	(label "non-ischemic cardiomyopathy and LVEF<=30")
	(operator AND))

([ATHENA_HF_Class50060] of  N_ary_Criterion

	(criteria [ATHENA_HF_Class50032])
	(label "non-ischemic cardiomyopathy")
	(operator AND))

([ATHENA_HF_Class50061] of  On_Screen_Message

	(label "nutritional supplements")
	(message "Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.")
	(message_type Class+III))

([ATHENA_HF_Class50062] of  Conditional_On_Screen_Message

	(label "valvular disease")
	(message "Valve replacement or repair should be recommended for patients with hemodynamically significant valvular stenosis or regurgitation and no symptoms of HF in accordance with contemporary guidelines.")
	(message_type Class+I)
	(rule_in_condition [ATHENA_HF_Class50063]))

([ATHENA_HF_Class50063] of  Presence_Criterion

	(domain_term Valvular+heart+disease)
	(entry_type Note_Entry)
	(label "presence of valvular disease")
	(presence TRUE))

([ATHENA_HF_Class50065] of  Conditional_On_Screen_Message

	(label "coronary revascularization")
	(message "Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).")
	(message_type Class+I)
	(rule_in_condition [ATHENA_HF_Class50055]))

([ATHENA_HF_Class50067] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50036]
		[ATHENA_HF_Class240003])
	(label "Stage C and EF<=40 and ADR ACE")
	(operator AND))

([ATHENA_HF_Class50068] of  Presence_Criterion

	(domain_term Stage+C+Heart+Failure)
	(entry_type Note_Entry)
	(label "Stage C HF")
	(presence TRUE))

([ATHENA_HF_Class50069] of  Drug_Usage

	(Absolute_Contraindications Heart_Failure)
	(Drug_Class_Name cardiotoxic+interventions)
	(label "cardiotoxic drugs"))

([ATHENA_HF_Class50074] of  Consultation_Guideline

	(first_step [ATHENA_HF_Class50075])
	(label "Stage C consultation template")
	(steps
		[ATHENA_HF_Class50075]
		[ATHENA_HF_Class50076]
		[ATHENA_HF_Class50079]
		[ATHENA_HF_Class50084]
		[ATHENA_HF_Class70011]
		[ATHENA_HF_Class70012]
		[ATHENA_HF_Class70008]
		[ATHENA_HF_Class70009]
		[ATHENA_HF_Class70010]
		[ATHENA_HF_Class50002]
		[ATHENA_HF_Class50003]
		[ATHENA_HF_Class60006]
		[ATHENA_HF_Class60007]
		[ATHENA_HF_Class110384]
		[ATHENA_HF_Class110390])
	(transitions
		[ATHENA_HF_Class50077]
		[ATHENA_HF_Class50080]
		[ATHENA_HF_Class60000]
		[ATHENA_HF_Class60001]
		[ATHENA_HF_Class60002]
		[ATHENA_HF_Class60003]
		[ATHENA_HF_Class70004]
		[ATHENA_HF_Class70005]
		[ATHENA_HF_Class70006]
		[ATHENA_HF_Class70007]
		[ATHENA_HF_Class80008]
		[ATHENA_HF_Class110386]
		[ATHENA_HF_Class110387]
		[ATHENA_HF_Class110391]))

([ATHENA_HF_Class50075] of  Consultation_Branch_Step

	(branches
		[ATHENA_HF_Class50076]
		[ATHENA_HF_Class50079]
		[ATHENA_HF_Class70011]
		[ATHENA_HF_Class70012]
		[ATHENA_HF_Class70008]
		[ATHENA_HF_Class70010]
		[ATHENA_HF_Class70009]
		[ATHENA_HF_Class60007]
		[ATHENA_HF_Class60006]
		[ATHENA_HF_Class50003]
		[ATHENA_HF_Class50002]
		[ATHENA_HF_Class110384]
		[ATHENA_HF_Class50084]
		[ATHENA_HF_Class110390])
	(label "Stage C HF")
	(selection_method all_of))

([ATHENA_HF_Class50076] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class50078])
	(label "Fluid management"))

([ATHENA_HF_Class50077] of  Followed_By

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class50076]))

([ATHENA_HF_Class50078] of  On_Screen_Message

	(label "Fluid management")
	(message_type Recommendation))

([ATHENA_HF_Class50079] of  Consultation_Action_Step

	(actions
		[ATHENA_HF_Class50081]
		[ATHENA_HF_Class50082]
		[ATHENA_HF_Class50083])
	(label "Serial assessments"))

([ATHENA_HF_Class50080] of  Followed_By

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class50079]))

([ATHENA_HF_Class50081] of  On_Screen_Message

	(description "Class I")
	(label "Assess activities of daily living")
	(message "Assess ability of patient to perform routine and desired activities of daily living. (Level of Evidence: C)")
	(message_type Recommendation))

([ATHENA_HF_Class50082] of  On_Screen_Message

	(description "Class I")
	(label "Assess volume status")
	(message "Assess volume status and weight. (Level of Evidence: C)")
	(message_type Recommendation))

([ATHENA_HF_Class50083] of  On_Screen_Message

	(description "Class I")
	(label "Assess use cardiotoxic drugs and behaviors")
	(message "Assess current use of alcohol, tobacco, illicit drugs, “alternative therapies,” and chemotherapy drugs, as well as diet and sodium intake. (Level of Evidence: C)")
	(message_type Recommendation))

([ATHENA_HF_Class50084] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class50086])
	(label "Repeat Echocardiogram"))

([ATHENA_HF_Class50086] of  On_Screen_Message

	(description "Class IIa")
	(label "Repeat Echocardiogram")
	(message "Repeat echocardiogram can provide useful information in patients with HF who have had a change in clinical status or who have experienced or recovered from a clinical event or received treatment that might have had a significant effect on cardiac function. (Level of Evidence: C)")
	(message_type Recommendation))

([ATHENA_HF_Class50087] of  Choice_Step

	(branches
		[ATHENA_HF_Class50089]
		[ATHENA_HF_Class50097]
		[ATHENA_HF_Class50009])
	(label " "))

([ATHENA_HF_Class50088] of  Followed_By

	(%3AFROM [ATHENA_HF_Class10004])
	(%3ATO [ATHENA_HF_Class50087]))

([ATHENA_HF_Class50089] of  Action_Choice

	(actions
		[ATHENA_HF_Class50096]
		[ATHENA_HF_Class70139]
		[ATHENA_HF_Class70140]
		[ATHENA_HF_Class70170]
		[ATHENA_HF_Class70173]
		[ATHENA_HF_Class70188]
		[ATHENA_HF_Class70193]
		[ATHENA_HF_Class70197]
		[ATHENA_HF_Class70199]
		[ATHENA_HF_Class100847]
		[ATHENA_HF_Class110823]
		[ATHENA_HF_Class124168]
		[ATHENA_HF_Class110363]
		[ATHENA_HF_Class110366]
		[ATHENA_HF_Class110368]
		[ATHENA_HF_Class100014]
		[ATHENA_HF_Class100015]
		[KB_261747_Class0])
	(label "General Recommendations")
	(strict_rule_in_condition [ATHENA_HF_Class70622]))

([ATHENA_HF_Class50090] of  Followed_By

	(%3AFROM [ATHENA_HF_Class50087])
	(%3ATO [ATHENA_HF_Class50089]))

([ATHENA_HF_Class50091] of  On_Screen_Message

	(label "Fluid management")
	(message "Diuretics and salt restriction are indicated if there is evidence of fluid retention. (Level of Evidence: C)")
	(message_type Class+I))

([ATHENA_HF_Class50092] of  Guideline_Drug

	(dose_strength_unit mg)
	(drug_usage [ATHENA_HF_Class50037])
	(generic_drug sustained+release+metoprolol+succinate)
	(label "Sustained release metoprolol succinate")
	(starting_dose 12.5))

([ATHENA_HF_Class50093] of  Guideline_Drug

	(generic_drug carvedilol)
	(label "Carvedilol")
	(starting_dose 6.25))

([ATHENA_HF_Class50094] of  Guideline_Drug

	(drug_usage [ATHENA_HF_Class50037])
	(generic_drug bisoprolol)
	(label "Bisoprolol")
	(starting_dose 1.25))

([ATHENA_HF_Class50096] of  On_Screen_Message

	(label "Exercise")
	(message "Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)")
	(message_type Class+I))

([ATHENA_HF_Class50097] of  Action_Choice

	(actions
		[ATHENA_HF_Class50099]
		[ATHENA_HF_Class50108])
	(label "Referrals")
	(strict_rule_in_condition [criterion_INSTANCE_00001]))

([ATHENA_HF_Class50098] of  Followed_By

	(%3AFROM [ATHENA_HF_Class50087])
	(%3ATO [ATHENA_HF_Class50097]))

([ATHENA_HF_Class50099] of  Conditional_On_Screen_Message

	(description "Class I")
	(label "ICD secondary prevention")
	(message "Patient has an indication for an implantable cardioverter-defibrillator, refer to cardiology.\n (Level of Evidence: A)")
	(message_type Recommendation)
	(rule_in_condition [ATHENA_HF_Class50104]))

([ATHENA_HF_Class50100] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50101]
		[ATHENA_HF_Class50102]
		[ATHENA_HF_Class50103])
	(label "ventricularfibrillation, cardiac arrest or hemodynamically destabilizing ventricular tachycardia")
	(operator OR))

([ATHENA_HF_Class50101] of  Presence_Criterion

	(domain_term cardiac+arrest)
	(entry_type Note_Entry)
	(label "presence of cardiac arrest")
	(presence TRUE))

([ATHENA_HF_Class50102] of  Presence_Criterion

	(domain_term ventricular+fibrillation)
	(entry_type Note_Entry)
	(label "presence of ventricular fibrillation")
	(presence TRUE))

([ATHENA_HF_Class50103] of  Presence_Criterion

	(domain_term hemodynamically+destabilizing+ventricular+tachycardia)
	(entry_type Note_Entry)
	(label "presence of hemodynamically destabilizing ventricular tachycardia")
	(presence TRUE))

([ATHENA_HF_Class50104] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50100]
		[ATHENA_HF_Class30004])
	(label "HF and EF<35 and presence of ventricular tachycardia, cardiac arrest or hemodynamically destabilizing ventricular tachycardi")
	(operator AND))

([ATHENA_HF_Class50105] of  Parameterized_Message

	(label "Indication for ICD")
	(message_type Recommendation))

([ATHENA_HF_Class50108] of  Referral

	(description "Class I")
	(label "Refer to cardiology - ICD")
	(rule_in_condition [ATHENA_HF_Class50104])
	(subsidiary_message "Recommend ICD")
	(who_to cardiologist))

([ATHENA_HF_Class60000] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class70011]))

([ATHENA_HF_Class60001] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class70012]))

([ATHENA_HF_Class60002] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class70008]))

([ATHENA_HF_Class60003] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class70010]))

([ATHENA_HF_Class60004] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50001])
	(%3ATO [ATHENA_HF_Class50002]))

([ATHENA_HF_Class60005] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50001])
	(%3ATO [ATHENA_HF_Class50003]))

([ATHENA_HF_Class60006] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class70028])
	(label "LV function evaluation")
	(rule_in [ATHENA_HF_Class70032]))

([ATHENA_HF_Class60007] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class70026])
	(label "Periodic evaluation")
	(rule_in [criterion_INSTANCE_00001])
	(rule_out [ATHENA_HF_Class50043]))

([ATHENA_HF_Class60012] of  Presence_Criterion

	(domain_term Angiotensin_II_receptor_blockers)
	(entry_type Adverse_Reaction)
	(label "Presence of adverse reaction to ARB")
	(presence TRUE))

([ATHENA_HF_Class60014] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50036]
		[ATHENA_HF_Class60012]
		[ATHENA_HF_Class60015]
		[ATHENA_HF_Class60016])
	(label "drug intolerance ACE/ARB OR hypotension OR renal insufficienc")
	(operator OR))

([ATHENA_HF_Class60015] of  Presence_Criterion

	(domain_term Renal_Insufficiency)
	(entry_type Note_Entry)
	(label "presence of renal insufficiency ICD9")
	(presence TRUE))

([ATHENA_HF_Class60016] of  Presence_Criterion

	(domain_term hypotension)
	(entry_type Note_Entry)
	(label "presence of hypotension")
	(presence TRUE))

([ATHENA_HF_Class60044] of  Presence_Criterion

	(domain_term Valvular+heart+disease)
	(entry_type Note_Entry)
	(label "Presence of valvular disease")
	(presence TRUE))

([ATHENA_HF_Class60053] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class10007]
		[ATHENA_HF_Class60054]
		[ATHENA_HF_Class60088])
	(label "Criteria for Stage B HF")
	(operator AND))

([ATHENA_HF_Class60054] of  Presence_Criterion

	(domain_term HF+signs+and+symptoms)
	(entry_type Note_Entry)
	(label "Absence of HF signs and symptoms")
	(presence FALSE))

([ATHENA_HF_Class60066] of  Choice_Step

	(branches [ATHENA_HF_Class60069])
	(label " "))

([ATHENA_HF_Class60067] of  Followed_By

	(%3AFROM [ATHENA_HF_Class10005])
	(%3ATO [ATHENA_HF_Class60066]))

([ATHENA_HF_Class60068] of  Choice_Step

	(branches [ATHENA_HF_Class30017])
	(label " "))

([ATHENA_HF_Class60069] of  Action_Choice

	(label "Stage D management action"))

([ATHENA_HF_Class60070] of  Followed_By

	(%3AFROM [ATHENA_HF_Class60068])
	(%3ATO [ATHENA_HF_Class30017]))

([ATHENA_HF_Class60071] of  Followed_By

	(%3AFROM [ATHENA_HF_Class60066])
	(%3ATO [ATHENA_HF_Class60069]))

([ATHENA_HF_Class60072] of  Presence_Criterion

	(domain_term HF+signs+and+symptoms)
	(entry_type Note_Entry)
	(label "Presence of HF signs and symptoms")
	(presence TRUE))

([ATHENA_HF_Class60088] of  Presence_Criterion

	(domain_term Heart_Failure)
	(entry_type Note_Entry)
	(label "Absence of HF")
	(presence FALSE))

([ATHENA_HF_Class70000] of  Drug_Usage

	(Compelling_Indications HF+%28HF+global+ICD+or+Symptoms%29+and+LVEF%3C%3D40+and+no+MI)
	(Drug_Class_Name Beta_Blocker+Stage+C+Heart+Failure)
	(formulary_preferred_drug_in_class
		[ATHENA_HF_Class50094]
		[ATHENA_HF_Class50092]
		[ATHENA_HF_Class50093])
	(label "DO NOT USE Beta blocker Stage C HF no MI"))

([ATHENA_HF_Class70001] of  Drug_Usage

	(Absolute_Contraindications Bronchospastic_Disease)
	(Compelling_Indications MI+no+HF)
	(Drug_Class_Name Beta+blocker+stage+B+post+MI)
	(formulary_preferred_drug_in_class
		[athena_runtime_INSTANCE_00110]
		[ATHENA_HF_Class50093]
		[ATHENA_HF_Class80002]
		[athena_runtime_INSTANCE_00112]
		[ATHENA_HF_Class80004])
	(label "Beta blocker Stage B HF post MI"))

([ATHENA_HF_Class70002] of  Presence_Criterion

	(domain_term Persistent+HF+signs+and+symptoms)
	(entry_type Note_Entry)
	(label "presence of persistent HF signs and symptoms")
	(presence TRUE))

([ATHENA_HF_Class70004] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class70009]))

([ATHENA_HF_Class70005] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class60007]))

([ATHENA_HF_Class70006] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class60006]))

([ATHENA_HF_Class70007] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class50003]))

([ATHENA_HF_Class70008] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class70027])
	(label "atherosclerotic vascular disease control")
	(rule_in [ATHENA_HF_Class70033])
	(rule_out [ATHENA_HF_Class50043]))

([ATHENA_HF_Class70009] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class70023])
	(label "behavior control")
	(rule_in [criterion_INSTANCE_00001])
	(rule_out [ATHENA_HF_Class50043]))

([ATHENA_HF_Class70010] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class70022])
	(label "Blood sugar control")
	(rule_in [ATHENA_DM_Eye_Instance_40003])
	(rule_out [ATHENA_HF_Class50043]))

([ATHENA_HF_Class70011] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class70025])
	(label "Thyroid disorder control;")
	(rule_in [ATHENA_HF_Class70034])
	(rule_out [ATHENA_HF_Class50043]))

([ATHENA_HF_Class70012] of  Consultation_Action_Step

	(actions [ATHENA_HF_Class70024])
	(label "Ventricular rate/sinus rhythm  control")
	(rule_in [ATHENA_HF_Class70035])
	(rule_out [ATHENA_HF_Class50043]))

([ATHENA_HF_Class70013] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50001])
	(%3ATO [ATHENA_HF_Class70009]))

([ATHENA_HF_Class70014] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50001])
	(%3ATO [ATHENA_HF_Class60006]))

([ATHENA_HF_Class70015] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50001])
	(%3ATO [ATHENA_HF_Class70008]))

([ATHENA_HF_Class70016] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50001])
	(%3ATO [ATHENA_HF_Class60007]))

([ATHENA_HF_Class70017] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50001])
	(%3ATO [ATHENA_HF_Class70010]))

([ATHENA_HF_Class70018] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50001])
	(%3ATO [ATHENA_HF_Class70012]))

([ATHENA_HF_Class70019] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50001])
	(%3ATO [ATHENA_HF_Class70011]))

([ATHENA_HF_Class70020] of  On_Screen_Message

	(label "Hypertension control message")
	(message "In patients at high risk for developing HF, systolic and diastolic hypertension should be controlled in accordance with contemporaryguidelines. (Level of Evidence: A)")
	(message_type Class+I))

([ATHENA_HF_Class70021] of  On_Screen_Message

	(label "Lipid disorder control message")
	(message "In patients at high risk for developing HF, lipid disorders should\nbe treated in accordance with contemporary guidelines. (Level of\nEvidence: A)")
	(message_type Class+I))

([ATHENA_HF_Class70022] of  On_Screen_Message

	(label "Blood sugar control message")
	(message "For patients with diabetes mellitus (who are all at high risk for developing HF), blood sugar should be controlled in accordance with contemporary guidelines. (Level of Evidence: C)")
	(message_type Class+I))

([ATHENA_HF_Class70023] of  On_Screen_Message

	(label "behavior  control message")
	(message "Patients at high risk for developing HF should be counseled to avoid behaviors that may increase the risk of HF (e.g., smoking, excessive alcohol consumption, and illicit drug use). (Level of\nEvidence: C)")
	(message_type Class+I))

([ATHENA_HF_Class70024] of  On_Screen_Message

	(label "Ventricular rate/sinus rhythm  control message")
	(message "Ventricular rate should be controlled or sinus rhythm restored in\npatients with supraventricular tachyarrhythmias who are at high\nrisk for developing HF. (Level of Evidence: B)")
	(message_type Class+I))

([ATHENA_HF_Class70025] of  On_Screen_Message

	(label "Thyroid disorder  control message")
	(message "Thyroid disorders should be treated in accordance with contemporary\nguidelines in patients at high risk for developing HF. (Level\nof Evidence: C)")
	(message_type Class+I))

([ATHENA_HF_Class70026] of  On_Screen_Message

	(label "Periodic evaluation message")
	(message "Healthcare providers should perform periodic evaluation for signs\nand symptoms of HF in patients at high risk for developing HF.\n(Level of Evidence: C)")
	(message_type Class+I))

([ATHENA_HF_Class70027] of  On_Screen_Message

	(label "atherosclerotic vascular disease control message")
	(message "In patients at high risk for developing HF who have known\natherosclerotic vascular disease, healthcare providers should\nfollow current guidelines for secondary prevention. (Level of\nEvidence: C)")
	(message_type Class+I))

([ATHENA_HF_Class70028] of  On_Screen_Message

	(label "LV function evaluation message")
	(message "Healthcare providers should perform a noninvasive evaluation of\nLV function (i.e., LVEF) in patients with a strong family history of\ncardiomyopathy or in those receiving cardiotoxic interventions.\n(Level of Evidence: C)")
	(message_type Class+I))

([ATHENA_HF_Class70029] of  N_ary_Criterion

	(criteria [athena_hypertension_INSTANCE_00004])
	(label "BP not under control")
	(operator NOT))

([ATHENA_HF_Class70030] of  N_ary_Criterion

	(label "DM and BP not under control")
	(operator AND))

([ATHENA_HF_Class70032] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class90208]
		[ATHENA_HF_Class90209])
	(label "strong family history of cardiomyopathy or in those receiving cardiotoxic interventions")
	(operator OR))

([ATHENA_HF_Class70033] of  Presence_Criterion

	(domain_term atherosclerotic_vascular_disease)
	(entry_type Note_Entry)
	(label "Presence of atherosclerotic vascular disease")
	(presence TRUE))

([ATHENA_HF_Class70034] of  Presence_Criterion

	(domain_term thyroid+disorders)
	(entry_type Note_Entry)
	(label "Presence of Thyroid Disorder")
	(presence TRUE))

([ATHENA_HF_Class70035] of  Presence_Criterion

	(domain_term supraventricular+tachyarrhythmias)
	(entry_type Note_Entry)
	(label "Presence of supraventricular tachyarrhythmias")
	(presence TRUE))

([ATHENA_HF_Class70036] of  N_ary_Criterion

	(criteria
		[ATHENA_DM_Eye_Instance_40003]
		[ATHENA_HF_Class50031]
		[ATHENA_HF_Class70033])
	(label "DM or HTN or atherosclerotic vascular disease")
	(operator OR))

([ATHENA_HF_Class70037] of  Evaluate_Start_Activity

	(activity_class "Medication")
	(alternatives
		[ATHENA_HF_Class10000]
		[ATHENA_HF_Class30018])
	(label "Evaluate ACE and ARB"))

([ATHENA_HF_Class70039] of  N_ary_Criterion

	(criteria
		[ATHENA_DM_Eye_Instance_40003]
		[ATHENA_HF_Class50031]
		[ATHENA_HF_Class70033])
	(label "High Risk for HF and DM, HTN, or atherosclerotic vascular disease")
	(operator OR))

([ATHENA_HF_Class70041] of  Presence_Criterion

	(domain_term at+risk+for+developing+HF)
	(entry_type Note_Entry)
	(label "hgiht risk for developing HF")
	(presence TRUE))

([ATHENA_HF_Class70043] of  Guideline_View

	(drug_usages
		[ATHENA_HF_Class10000]
		[ATHENA_HF_Class70157]
		[ATHENA_HF_Class30018]
		[ATHENA_HF_Class50037]
		[ATHENA_HF_Class50069]
		[ATHENA_HF_Class50046]
		[ATHENA_HF_Class70183]
		[ATHENA_HF_Class50045]
		[ATHENA_HF_Class80000]
		[ATHENA_HF_Class70001]
		[ATHENA_HF_Class70000]
		[ATHENA_HF_Class90000]
		[ATHENA_HF_Class50045])
	(guideline [ATHENA_HF_Class0])
	(guideline_drugs
		[ATHENA_HF_Class50094]
		[ATHENA_HF_Class50093]
		[ATHENA_HF_Class50042]
		[ATHENA_HF_Class50092]
		[KB_443299_Class0]
		[KB_443299_Class1]
		[KB_234689_Class3]))

([ATHENA_HF_Class70138] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class60054]
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50036]
		[ATHENA_HF_Class60088]
		[ATHENA_HF_Class10007])
	(label "Stage B and LVEF<=40 and ADR ACE")
	(operator AND))

([ATHENA_HF_Class70139] of  Conditional_On_Screen_Message

	(label "ICD secondary prev rec Stage C")
	(message "An implantable cardioverter-defibrillator is recommended as secondary prevention to prolong survival in patients with current or prior symptoms of HF and reduced LVEF who have a history of cardiac arrest, ventricular fibrillation, or hemodynamically destabilizing ventricular tachycardia. (Level of Evidence: A)")
	(message_type Class+I)
	(rule_in_condition [ATHENA_HF_Class50104]))

([ATHENA_HF_Class70140] of  Conditional_On_Screen_Message

	(label "ICD primary prev rec Stage C")
	(message "Implantable cardioverter-defibrillator therapy is recommended for primary prevention of sudden cardiac death to reduce total mortality in patients with non-ischemic dilated cardiomyopathy or ischemic heart disease at least 40 days post-MI, a LVEF less than or equal to 35%, and NYHA functional class II or III symptoms while receiving chronic optimal medical therapy, and who have reasonable expectation of survival with a good functional status for more than 1 year. (Level of Evidence: A)")
	(message_type Class+I)
	(rule_in_condition [ATHENA_HF_Class70141]))

([ATHENA_HF_Class70141] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class100434])
	(label "LVEF<= 35 and (non isch dilated cardiomyopathy OR MI>40days old")
	(operator AND))

([ATHENA_HF_Class70142] of  Numeric_Term_Criterion

	(entry_type Numeric_Entry)
	(label "LVEF <=35")
	(numeric_domain_term Left+Ventricular+Ejection+fraction)
	(operator %3C%3D)
	(value 35.0))

([ATHENA_HF_Class70143] of  Presence_Criterion

	(domain_term nonischemic+cardiomyopathy)
	(entry_type Note_Entry)
	(label "Presence of non ischemic heart disease")
	(presence TRUE))

([ATHENA_HF_Class70145] of  Presence_Criterion

	(domain_term non-ischemic+dilated+cardiomyopathy)
	(entry_type Note_Entry)
	(label "presence of non-ischemic dilated cardiomyopathy")
	(presence TRUE))

([ATHENA_HF_Class70148] of  Relative_Time_Interval_Definite

	(how_many "40")
	(label ">40 days")
	(polarity Before)
	(relative_time_point [time%3AINSTANCE_1])
	(time_unit day))

([ATHENA_HF_Class70151] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70152]
		[ATHENA_HF_Class50024]
		[ATHENA_HF_Class70156]
		[ATHENA_HF_Class70168]
		[ATHENA_HF_Class70169])
	(label "African american (black) and moderate symptoms and using ACE, BB, diureti")
	(operator AND))

([ATHENA_HF_Class70152] of  Presence_Criterion

	(domain_term Black)
	(entry_type Note_Entry)
	(label "African american (black)")
	(presence TRUE))

([ATHENA_HF_Class70153] of  Qualitative_Data

	(label "moderate HF symptoms")
	(sensitive FALSE))

([ATHENA_HF_Class70154] of  Qualitative_Data

	(label "severe HF symptoms")
	(sensitive FALSE))

([ATHENA_HF_Class70155] of  Qualitative_Data

	(sensitive FALSE))

([ATHENA_HF_Class70156] of  Presence_Criterion

	(domain_term Moderate+HF+signs+and+symptoms)
	(entry_type Note_Entry)
	(label "presence of moderate HF symptoms")
	(presence TRUE))

([ATHENA_HF_Class70157] of  Drug_Usage

	(Absolute_Contraindications
		Female+and+most+recent+creatinine++%3E2
		Male+and+most+recent+creatinine%3E2.5
		Acitve+prescription+for+ACE+and+ARB
		Renal_Insufficiency)
	(collateral_actions [ATHENA_HF_Class70166])
	(Compelling_Indications HF+and+LVEF%3C%3D35+%26+HF+%26+moderate%2Fsevere+symptoms+%26+low+creatinine+%26+K%3C5)
	(Drug_Class_Name aldosterone+antagonist)
	(label "Aldosterone antagonist"))

([ATHENA_HF_Class70159] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "Most recent K>=5")
	(numeric_domain_term Potassium)
	(operator %3E%3D)
	(value 5.0))

([ATHENA_HF_Class70161] of  N_ary_Criterion

	(criteria
		[ATHENA_CKD_Instance_70005]
		[ATHENA_HF_Class70162])
	(label "Male and creatinine  >2.5")
	(operator AND))

([ATHENA_HF_Class70162] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "creatinine  >2.5")
	(numeric_domain_term Creatinine)
	(operator %3E)
	(value 2.5))

([ATHENA_HF_Class70164] of  N_ary_Criterion

	(criteria
		[ATHENA_CKD_Instance_40003]
		[ATHENA_HF_Class70165])
	(label "Female and most recent creatinine  >2")
	(operator AND))

([ATHENA_HF_Class70165] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "creatinine >2")
	(numeric_domain_term Creatinine)
	(operator %3E)
	(value 2.0))

([ATHENA_HF_Class70166] of  Collateral_Action

	(actions
		[ATHENA_HF_Class70167]
		[ATHENA_HF_Class110353])
	(mood Recommend_Add))

([ATHENA_HF_Class70167] of  On_Screen_Message

	(label "Aldosterone antagonist warning")
	(message "Addition of an aldosterone antagonist is recommended in selected patients with moderately severe to severe symptoms of HF and reduced LVEF who CAN BE CAREFULLY MONITORED for PRESERVED RENAL FUNCTION and NORMAL POTASSIUM concentration. Creatinine should be 2.5 mg per dL or less in men or 2.0 mg per dL or less in women and potassium should be less than 5.0 mEq per liter. Under circumstances where monitoring for hyperkalemia or renal dysfunction is not anticipated to be feasible, the risks may outweigh the benefits of aldosterone anatgonists.")
	(message_type Recommendation))

([ATHENA_HF_Class70168] of  Presence_Criterion

	(domain_term Beta-Blockers)
	(entry_type Medication)
	(label "presence of beta blocker")
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class70169] of  Presence_Criterion

	(domain_term Diuretics)
	(entry_type Medication)
	(label "presence of diuretics")
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class70170] of  Conditional_On_Screen_Message

	(label "atrial fibrillation and HF")
	(message "It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)")
	(message_type Class+II+a)
	(rule_in_condition [ATHENA_HF_Class70171]))

([ATHENA_HF_Class70171] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class30004]
		[ATHENA_HF_Class70172])
	(label "HF and atrial fibrillation")
	(operator AND))

([ATHENA_HF_Class70172] of  Presence_Criterion

	(domain_term Atrial_Fibrillation)
	(entry_type Note_Entry)
	(label "presence of atrial fibrillation")
	(presence TRUE))

([ATHENA_HF_Class70173] of  On_Screen_Message

	(label "Maximal exercise testing")
	(message "Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)")
	(message_type Class+II+a))

([ATHENA_HF_Class70179] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class70180]
		[athena_hypertension_203766])
	(label "Mild-moderate HF symptoms and LVEF<= 40 and ADR ACE")
	(operator AND))

([ATHENA_HF_Class70180] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70156]
		[ATHENA_HF_Class70181])
	(label "Presence of  mild or moderate HF symptoms")
	(operator OR))

([ATHENA_HF_Class70181] of  Presence_Criterion

	(domain_term Mild+HF+signs+and+symptoms)
	(entry_type Note_Entry)
	(label "Presence of  mild HF symptoms")
	(presence TRUE))

([ATHENA_HF_Class70183] of  Drug_Usage

	(collateral_actions [ATHENA_HF_Class110382])
	(Compelling_Indications African+american+%28black%29+and+moderate+symptoms+and+using+ACE%2C+BB%2C+diuretic)
	(Drug_Class_Name Hydralazine_and_nitrates)
	(label "Hydralazine and nitrates")
	(Relative_Indications
		LVEF%3C%3D40+%26+using+ACE+%26+using+BB+%26+HF+symptoms
		LVEF%3C%3D40+and+contraindications+to+ACE%2FARB+%28hypotension%2C+renal+insufficiency+or+drug+intolerance%29))

([ATHENA_HF_Class70185] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50024]
		[ATHENA_HF_Class70168]
		[ATHENA_HF_Class30004]
		[ATHENA_HF_Class70187])
	(label "LVEF<=40 and using ACE and BB and HF and symptomatic")
	(operator AND))

([ATHENA_HF_Class70186] of  Presence_Criterion

	(domain_term Severe+HF+signs+and+symptoms)
	(entry_type Note_Entry)
	(label "Presence of severe HF symptoms")
	(presence TRUE))

([ATHENA_HF_Class70187] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70181]
		[ATHENA_HF_Class70156]
		[ATHENA_HF_Class70186])
	(label "mild or moderate or severe HF symptoms")
	(operator OR))

([ATHENA_HF_Class70188] of  Conditional_On_Screen_Message

	(label "CRT when LVEF<=35% and QRS>=0.12s and atrial fibrillation")
	(message "For patients who have LVEF less than or equal to 35%, a QRS duration of greater than or equal to 0.12 seconds, and atrial fibrillation (AF), CRT with or without an ICD is reasonable for the treatment of NYHA functional class III or ambulatory class IV heart failure symptoms on optimal recommended medical therapy. (Level of Evidence: B)")
	(message_type Class+II+a)
	(rule_in_condition [ATHENA_HF_Class70189]))

([ATHENA_HF_Class70189] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class70172]
		[ATHENA_HF_Class70192]
		[ATHENA_HF_Class170334])
	(label "LVEF<=35% and QRS>=0.12s and atrial fibrillation and  NYHA functional class III or ambulatory class IV symptoms")
	(operator AND))

([ATHENA_HF_Class70192] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "QRS>= 0.12")
	(numeric_domain_term QRS)
	(operator %3E%3D)
	(value 0.12))

([ATHENA_HF_Class70193] of  Conditional_On_Screen_Message

	(label "CRT  frequent dependence ventricular pacing")
	(message "For patients with LVEF of less than or equal to 35% with NYHA functional class III or ambulatory class IV symptoms who are receiving optimal recommended medical therapy and who have frequent dependence on ventricular pacing, CRT is reasonable (2). (Level of Evidence: C)")
	(message_type Class+II+a)
	(rule_in_condition [ATHENA_HF_Class70194]))

([ATHENA_HF_Class70194] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class230011])
	(label "NYHA functional class III or ambulatory class IV symptoms and LVEF<=35%")
	(operator AND))

([ATHENA_HF_Class70195] of  Presence_Criterion

	(domain_term NYHA+functional+class+III+ambulatory+class+IV+symptoms)
	(entry_type Note_Entry)
	(label "Presence of  NYHA functional class III or ambulatory class IV symptoms")
	(presence TRUE))

([ATHENA_HF_Class70197] of  Conditional_On_Screen_Message

	(label "nutritional supplements and stage C")
	(message "Use of NUTRITIONAL SUPPLEMENTS as treatment for HF is NOT INDICATED in patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: C)")
	(message_type Class+III)
	(rule_in_condition [ATHENA_HF_Class70198]))

([ATHENA_HF_Class70198] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[KB_056864_Class6])
	(label "(HF ICD9 or symptoms) and LVEF<=40")
	(operator AND))

([ATHENA_HF_Class70199] of  Conditional_On_Screen_Message

	(label "hormonal therapies and stage C")
	(message "HORMONAL THERAPIES other than to replete deficiencies are NOT RECOMMENDED and may be harmful to patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: C)")
	(message_type Class+III)
	(rule_in_condition [ATHENA_HF_Class70198]))

([ATHENA_HF_Class70622] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50043]
		[ATHENA_HF_Class70623])
	(label "HF ICD9 code OR( signs and structural abnormality)")
	(operator OR))

([ATHENA_HF_Class70623] of  N_ary_Criterion

	(criteria [ATHENA_HF_Class10007])
	(label "HF signs/symptoms and structural abnormality of heart")
	(operator AND))

([ATHENA_HF_Class70628] of  Presence_Criterion

	(domain_term Low_Ejection_Fraction)
	(entry_type Note_Entry)
	(label "Low Ejection Fraction")
	(presence TRUE))

([ATHENA_HF_Class80000] of  Drug_Usage

	(Compelling_Indications LVEF%3C%3D40+and+no+HF+and+no+MI)
	(Drug_Class_Name Beta+Blocker+Stage+B+no+MI)
	(label "Beta Blocker Stage B HF no MI"))

([ATHENA_HF_Class80002] of  Guideline_Drug

	(generic_drug sustained+release+metoprolol+tartrate)
	(label "metoprolol tartrate"))

([ATHENA_HF_Class80004] of  Guideline_Drug

	(generic_drug timolol)
	(label "timolol"))

([ATHENA_HF_Class80008] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class50075])
	(%3ATO [ATHENA_HF_Class50002]))

([ATHENA_HF_Class80352] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class30004])
	(label "HF ICD9 and LVEF<=40")
	(operator AND))

([ATHENA_HF_Class80353] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[athena_hypertension_INSTANCE_00377]
		[ATHENA_HF_Class100851]
		[ATHENA_HF_Class133534])
	(label "HF and LVEF<=40 & moderate/severe symptoms & ((creatinine<=2.5 and male) OR (creatinine<=2 female)) & K<5")
	(operator AND))

([ATHENA_HF_Class80354] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class60072])
	(label "HF symptoms and LVEF<=40")
	(operator AND))

([ATHENA_HF_Class80356] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[athena_hypertension_domain_INSTANCE_00002]
		[ATHENA_HF_Class60054])
	(label "LVEF<=40 and no HF symptoms")
	(operator AND))

([ATHENA_HF_Class90000] of  Drug_Usage

	(collateral_actions [KB_899077_Class8])
	(Compelling_Indications HF+%28ICD+or+Symptoms%29+and+LVEF%3C%3D40+and+MI)
	(Drug_Class_Name carvedilol)
	(formulary_preferred_drug_in_class [ATHENA_HF_Class50093])
	(label "Beta blocker Stage C with MI"))

([ATHENA_HF_Class90002] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50018]
		[ATHENA_HF_Class60088])
	(label "LVEF<=40 and no HF and no MI")
	(operator AND))

([ATHENA_HF_Class90005] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class60088]
		[ATHENA_HF_Class50011])
	(label "MI and no HF")
	(operator AND))

([ATHENA_HF_Class90208] of  Presence_Criterion

	(domain_term family+history+of+cardiomyopathy)
	(entry_type Note_Entry)
	(label "Family history of cardiomopathy")
	(presence TRUE))

([ATHENA_HF_Class90209] of  Presence_Criterion

	(domain_term cardiotoxic+interventions)
	(entry_type Medication)
	(label "Presence of cardiotoxicity drug")
	(presence TRUE)
	(status "active"))

([ATHENA_HF_Class90384] of  N_ary_Criterion

	(criteria [ATHENA_HF_Class90385])
	(label "Absence of MI within 41 days")
	(operator NOT))

([ATHENA_HF_Class90385] of  Presence_Criterion

	(domain_term Myocardial_Infarction)
	(entry_type Note_Entry)
	(label "Presence of MI within 41 days")
	(period [ATHENA_HF_Class50057])
	(presence TRUE))

([cardiologist] of  Canonical_Terms_Metaclass

	(data_source VISTA_data_element))

([cardiotoxic+antiarrythmic+drugs] of  Medications_Metaclass

	(data_source VISTA_data_element))

([cardiotoxic+CA+channel+blockers] of  Medications_Metaclass

	(data_source VISTA_data_element))

([cifenline] of  Medications_Metaclass

	(data_source VISTA_data_element))

([CKDstage3_30gt_eGFR_lte60] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_155357_Class41])
	(PrettyName "CKD Stage 3 or 30<=eGFR<=60"))

([CKDstage4_5_eGFRlte30_highcreatinine] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_155357_Class38])
	(PrettyName "CKD stage 4/5 or eGFR<30 or high creatinine"))

([Class+II+a] of  Canonical_Terms_Metaclass
)

([Class+II+b] of  Canonical_Terms_Metaclass
)

([Class+III] of  Canonical_Terms_Metaclass
)

([CompellingIndAfrican+american+and+moderate+symptoms+and+using+ACE%2C+BB%2C+diuretichydralazine+and+nitrates] of  Drug_Indication_Relation

	(degree compelling)
	(indication African+american+%28black%29+and+moderate+symptoms+and+using+ACE%2C+BB%2C+diuretic))

([CompellingIndHF+symptoms%2FHF+and+LVEF%3C%3D40ACE_Inhibitors] of  Drug_Indication_Relation

	(degree compelling)
	(indication HF+and+LVEF%3C%3D35+%26+HF+%26+moderate%2Fsevere+symptoms+%26+low+creatinine+%26+K%3C5))

([CompellingIndHF+symptoms%2FHF+and+LVEF%3C%3D40aldosterone+antagonist] of  Drug_Indication_Relation

	(degree compelling)
	(indication HF+and+LVEF%3C%3D35+%26+HF+%26+moderate%2Fsevere+symptoms+%26+low+creatinine+%26+K%3C5))

([CompellingIndHF+symptoms%2FHF+and+LVEF%3C%3D40Beta-Blockers] of  Drug_Indication_Relation

	(degree compelling)
	(indication HF+and+LVEF%3C%3D35+%26+HF+%26+moderate%2Fsevere+symptoms+%26+low+creatinine+%26+K%3C5))

([CompellingIndLVEF%3C%3D40+and+no+HF+symptomsACE_Inhibitors] of  Drug_Indication_Relation

	(degree compelling)
	(indication LVEF%3C%3D40+and+no+HF+symptoms))

([CompellingIndLVEF%3C%3D40+and+no+HF+symptomsBeta-Blockers] of  Drug_Indication_Relation

	(degree compelling)
	(indication LVEF%3C%3D40+and+no+HF+symptoms))

([CompellingIndMI+and+LVEF%3C%3D40+and+ADR+ACEAngiotensin_II_receptor_blockers] of  Drug_Indication_Relation

	(degree compelling)
	(indication No+HF%2C+MI%2C++LVEF%3C%3D40+and+ADR+ACE))

([CompellingIndMyocardial_InfarctionACE_Inhibitors] of  Drug_Indication_Relation

	(degree compelling)
	(indication Myocardial_Infarction))

([CompellingIndMyocardial_InfarctionBeta-Blockers] of  Drug_Indication_Relation

	(degree compelling)
	(indication Myocardial_Infarction))

([CompellingIndStage+C+and+LVEF%3C%3D40+and+ADR+ACEAngiotensin_II_receptor_blockers] of  Drug_Indication_Relation

	(degree compelling)
	(indication Stage+C+and+LVEF%3C%3D40+and+ADR+ACE))

([Decision_eGFR] of  Diagnostic_Term_Metaclass

	(controllable FALSE)
	(DiagnosticCriteria [library_Class110013]))

([DecisionCreatinine] of  Diagnostic_Term_Metaclass

	(controllable FALSE)
	(DiagnosticCriteria [library_Class110016])
	(PrettyName "Decision eGFR>=60 or decision creatinine <1.5 (male) or <1.3 (female)"))

([DECLINED+TO+ANSWER%2C+DECLINED+TO+ANSWER] of  Canonical_Terms_Metaclass
)

([disopyramide] of  Medications_Metaclass

	(data_source VISTA_data_element))

([drug+intolerance+ACE%2FARB+OR+hypotension+OR+renal+insufficiency] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class60014]))

([eGFR%3C30] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class110374]))

([fatigue] of  Canonical_Terms_Metaclass

	(data_source clinical_assessment))

([Female+and+most+recent+creatinine++%3E2] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class70164]))

([Heart+Failure+Stage] of  Medical_Conditions_Metaclass

	(data_source clinical_assessment))

([HF+%26+LVEF%3C%3D35+%26+%28IF+moderate+or+severe+symptoms%29] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class150003]))

([HF+%28HF+global+ICD+or+Symptoms%29+and+LVEF%3C%3D40+and+no+MI] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element clinical_assessment VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class100002]))

([HF+%28ICD+or+Symptoms%29+and+LVEF%3C%3D40+and+MI] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element VISTA_freetext clinical_assessment)
	(DiagnosticCriteria [ATHENA_HF_Class100004])
	(PrettyName "LVEF<=40 and MI"))

([HF+%28ICD9+or+symptoms%29+and+LVEF%3C%3D40] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element VISTA_freetext clinical_assessment)
	(DiagnosticCriteria [ATHENA_HF_Class70198]))

([HF+and+LVEF%3C%3D35+%26+HF+%26+moderate%2Fsevere+symptoms+%26+low+creatinine+%26+K%3C5] of  Diagnostic_Term_Metaclass

	(data_source clinical_assessment VISTA_freetext VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class130007])
	(PrettyName "Heart Failure & LVEF<=35 & moderate/severe symptoms"))

([HF+with+persistent+symptoms+and+LVEF%3C%3D40+and+treated+with+conventional+therapy] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element clinical_assessment VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class100394])
	(PrettyName "HF with persistent symptoms, low EF using ACE inhibitor and beta blocker"))

([HF_and_+LVEF%3C%3D35_and_IF_NYHA_Class_II_or_Class_III_or_Class_IV] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class180002])
	(PrettyName "HF & LVEF<=35 & (IF NYHA Class II or ClassIII or ClassIV symptoms"))

([HF_and_+LVEF%3C%3D35_and_IF_NYHA_Class_III_or__IV_or_II_and_elevated_BNP] of  Diagnostic_Term_Metaclass

	(coding_system "LVEF <=35 & HF & (IF NYHA Class III or IV symptoms or (NYHA II and elevated BNP)) & (creatinine low or egfr>30) & K<5")
	(DiagnosticCriteria [ATHENA_HF_Class190011]))

([HF_and_LVEF%3C%3D35_and_NYHA_Class_III_IV_or_Class_II_and_elevated_BNP] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class190013])
	(PrettyName "LVEF<=35; NYHA Class III or IV, or (II & elevated BNP); on ACE/ARB or contra; on BB or contra; K<5; creatiine ok or eGFR>30;"))

([HF_and_LVEF_le_40_and_NYHA_II_III_IIV_or_DM] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class240009])
	(PrettyName "LVEF<=40; MI in last 6 months; NYHA Class II or II or IV or DM; K<5, ACE/ARB or contra; BB or contra"))

([High+Risk+for+HF+and+DM%2C+HTN%2C+or+atherosclerotic+vascular+disease] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class144252]))

([HTN+and+LVH] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class50030]))

([Hydralazine_and_nitrates] of  Medications_Metaclass

	(data_source VISTA_data_element)
	(PrettyName "hydralazine and nitrates"))

([idecainide] of  Medications_Metaclass

	(data_source VISTA_data_element))

([If_moderate_or_severe_symptoms_are_present] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class60054])
	(PrettyName "IF moderate or severe symptoms are present"))

([If_moderate_symptoms_+are_present] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class60054])
	(PrettyName "If moderate symptoms are present"))

([IF_NHYA_Class_II_symptoms] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class60054])
	(PrettyName "IF NYHA Class II symptoms present"))

([IF_NYHA_Class_II_III_IV_symptoms] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class60054])
	(PrettyName "IF NYHA Class II or Class III or Class IV symptoms"))

([IF_NYHA_class_III_IV_symptoms] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class60054])
	(PrettyName "IF NYHA class II-IV symptoms"))

([IF_NYHA_functional_class_II_o_+III_symptoms] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class60054])
	(PrettyName "NYHA functional class II or III symptoms"))

([IF_NYHA_functional_class_III_or+_mbulatory_class_IV_heart_failure_symptoms] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class60054])
	(PrettyName "IF NYHA functional class III or ambulatory class IV heart failure symptoms"))

([indomethacin] of  Medications_Metaclass

	(data_source VISTA_data_element))

([K%3E5.0] of  Diagnostic_Term_Metaclass

	(controllable TRUE)
	(DiagnosticCriteria [library_Class30019])
	(PrettyName "Most recent K>5.0"))

([KB_020015_Class216] of  Qualitative_Constant

	(value "Female"))

([KB_020015_Class219] of  Qualitative_Constant

	(value "Male"))

([KB_020015_Class233] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "There exists a compellingly indicated drug that is not already given or contraindicated or has complications")
	(%3APAL-RANGE "(defrange ?drug_usage :FRAME Drug_Usage)\n(defrange ?current_med :FRAME Medication)\n(defrange ?condition :FRAME Note_Entry)\n(defrange ?med_condition :FRAME Note_Entry)\n(defrange ?indication :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_indication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_contraindication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?complication :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_complication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?problem :FRAME Note_Entry)")
	(%3APAL-STATEMENT "(exists ?drug_usage\n        (and  (not (exists ?current_med  \n                           (and (patient_id ?current_med \"1305700708195\")\n                                (is-class (drug_name ?current_med))\n                                (subclass-of  (coerce-to-class (drug_name ?current_med)) (Drug_Class_Name ?drug_usage )))))             \n             (not (= (Drug_Class_Name ?drug_usage)(coerce-to-class Loop_diuretics)))\n             (or (exists ?indication\n                         (and (Compelling_Indications ?drug_usage ?indication)\n                              (exists ?condition \n                                      (and (isa-classname (domain_term ?condition))\n                                           (patient_id ?condition \"1305700708195\")\n                                           (equal-or-subclass-of (coerce-to-class (domain_term ?condition)) ?indication)))))\n                 (exists ?derived_indication \n                         (and (Compelling_Indications ?drug_usage ?derived_indication)\n                              (is-derivable ?derived_indication))))\n             (not (exists ?contraindication \n                          (and (Absolute_Contraindications ?drug_usage ?contraindication)\n                               (exists ?med_condition \n                                       (and (patient_id ?med_condition \"1305700708195\")\n                                            (isa-classname (domain_term ?med_condition))\n                                            (equal-or-subclass-of (coerce-to-class (domain_term ?med_condition)) ?contraindication))))))\n             (not (exists ?derived_contraindication\n                          (and (Absolute_Contraindications ?drug_usage ?derived_contraindication)\n                               (is-derivable ?derived_contraindication))))\n             (not (exists ?complication \n                          (and (Complication_Factor ?drug_usage ?complication)\n                               (exists ?problem \n                                       (and (patient_id ?problem \"1305700708195\")\n                                            (isa-classname (domain_term ?problem))\n                                            (equal-or-subclass-of (coerce-to-class (domain_term ?problem)) ?complication))))))\n             (not (exists ?derived_complication\n                          (and (Complication_Factor ?drug_usage ?derived_complication)\n                               (is-derivable ?derived_complication))))\n        )\n)\n\n"))

([KB_020015_Class81] of  N_ary_Criterion

	(label "Eligibility criteria")
	(operator AND))

([KB_048666_Class0] of  Case_Step

	(branches [KB_048666_Class4])
	(expression [KB_048666_Class1])
	(label "Presence of hydralazine or nitrates"))

([KB_048666_Class1] of  N_ary_Criterion

	(criteria
		[KB_048666_Class3]
		[KB_048666_Class2])
	(label "Presence of hydralazine or nitrates rec add")
	(operator OR))

([KB_048666_Class2] of  Presence_Criterion

	(domain_term hydralazine)
	(entry_type Medication)
	(label "Presence of hydralazine rec add")
	(mood Recommend_Add)
	(presence TRUE)
	(status "active"))

([KB_048666_Class3] of  Presence_Criterion

	(domain_term Isosorbide_dinitrate)
	(entry_type Medication)
	(label "Presence of nitrate rec add")
	(mood Recommend_Add)
	(presence TRUE)
	(status "active"))

([KB_048666_Class4] of  Action_Choice

	(actions
		[KB_486502_Class3]
		[KB_486502_Class2]
		[ATHENA_HF_Class110353]
		[KB_155357_Class35]
		[KB_155357_Class59]
		[KB_155357_Class69]
		[KB_155357_Class72]
		[KB_222371_Class1]
		[KB_222371_Class4]
		[KB_222371_Class6]
		[KB_222371_Class3]
		[KB_502940_Class6]
		[KB_335875_Class8]
		[KB_155357_Class18]
		[KB_155357_Class29]
		[KB_155357_Class25]
		[KB_155357_Class32]
		[KB_155357_Class3]
		[KB_212231_Class1]
		[KB_486502_Class0]
		[KB_335875_Class12]
		[KB_335875_Class19]
		[KB_335875_Class22]
		[ATHENA_HF_Class371546]
		[ATHENA_HF_Class380470]
		[ATHENA_HF_Class401993]
		[ATHENA_HF_Class390605]
		[ATHENA_HF_Class390608]
		[ATHENA_HF_Class110388]
		[KB_150996_Class0]
		[ATHENA_HF_Class390000]
		[ATHENA_HF_Class390004]
		[KB_313397_Class23]
		[KB_313397_Class22]
		[KB_486502_Class6]
		[KB_313397_Class16]
		[KB_313397_Class14]
		[KB_313397_Class18]
		[KB_486502_Class2])
	(label "PM after generating recommendations")
	(strict_rule_in_condition [criterion_INSTANCE_00001]))

([KB_048666_Class5] of  On_Screen_Message

	(label "Prim msg hydralazine and nitrates together are beneficial")
	(message "Hydralazine and nitrates TOGETHER are beneficial to patients with HF.")
	(message_type Primary_Recommendation))

([KB_048666_Class6] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130004])
	(%3ATO [KB_048666_Class0]))

([KB_048666_Class8] of  Followed_By

	(%3AFROM [ATHENA_HF_Class270000])
	(%3ATO [KB_048666_Class0]))

([KB_055251_Class2] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class290002]
		[ATHENA_HF_Class120002])
	(label "Low LVEF and high creatinine")
	(operator AND))

([KB_055251_Class3] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class120002]
		[library_Class30002])
	(label "Low LVEF and Low SBC")
	(operator AND))

([KB_056864_Class0] of  General_Comparison_Criterion

	(domain_term HF+signs+and+symptoms)
	(entry_type Note_Entry)
	(label "NYHA Class I")
	(operator eq)
	(value [KB_660669_Class0]))

([KB_056864_Class1] of  General_Comparison_Criterion

	(domain_term HF+signs+and+symptoms)
	(entry_type Note_Entry)
	(label "NYHA Class II")
	(operator eq)
	(value [KB_660669_Class1]))

([KB_056864_Class10] of  N_ary_Criterion

	(criteria
		[KB_056864_Class5]
		[KB_341641_Class2])
	(label "ExpComp NYHA Class II or III or IV or DM")
	(operator OR))

([KB_056864_Class2] of  General_Comparison_Criterion

	(domain_term HF+signs+and+symptoms)
	(entry_type Note_Entry)
	(label "NYHA Class III")
	(operator eq)
	(value [KB_660669_Class2]))

([KB_056864_Class3] of  General_Comparison_Criterion

	(domain_term HF+signs+and+symptoms)
	(entry_type Note_Entry)
	(label "NYHA Class IV")
	(operator eq)
	(value [KB_660669_Class3]))

([KB_056864_Class4] of  General_Comparison_Criterion

	(domain_term HF+signs+and+symptoms)
	(entry_type Note_Entry)
	(label "NYHA Class IV ambulatory")
	(operator eq)
	(value [KB_660669_Class4]))

([KB_056864_Class5] of  N_ary_Criterion

	(criteria
		[KB_056864_Class1]
		[KB_056864_Class2]
		[KB_056864_Class3]
		[KB_056864_Class4])
	(label "ExpComp NYHA Class II or III or IV or IV ambulatory")
	(operator OR))

([KB_056864_Class6] of  N_ary_Criterion

	(criteria
		[KB_056864_Class5]
		[KB_886846_Class0])
	(label "HF or ExpComp NYHA symptoms II II IV")
	(operator OR))

([KB_056864_Class7] of  N_ary_Criterion

	(criteria
		[KB_056864_Class2]
		[KB_056864_Class3])
	(label "NYHA Class III or IV")
	(operator OR))

([KB_056864_Class8] of  N_ary_Criterion

	(criteria
		[KB_056864_Class1]
		[ATHENA_HF_Class200003])
	(label "EXpComp NYHA Class II and (elevated BNP or NTproBNP or prior cardiovascular hospitalization)")
	(operator AND))

([KB_056864_Class9] of  N_ary_Criterion

	(criteria
		[KB_056864_Class7]
		[KB_056864_Class8])
	(label "ExpComp NHYA Class III or IV OR Class II and elevated BNP")
	(operator OR))

([KB_063169_Class0] of  Parameterized_Message

	(label "test multi-valued substitutions from same instance")
	(message_type Recommendation)
	(parameterized_message [KB_063169_Class1])
	(rule_in_condition [criterion_INSTANCE_00001]))

([KB_063169_Class1] of  Parameterized_String

	(label "test multi-valued substitutions from same instance")
	(multivalued_variables [eon2_Class20000])
	(value "?drugName has daily dose of ?dose mg."))

([KB_065193_Class110] of  Qualitative_Constant

	(value "Male"))

([KB_065193_Class112] of  Qualitative_Constant

	(value "Female"))

([KB_065193_Class84] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_081292_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_081292_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_081292_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_094729_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_094729_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_094729_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_102662_Class216] of  Qualitative_Constant

	(value "Female"))

([KB_102662_Class219] of  Qualitative_Constant

	(value "Male"))

([KB_102662_Class81] of  N_ary_Criterion

	(label "Eligibility criteria")
	(operator AND))

([KB_104075_Class0] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "BB Stace C in guideline has relative or absolute contraindication")
	(%3APAL-RANGE "(defrange ?current_med :FRAME Medication)\n(defrange ?med_class :FRAME Drug_Usage)\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)\n(defrange ?condition :FRAME Note_Entry)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(exists ?drug_usage\n        (and (Drug_Class_Name ?drug_usage  \"Beta_Blocker Stage C Heart Failure\")\n             		(exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")\n                                       (drug_usages ?guideline ?drug_usage)))           \n             (or (exists ?condition\n                         (and (patient_id ?condition $patient_id)\n                              (is-class (domain_term ?condition))\n                              (exists ?contraindication \n                                      (and (or (Absolute_Contraindications ?drug_usage ?contraindication)\n                                               (Relative_Contraindications ?drug_usage ?contraindication))\n                                          \n                                           (or (= (coerce-to-class (domain_term ?condition)) ?contraindication )\n                                               (subclass-of (coerce-to-class (domain_term ?condition)) ?contraindication ))\n                                      ))))\n                 (exists  ?derived_problem\n                          (and (or (Absolute_Contraindications ?drug_usage ?derived_problem)\n                                   (Relative_Contraindications ?drug_usage ?derived_problem))\n                               (is-derivable ?derived_problem))))\n        )\n)\n"))

([KB_104075_Class1] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "ARB in guidelinehas relative or absolute contraindication")
	(%3APAL-RANGE "(defrange ?current_med :FRAME Medication)\n(defrange ?problem :FRAME Note_Entry)\n(defrange ?med_class :FRAME Drug_Usage)\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_contraindication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)\n(defrange ?condition :FRAME Note_Entry)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(exists ?drug_usage\n        (and (Drug_Class_Name ?drug_usage Angiotensin_II_receptor_blockers)\n             		(exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")\n                                       (drug_usages ?guideline ?drug_usage)))           \n             (or (exists ?condition\n                         (and (patient_id ?condition $patient_id)\n                                            (is-class (domain_term ?condition))\n                             (exists ?problem\n                                      (and (or (Absolute_Contraindications ?drug_usage ?problem)\n                                               (Relative_Contraindications ?drug_usage ?problem))\n                                           (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                               (subclass-of (coerce-to-class (domain_term ?condition)) ?problem ))\n                                      ))))\n                 (exists  ?derived_problem\n                          (and (or (Absolute_Contraindications ?drug_usage ?derived_problem)\n                                   (Relative_Contraindications ?drug_usage ?derived_problem))\n                               (is-derivable ?derived_problem))))\n        )\n)\n"))

([KB_104075_Class2] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "ACE Inhibitor in guideline has relative or absolute contraindication")
	(PAL_constraint [KB_433271_Class6]))

([KB_104075_Class3] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "ARB in guideline has relative or absolute contraindication")
	(PAL_constraint [KB_104075_Class1]))

([KB_104075_Class4] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "BB in guideline has relative or absolute contraindication")
	(PAL_constraint [KB_104075_Class0]))

([KB_104117_Class0] of  Action_Choice

	(actions [KB_104117_Class1])
	(label "Presence of ACE-I good")
	(strict_rule_in_condition [ATHENA_HF_Class50024])
	(strict_rule_out_condition [ATHENA_HF_Class210005]))

([KB_104117_Class1] of  On_Screen_Message

	(label "Presence of ACE good message")
	(message "Patient is on ACE Inhibitor. Good!")
	(message_type Recommendation))

([KB_104117_Class3] of  Followed_By

	(%3AFROM [ATHENA_HF_Class340250])
	(%3ATO [KB_104117_Class0]))

([KB_104117_Class4] of  Presence_Criterion

	(domain_term Cardiac_resynchronization_therapy)
	(entry_type Procedure)
	(label "Presence of CRT")
	(presence TRUE))

([KB_104117_Class5] of  Presence_Criterion

	(domain_term Implantable_cardioverter_defibrillator)
	(entry_type Procedure)
	(label "Presence of ICD")
	(presence TRUE))

([KB_104117_Class6] of  Presence_Criterion

	(domain_term Implantable_cardioverter_defibrillator)
	(entry_type Procedure)
	(label "Absence of ICD")
	(presence FALSE))

([KB_104117_Class7] of  Presence_Criterion

	(domain_term Cardiac_resynchronization_therapy)
	(entry_type Procedure)
	(label "Absence of CRT")
	(presence FALSE))

([KB_109062_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_109062_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_109062_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_126607_Class0] of  Guideline_Drug

	(dose_strength_unit mg)
	(generic_drug eplerenone)
	(label "Eplerenone")
	(starting_dose 25.0))

([KB_126607_Class2] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "hydralazine contraindicated")
	(%3APAL-RANGE "(defrange ?condition :FRAME Note_Entry)\n(defrange ?problem :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(forall ?drug_usage\n        (=> (Drug_Class_Name ?drug_usage hydralazine)\n            (or (exists ?condition \n                        (and (patient_id ?condition $patient_id)\n                             (exists ?problem \n                                     (and (Absolute_Contraindications ?drug_usage ?problem)\n                                          (is-class (domain_term ?condition))\n                                          (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                              (subclass-of (coerce-to-class (domain_term ?condition)) ?problem )) \n                                     ))))\n                (exists  ?derived_problem \n                         (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                              (is-derivable ?derived_problem))))\n        )\n)"))

([KB_126607_Class3] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "diisosorbide nitrates contraindicated")
	(%3APAL-RANGE "defrange ?condition :FRAME Note_Entry)\n(defrange ?problem :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(forall ?drug_usage\n        (=> (Drug_Class_Name ?drug_usage Isosorbide_dinitrate)\n            (or (exists ?condition \n                        (and (patient_id ?condition $patient_id)\n                             (is-class (domain_term ?condition))\n                             (exists ?problem \n                                     (and (Absolute_Contraindications ?drug_usage ?problem)\n                                          (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                              (subclass-of (coerce-to-class (domain_term ?condition)) ?problem )) \n                                     ))))\n                (exists  ?derived_problem \n                         (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                              (is-derivable ?derived_problem))))\n        )\n)"))

([KB_126607_Class4] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "hydralazine contraindicated")
	(PAL_constraint [KB_126607_Class2]))

([KB_126607_Class5] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "isosorbide dinitrates contraindicated")
	(PAL_constraint [KB_126607_Class3]))

([KB_127550_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_127550_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_127550_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_149589_Class0] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "ACE Inhibitor in guideline contraindicated")
	(%3APAL-RANGE "\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)\n(defrange ?condition :FRAME Note_Entry)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(exists ?drug_usage\n        (and (Drug_Class_Name ?drug_usage ACE_Inhibitors)\n             (exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")\n                                     (drug_usages ?guideline ?drug_usage)))           \n             (or (exists ?condition\n                         (and (patient_id ?condition $patient_id)\n                              (is-class (domain_term ?condition))\n                              (exists ?contraindication \n                                      (and (Absolute_Contraindications ?drug_usage ?contraindication )\n                                           (or (= (coerce-to-class (domain_term ?condition)) ?contraindication  )\n                                               (subclass-of (coerce-to-class (domain_term ?condition)) ?contraindication  ))\n                                      ))))\n                 (exists  ?derived_problem\n                          (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                               (is-derivable ?derived_problem))))\n        )\n)\n"))

([KB_149589_Class1] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "ACE Inhibitor in guideline contraindicated")
	(PAL_constraint [KB_149589_Class0]))

([KB_149589_Class10] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class460018]
		[KB_149589_Class16])
	(label "Presence of Isosorbide_dinitrates or contraindication")
	(operator OR))

([KB_149589_Class11] of  N_ary_Criterion

	(criteria
		[KB_149589_Class15]
		[ATHENA_HF_Class460022])
	(label "Presence of hydralazine or contraindication to hydralazine")
	(operator OR))

([KB_149589_Class12] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "Hydralazine in guideline contraindicated")
	(PAL_constraint [KB_149589_Class13]))

([KB_149589_Class13] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "Hydralazine in guideline contraindicated")
	(%3APAL-RANGE "\n(defrange ?med_class :FRAME Drug_Usage)\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)\n(defrange ?condition :FRAME Note_Entry)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(exists ?drug_usage\n        (and (Drug_Class_Name ?drug_usage hydralazine)\n             		(exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")\n                                       (drug_usages ?guideline ?drug_usage)))           \n             (or (exists ?condition\n                         (and (patient_id ?condition $patient_id)\n                              (is-class (domain_term ?condition))\n                              (exists ?contraindication\n                                      (and (Absolute_Contraindications ?drug_usage ?contraindication)\n                                           (or (= (coerce-to-class (domain_term ?condition)) ?contraindication )\n                                               (subclass-of (coerce-to-class (domain_term ?condition)) ?contraindication ))\n                                      ))))\n                 (exists  ?derived_problem\n                          (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                               (is-derivable ?derived_problem))))\n        )\n)\n"))

([KB_149589_Class14] of  N_ary_Criterion

	(criteria
		[KB_149589_Class11]
		[KB_149589_Class10])
	(label "Hyralazine or contra to hydralazine AND nitrates or contra to nitrates")
	(operator AND))

([KB_149589_Class15] of  Presence_Criterion

	(domain_term hydralazine)
	(entry_type Medication)
	(label "Presence of hydralazine only")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([KB_149589_Class16] of  Presence_Criterion

	(domain_term Isosorbide_dinitrate)
	(entry_type Medication)
	(label "Presence of isosoribde dinitrates only")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([KB_149589_Class17] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50025]
		[KB_261275_Class7])
	(label "Presence of ACE or ARB or Absence of ACE or ARB AND intolerance")
	(operator OR))

([KB_149589_Class2] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "ARB in guideline contraindicated")
	(%3APAL-RANGE "(defrange ?current_med :FRAME Medication)\n(defrange ?problem :FRAME Note_Entry)\n(defrange ?med_class :FRAME Drug_Usage)\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_contraindication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)\n(defrange ?condition :FRAME Note_Entry)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(exists ?drug_usage\n        (and (Drug_Class_Name ?drug_usage Angiotensin_II_receptor_blockers)\n             		(exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")\n                                       (drug_usages ?guideline ?drug_usage)))           \n             (or (exists ?condition\n                         (and (patient_id ?condition $patient_id)\n                                            (isa-classname (domain_term ?condition))\n                             (exists ?problem\n                                      (and (Absolute_Contraindications ?drug_usage ?problem)\n                                           (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                               (subclass-of (coerce-to-class (domain_term ?condition)) ?problem ))\n                                      ))))\n                 (exists  ?derived_problem\n                          (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                               (is-derivable ?derived_problem))))\n        )\n)\n"))

([KB_149589_Class3] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "ARB in guideline contraindicated")
	(PAL_constraint [KB_149589_Class2]))

([KB_149589_Class4] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "Aldosterone antagonist in guideline contraindicated")
	(%3APAL-RANGE "(defrange ?current_med :FRAME Medication)\n(defrange ?problem :FRAME Note_Entry)\n(defrange ?med_class :FRAME Drug_Usage)\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_contraindication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)\n(defrange ?condition :FRAME Note_Entry)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(exists ?drug_usage\n        (and (Drug_Class_Name ?drug_usage  \"aldosterone antagonist\")\n             		(exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")\n                                       (drug_usages ?guideline ?drug_usage)))           \n             (or (exists ?condition\n                         (and (patient_id ?condition $patient_id)\n                                  (is-class (domain_term ?condition))\n                             (exists ?problem\n                                      (and (Absolute_Contraindications ?drug_usage ?problem)\n                                           (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                               (subclass-of (coerce-to-class (domain_term ?condition)) ?problem ))\n                                      ))))\n                 (exists  ?derived_problem\n                          (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                               (is-derivable ?derived_problem))))\n        )\n)\n"))

([KB_149589_Class5] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "Aldosterone antagonist in guideline contraindicated")
	(PAL_constraint [KB_149589_Class4]))

([KB_149589_Class6] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "BB Stace C in guideline contraindicated")
	(%3APAL-RANGE "(defrange ?current_med :FRAME Medication)\n(defrange ?problem :FRAME Note_Entry)\n(defrange ?med_class :FRAME Drug_Usage)\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_contraindication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)\n(defrange ?condition :FRAME Note_Entry)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(exists ?drug_usage\n        (and (Drug_Class_Name ?drug_usage  \"Beta_Blocker Stage C Heart Failure\")\n             		(exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")\n                                       (drug_usages ?guideline ?drug_usage)))           \n             (or (exists ?condition\n                         (and (patient_id ?condition $patient_id)\n                              (is-class (domain_term ?condition))\n                              (exists ?problem\n                                      (and (Absolute_Contraindications ?drug_usage ?problem)\n                                           (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                               (subclass-of (coerce-to-class (domain_term ?condition)) ?problem ))\n                                      ))))\n                 (exists  ?derived_problem\n                          (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                               (is-derivable ?derived_problem))))\n        )\n)\n"))

([KB_149589_Class7] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "BB Stage C in guideline contraindicated")
	(PAL_constraint [KB_149589_Class6]))

([KB_149589_Class8] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "Isosorbide_dinitrate in guideline contraindicated")
	(%3APAL-RANGE "\n\n(defrange ?problem :FRAME Medical_Conditions_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)\n(defrange ?condition :FRAME Note_Entry)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(exists ?drug_usage\n        (and (Drug_Class_Name ?drug_usage Isosorbide_dinitrate)\n             		(exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")\n                                       (drug_usages ?guideline ?drug_usage)))           \n             (or (exists ?condition\n                         (and (patient_id ?condition $patient_id)\n                              (isa-classname (domain_term ?condition))\n                              (exists ?problem\n                                      (and (Absolute_Contraindications ?drug_usage ?problem)\n                                           (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                               (subclass-of (coerce-to-class (domain_term ?condition)) ?problem ))\n                                      ))))\n                 (exists  ?derived_problem\n                          (and (Absolute_Contraindications ?drug_usage ?derived_problem)\n                               (is-derivable ?derived_problem))))\n        )\n)\n"))

([KB_149589_Class9] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "Isosorbide dinitrate in guideline contraindicated")
	(PAL_constraint [KB_149589_Class8]))

([KB_150996_Class0] of  Conditional_On_Screen_Message

	(label "Rec add AA suppressed no NYHA or DM")
	(message "Recommendation for adding aldosterone antagonist has not been evaluated because \npatient is missing values for NYHA Class symptoms or presence of DM.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_768321_Class0]))

([KB_150996_Class1] of  N_ary_Criterion

	(criteria [KB_056864_Class10])
	(label "NOT ExpComp NYHA Class II or III or IV or DM")
	(operator NOT))

([KB_155357_Class0] of  Parameterized_Message

	(label "guideline med MPR < 0.9 message")
	(message_type Recommendation)
	(parameterized_message [KB_606662_Class4])
	(rule_in_condition [KB_606662_Class2]))

([KB_155357_Class1] of  Parameterized_Message

	(label "guideline med MPR < 0.9 message")
	(message_type Recommendation)
	(parameterized_message [KB_606662_Class4])
	(rule_in_condition [KB_606662_Class2]))

([KB_155357_Class10] of  Structured_Query

	(aggregation_operator most_recent)
	(attribute [valid_time])
	(label "date of most recent K")
	(type Numeric_Entry)
	(where_restriction [KB_155357_Class11]))

([KB_155357_Class11] of  Comparison_Filter

	(attribute [domain_term])
	(label "domain term eq to potassium")
	(operator eq)
	(value_expression [Potassium]))

([KB_155357_Class13] of  Parameterized_String

	(label "most recent K >5 and on ARB")
	(value "Patient's most recent potassium (date ?date) was greater than 5; consider discontinuing angiotensin receptor blocker or other drugs contributing to hyperkalemia. Evaluate clinical significance.")
	(variables [KB_155357_Class8]))

([KB_155357_Class14] of  Parameterized_Message

	(label "PM most recent SPB<110 and On ARB")
	(message_type Primary_Recommendation)
	(parameterized_message [KB_155357_Class16])
	(rule_in_condition [KB_155357_Class15]))

([KB_155357_Class15] of  N_ary_Criterion

	(criteria
		[library_Class30002]
		[athena_hypertension_141022])
	(label "On ARB and most recent SBP<110")
	(operator AND))

([KB_155357_Class16] of  Parameterized_String

	(label "SBP<110 and on ARB")
	(value "Patient's most recent SBP (date ?date) was less than 110mmHg. Consider evaluating dose of angiotensin receptor blocker.")
	(variables [KB_212231_Class3]))

([KB_155357_Class18] of  Parameterized_Message

	(label "Female, most recent creatinine >=2.3, on ACE")
	(message_type Primary_Recommendation)
	(parameterized_message [KB_155357_Class21])
	(rule_in_condition [KB_155357_Class19]))

([KB_155357_Class19] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00100]
		[KB_155357_Class20]
		[athena_hypertension_INSTANCE_00016])
	(label "Female, most recent creatinine >=2.3, on ACE")
	(operator AND))

([KB_155357_Class2] of  Parameterized_Message

	(label "PM most recent SPB<110 and On ACE")
	(message_type Primary_Recommendation)
	(parameterized_message [KB_212231_Class2])
	(rule_in_condition [KB_155357_Class6]))

([KB_155357_Class20] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "creatinine >=2.3")
	(numeric_domain_term Creatinine)
	(operator %3E%3D)
	(status "active")
	(value 2.3))

([KB_155357_Class21] of  Parameterized_String

	(label "Female, most recent creatinine >=2.3, on ACE")
	(value "Patient has active prescription for ACE inhibitorand most recent creatinine (date ?date) is greater than 2.2.  Evaluate clinically.")
	(variables [KB_155357_Class22]))

([KB_155357_Class22] of  Variable

	(derivation_expression [KB_155357_Class23])
	(label "date for most recent creatinine")
	(string_name "?date"))

([KB_155357_Class23] of  Structured_Query

	(aggregation_operator most_recent)
	(attribute [valid_time])
	(label "date of most recent creatinine")
	(type Numeric_Entry)
	(where_restriction [KB_155357_Class24]))

([KB_155357_Class24] of  Comparison_Filter

	(attribute [domain_term])
	(label "domain term eq creatinine")
	(operator eq)
	(value_expression [Creatinine]))

([KB_155357_Class25] of  Parameterized_Message

	(label "Male, most recent creatinine >=2.5 and on ACE")
	(message_type Primary_Recommendation)
	(parameterized_message [KB_155357_Class28])
	(rule_in_condition [KB_155357_Class26]))

([KB_155357_Class26] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00102]
		[athena_hypertension_INSTANCE_00016]
		[KB_155357_Class27])
	(label "male, most recent creatinine >=2.5 and on ACE")
	(operator AND))

([KB_155357_Class27] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "creatinine >=2.5")
	(numeric_domain_term Creatinine)
	(operator %3E%3D)
	(status "active")
	(value 2.5))

([KB_155357_Class28] of  Parameterized_String

	(label "Male, most recent creatinine >=2.5, on ACE")
	(value "Patient has active prescription for ACE inhibitor and most recent creatinine (date ?date) is greater than 2.4.  Evaluate clinically.")
	(variables [KB_155357_Class22]))

([KB_155357_Class29] of  Parameterized_Message

	(label "Female, most recent creatinine >=2.3, on ARB")
	(message_type Primary_Recommendation)
	(parameterized_message [KB_155357_Class31])
	(rule_in_condition [KB_155357_Class30]))

([KB_155357_Class3] of  Parameterized_Message

	(label "PM K>5 and On ACE")
	(message_type Primary_Recommendation)
	(parameterized_message [KB_155357_Class7])
	(rule_in_condition [KB_155357_Class4]))

([KB_155357_Class30] of  N_ary_Criterion

	(criteria
		[KB_155357_Class20]
		[athena_hypertension_INSTANCE_00100]
		[athena_hypertension_141022])
	(label "Female, most recent creatinine >=2.3, on ARB")
	(operator AND))

([KB_155357_Class31] of  Parameterized_String

	(label "Female, most recent creatinine >=2.3, on ARB")
	(value "Patient has active prescription for angiotensin receptor blocker and most recent creatinine (date ?date) is greater than 2.2.  Evaluate clinically.")
	(variables [KB_155357_Class22]))

([KB_155357_Class32] of  Parameterized_Message

	(label "Male, most recent creatinine >=2.5 and on ARB")
	(message_type Primary_Recommendation)
	(parameterized_message [KB_155357_Class34])
	(rule_in_condition [KB_155357_Class33]))

([KB_155357_Class33] of  N_ary_Criterion

	(criteria
		[athena_hypertension_141022]
		[athena_hypertension_INSTANCE_00102]
		[KB_155357_Class27])
	(label "Male, most recent creatinine >=2.5 and on ARB")
	(operator AND))

([KB_155357_Class34] of  Parameterized_String

	(label "Male, most recent creatinine >=2.5, on ARB")
	(value "Patient has active prescription for an angiotensin receptor blocker and most recent creatinine (date ?date) is greater than 2.4.  Evaluate clinically.")
	(variables [KB_155357_Class22]))

([KB_155357_Class35] of  Conditional_On_Screen_Message

	(description "rec add AA and using ARB")
	(label "PM rec add AA and using ARB")
	(message "Patient has active prescription for angiotensin receptor blocker. Potassium and kidney function should be measured within 3 days of starting aldosterone antagonists, at 1 week, then every 4 weeks for the first 12 weeks, then every 3 months thereafter.")
	(message_type Primary_Recommendation)
	(references [ATHENA_HF_Class110381])
	(rule_in_condition [athena_hypertension_141022]))

([KB_155357_Class38] of  N_ary_Criterion

	(criteria
		[library_Class50008]
		[KB_261275_Class0]
		[ATHENA_HF_Class290003]
		[ATHENA_HF_Class290005]
		[KB_155357_Class39])
	(label "CKD stage 4/5 OR eGFR<30 OR creat>=2.5 (male) OR creat>=2.3 (female)")
	(operator OR))

([KB_155357_Class39] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "most recent eGFR<30")
	(numeric_domain_term eGFR)
	(operator %3C)
	(status "active")
	(value 30.0))

([KB_155357_Class4] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00016]
		[athena_hypertension_301090])
	(label "On ACE inhibitor and K>5")
	(operator AND))

([KB_155357_Class41] of  N_ary_Criterion

	(criteria
		[KB_155357_Class42]
		[KB_155357_Class43])
	(label "CKD stage 3 OR 30<eGFR<=60")
	(operator OR))

([KB_155357_Class42] of  Presence_Criterion

	(domain_term Chronic_kidney_disease_stage3)
	(entry_type Note_Entry)
	(label "CKD stage 3")
	(presence TRUE)
	(status "active"))

([KB_155357_Class43] of  N_ary_Criterion

	(criteria
		[athena_hypertension_477393]
		[KB_155357_Class44])
	(label "30<eGFR<=60")
	(operator AND))

([KB_155357_Class44] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "most recent eGFR<=60")
	(numeric_domain_term eGFR)
	(operator %3C%3D)
	(status "active")
	(value 60.0))

([KB_155357_Class47] of  Presence_Criterion

	(domain_term Potassium_supplements)
	(entry_type Medication)
	(label "Presence Potassium supplements")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([KB_155357_Class49] of  Presence_Criterion

	(domain_term heparin)
	(entry_type Medication)
	(label "Prescription for heparin")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([KB_155357_Class5] of  N_ary_Criterion

	(criteria
		[athena_hypertension_301090]
		[athena_hypertension_141022])
	(label "On ARB and K>5")
	(operator AND))

([KB_155357_Class51] of  Presence_Criterion

	(domain_term cholestyramine)
	(entry_type Medication)
	(label "prescription for cholestyramine")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([KB_155357_Class52] of  Conditional_On_Screen_Message

	(description "Age >=70, add hydralazine")
	(label "Age >=70, add hydralazine")
	(message "Hydralazine may be eliminated more slowly in elderly patients. Initiate therapy at the low end of the dosing range.")
	(message_type Recommendation)
	(rule_in_condition [KB_155357_Class53]))

([KB_155357_Class53] of  Numeric_Term_Criterion

	(entry_type Numeric_Entry)
	(label "Age >=70")
	(numeric_domain_term Age)
	(operator %3E%3D)
	(status "active")
	(value 70.0))

([KB_155357_Class55] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "lupus as ADR to hydralazine")
	(PAL_constraint [KB_155357_Class56]))

([KB_155357_Class56] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "Presence of lupus as ADR to hydralazine")
	(%3APAL-RANGE "(defrange ?reaction :FRAME Adverse_Reaction)")
	(%3APAL-STATEMENT "(exists ?reaction \n        (and (= (patient_id ?reaction) $patient_id) \n             (or (= (substance ?reaction) \"hydralazine\")\n                 (and (is-class (substance ?reaction)) ( subclass-of (coerce-to-class (substance ?reaction)) ACE_Inhibitors)))\n             (or (= (domain_term ?reaction) Lupus))\n        )\n)"))

([KB_155357_Class59] of  Conditional_On_Screen_Message

	(description "deleting nitrates because prescription for phosphodiesterase inhibitors")
	(label "deleting nitrates because prescription for phosphodiesterase inhibitors")
	(message "Should stop nitrates but continue hydralazine. Need to stop either nitrates or the phosphodiesterase inhibitors")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_155357_Class60]))

([KB_155357_Class6] of  N_ary_Criterion

	(criteria
		[library_Class30002]
		[athena_hypertension_INSTANCE_00016])
	(label "SBP<110 and on ACE")
	(operator AND))

([KB_155357_Class60] of  Presence_Criterion

	(domain_term Isosorbide_dinitrate)
	(entry_type Medication)
	(label "Recommend delete nitrates")
	(mood Recommend_Delete)
	(presence TRUE)
	(status "active"))

([KB_155357_Class62] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "pulse <60")
	(numeric_domain_term Pulse)
	(operator %3C)
	(status "active")
	(value 60.0))

([KB_155357_Class64] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class430000]
		[ATHENA_HF_Class430001])
	(label "Prescription for verapamil or diltiazem")
	(operator OR))

([KB_155357_Class67] of  Presence_Criterion

	(domain_term Beta_blocker_not_StageC_HF)
	(entry_type Medication)
	(label "Prescription_betablocker_notstageC_HF")
	(mood Authorized)
	(presence TRUE)
	(status "active"))

([KB_155357_Class69] of  Conditional_On_Screen_Message

	(description "PM on other BB rec add BB for stage C HF")
	(label "PM on other BB rec add BB for stage C HF")
	(message "Patient already has active prescription for a different beta blocker.  Consider appropriateness of change to the recommended beta blocker")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_155357_Class70]))

([KB_155357_Class7] of  Parameterized_String

	(label "most recent K>5 and on ACE inhibitor")
	(value "Patient's most recent potassium (date ?date) was greater than 5; consider discontinuing ACE inhibitor or other drugs contributing to hyperkalemia. Evaluate clinical significance.")
	(variables [KB_155357_Class8]))

([KB_155357_Class70] of  N_ary_Criterion

	(criteria
		[KB_155357_Class67]
		[KB_155357_Class71])
	(label "rec add bb and on other bb (not sotalol)")
	(operator AND))

([KB_155357_Class71] of  Presence_Criterion

	(domain_term Beta_Blocker+Stage+C+Heart+Failure)
	(entry_type Medication)
	(label "rec add stage C BB")
	(mood Recommend_Add)
	(presence TRUE)
	(status "active"))

([KB_155357_Class72] of  Conditional_On_Screen_Message

	(description "PM on sotalol rec add BB for stage C HF")
	(label "PM on sotalol rec add BB for stage C HF")
	(message "Note that patient has prescription for sotalol. Consider discussion with cardiology before changing beta blockers")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_155357_Class73]))

([KB_155357_Class73] of  N_ary_Criterion

	(criteria
		[athena_hypertension_299947]
		[KB_155357_Class71])
	(label "PM on sotalol rec add BB for stage C HF")
	(operator AND))

([KB_155357_Class77] of  Presence_Criterion

	(domain_term Palliative_care)
	(entry_type Note_Entry)
	(label "presence of palliative care")
	(presence TRUE)
	(status "active"))

([KB_155357_Class8] of  Variable

	(derivation_expression [KB_155357_Class9])
	(label "date for most recent K")
	(string_name "?date"))

([KB_155357_Class9] of  Variable

	(derivation_expression [KB_155357_Class10])
	(label "most recent K"))

([KB_165290_Class0] of  Presence_Criterion

	(domain_term sotalol)
	(entry_type Medication)
	(label "Presence of sotalol")
	(presence TRUE)
	(status "active"))

([KB_165774_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_165774_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_165774_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_175204_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_175204_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_175204_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_178456_Class110] of  Qualitative_Constant

	(value "Male"))

([KB_178456_Class112] of  Qualitative_Constant

	(value "Female"))

([KB_178456_Class209] of  Qualitative_Constant

	(value "Female"))

([KB_178456_Class84] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_212231_Class1] of  Parameterized_Message

	(label "PM K>5 and On ARB")
	(message_type Primary_Recommendation)
	(parameterized_message [KB_155357_Class13])
	(rule_in_condition [KB_155357_Class5]))

([KB_212231_Class2] of  Parameterized_String

	(label "SBP<110 and on ACE inhibitor")
	(value "Patient's most recent SBP (date ?date) was less than 110mmHg. Consider evaluating dose of ACE inhibitor.")
	(variables [KB_212231_Class3]))

([KB_212231_Class3] of  Variable

	(derivation_expression [KB_987641_Class1])
	(label "date for most recent Systolic_BP")
	(string_name "?date"))

([KB_212231_Class4] of  Structured_Query

	(aggregation_operator most_recent)
	(attribute [valid_time])
	(label "date of most recent potassium")
	(type Numeric_Entry)
	(where_restriction [KB_212231_Class5]))

([KB_212231_Class5] of  Comparison_Filter

	(attribute [domain_term])
	(label "domain term eq Potassium")
	(operator eq)
	(value_expression [Potassium]))

([KB_219746_Class0] of  Drug_Indication_Relation

	(degree compelling)
	(indication LVEF%3C%3D40)
	(label "LVEF<=40: Source")
	(supporting_materials [KB_219746_Class1]))

([KB_219746_Class1] of  Supporting_Material

	(label "Source for ACE-I compelling indication")
	(URL "<html>\n  <head>\n    <style type=\"text/css\">\n      <!--\n        body { font-size: 12pt; font-family: arial }\n        p { margin-bottom: 2; margin-right: 2; margin-left: 2; margin-top: 2; font-family: arial }\n      -->\n    </style>\n    \n  </head>\n  <body>\n    <a href=\"http://www.stanford.edu/~swt/VAShare/Rules%20Document%20for%20Heart%20Failure%202013_v13.htm#ACECompellingIndication\">http://www.stanford.edu/~swt/VAShare/Rules%20Document%20for%20Heart%20Failure%202013_v13.htm#ACECompellingIndication</a></body>\n</html>"))

([KB_219870_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_219870_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_219870_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_222371_Class1] of  Conditional_On_Screen_Message

	(label "Rec add AA suppressed K")
	(message "Recommendation for adding aldosterone antagonist has not been evaluated because patient is missing values for potassium")
	(message_type Primary_Recommendation)
	(rule_in_condition [athena_runtime_38615]))

([KB_222371_Class2] of  N_ary_Criterion

	(criteria
		[athena_runtime_38615]
		[ATHENA_HF_Class60054])
	(label "Absence of K or  NYHA symptoms")
	(operator OR))

([KB_222371_Class3] of  Conditional_On_Screen_Message

	(label "rec add hydralazine or nitrates suppressed no symptoms")
	(message "Recommendation for adding hydralaine and/or nitrates was not evaluated because patient is missing data for NYHA Class symptoms.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_768321_Class2]))

([KB_222371_Class4] of  Conditional_On_Screen_Message

	(description "rec add AA suppressed no BNP")
	(label "rec add AA suppressed no BNP")
	(message "Recommendation for adding aldosterone antagonist when patient has NYHA Class II symptoms was not evaluated because patient is missing values for BNP.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_222371_Class5]))

([KB_222371_Class5] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class200015]
		[KB_056864_Class1]
		[ATHENA_HF_Class270266]
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class133535]
		[ATHENA_HF_Class170000]
		[KB_886846_Class0]
		[ATHENA_HF_Class220005]
		[ATHENA_HF_Class200001])
	(label "NYHA Class II symptoms and no BNP and absence of AA")
	(operator AND))

([KB_222371_Class6] of  Conditional_On_Screen_Message

	(description "rec add hydralazine and nitrates suppressed no Race")
	(label "rec add hydralazine and nitrates suppressed no Race")
	(message "Recommendation for adding hydralazine and/or isosobide dinitrates  to African Americans was not evaluated because patient is missing values for race")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_222371_Class9]))

([KB_222371_Class7] of  Presence_Criterion

	(domain_term Race)
	(entry_type Patient)
	(label "Absence of race")
	(presence FALSE))

([KB_222371_Class8] of  Presence_Criterion

	(domain_term Unknown_Race)
	(entry_type Patient)
	(label "presence of unknown race")
	(presence TRUE))

([KB_222371_Class9] of  N_ary_Criterion

	(criteria
		[KB_222371_Class7]
		[KB_482846_Class6])
	(label "Absence of race or presence of uknown race")
	(operator OR))

([KB_234689_Class0] of  On_Screen_Message

	(description "diuretcs out of scope")
	(label "diuretcs out of scope")
	(message "HF with reduced EF with fluid retention is an indication for diuretic therapy, but is beyond the scope of this project recommendations.")
	(message_type Primary_Recommendation))

([KB_234689_Class1] of  Consultation_Action_Step

	(actions [KB_234689_Class0])
	(label "diuretics out of scope msg")
	(rule_in [criterion_INSTANCE_00001]))

([KB_234689_Class2] of  Consultation_Selection

	(%3AFROM [ATHENA_HF_Class170006])
	(%3ATO [KB_234689_Class1]))

([KB_234689_Class3] of  Guideline_Drug

	(dose_strength_unit mg)
	(generic_drug fosinopril)
	(label "Fosinopril")
	(rule_in [ATHENA_HF_Class50043])
	(starting_dose 5.0))

([KB_240498_Class0] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50025]
		[KB_421296_Class9])
	(label "Presence of ACE or ARB and not African American too")
	(operator AND))

([KB_240498_Class1] of  N_ary_Criterion

	(criteria
		[KB_240498_Class0]
		[KB_421296_Class15]
		[KB_247253_Class2])
	(label "hydralazine and nitrate criteria for GDMT")
	(operator OR))

([KB_240498_Class10] of  N_ary_Criterion

	(criteria
		[KB_149589_Class16]
		[KB_240498_Class7]
		[ATHENA_HF_Class460022])
	(label "Presence of isosorbide dinitrate and (African American or cannot tolerate ACE/ARB) and contra to hydrlazine")
	(operator AND))

([KB_240498_Class11] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class460018]
		[ATHENA_HF_Class460022])
	(label "contra to hydralazine and contra to isosorbide dinitrates")
	(operator AND))

([KB_240498_Class12] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50025]
		[KB_421296_Class9]
		[KB_240498_Class13])
	(label "Presence of ACE or ARB and absence of hydralazine and nitrates and not African American")
	(operator AND))

([KB_240498_Class13] of  N_ary_Criterion

	(criteria
		[KB_240498_Class14]
		[KB_240498_Class15])
	(label "Absence of hydralazine and isosorbide dinitrates")
	(operator AND))

([KB_240498_Class14] of  Presence_Criterion

	(domain_term hydralazine)
	(entry_type Medication)
	(label "Absence of hydralazine")
	(presence FALSE)
	(status "active"))

([KB_240498_Class15] of  Presence_Criterion

	(domain_term Isosorbide_dinitrate)
	(entry_type Medication)
	(label "Absence of isosorbide dinitrates")
	(presence FALSE)
	(status "active"))

([KB_240498_Class16] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50011]
		[ATHENA_HF_Class90384])
	(label "Presence of MI older than 41 days use me")
	(operator AND))

([KB_240498_Class2] of  N_ary_Criterion

	(criteria
		[KB_240498_Class8]
		[KB_240498_Class9]
		[KB_240498_Class10]
		[KB_240498_Class11]
		[KB_240498_Class12])
	(label "hydralazine and nitrate criteria for GDMT too")
	(operator OR))

([KB_240498_Class3] of  N_ary_Criterion

	(criteria
		[KB_149589_Class15]
		[KB_149589_Class16])
	(label "Presence of hydralazine and isosobide dinitrate")
	(operator AND))

([KB_240498_Class4] of  N_ary_Criterion

	(criteria
		[KB_149589_Class15]
		[KB_126607_Class5])
	(label "Presence of hydralazine and contra to isosorbide dinitrates")
	(operator AND))

([KB_240498_Class5] of  N_ary_Criterion

	(criteria
		[KB_149589_Class16]
		[ATHENA_HF_Class460022])
	(label "Presence of isosorbide dinitrate and contra to hydrlazine")
	(operator AND))

([KB_240498_Class6] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class460018]
		[ATHENA_HF_Class460022])
	(label "contra to hyralazine and isosorbide dinitrates")
	(operator AND))

([KB_240498_Class7] of  N_ary_Criterion

	(criteria
		[KB_421296_Class8]
		[KB_261275_Class3])
	(label "African American or cannot tolerate ACE/ARB")
	(operator OR))

([KB_240498_Class8] of  N_ary_Criterion

	(criteria
		[KB_149589_Class15]
		[KB_149589_Class16]
		[KB_240498_Class7])
	(label "Presence of hydralazine and isosobide dinitrate and (African American or cannot tolerate ACE/ARB)")
	(operator AND))

([KB_240498_Class9] of  N_ary_Criterion

	(criteria
		[KB_149589_Class15]
		[KB_240498_Class7]
		[ATHENA_HF_Class460018])
	(label "Presence of hydralazine and (African American or cannot tolerate ACE/ARB) and contra to isosorbide dinitrate")
	(operator AND))

([KB_243202_Class0] of  Action_Choice

	(actions [KB_243202_Class1])
	(label "Out of Scope Msg")
	(strict_rule_in_condition [ATHENA_HF_Class350002]))

([KB_243202_Class1] of  On_Screen_Message

	(label "Out of scope message")
	(message "HF patients with preserved EJ function, LVEF>40 or without an LVEF value are out of scope of this CDS.")
	(message_type Primary_Recommendation))

([KB_243202_Class2] of  Followed_By

	(%3AFROM [ATHENA_HF_Class340250])
	(%3ATO [KB_243202_Class0]))

([KB_247253_Class0] of  N_ary_Criterion

	(criteria
		[KB_056864_Class1]
		[KB_056864_Class2])
	(label "ExpComp NYHA Class II or III")
	(operator OR))

([KB_247253_Class1] of  N_ary_Criterion

	(criteria
		[KB_056864_Class1]
		[KB_056864_Class2]
		[KB_056864_Class4])
	(label "ExpComp NYHA Class II or III or IV ambulatory")
	(operator OR))

([KB_247253_Class2] of  N_ary_Criterion

	(criteria
		[KB_149589_Class14]
		[KB_421296_Class8])
	(label "Hydralazine and nitrates or contra AND African American")
	(operator AND))

([KB_247253_Class3] of  N_ary_Criterion

	(criteria [ATHENA_CKD_Instance_70019])
	(label "not African American")
	(operator NOT))

([KB_247253_Class4] of  N_ary_Criterion

	(criteria
		[KB_247253_Class2]
		[KB_421296_Class9])
	(label "Hydralazine and nitrates or contra AND African American OR not African American")
	(operator OR))

([KB_261275_Class0] of  Presence_Criterion

	(domain_term Chronic_kidney_disease_stage4)
	(entry_type Note_Entry)
	(label "Presence of CKD Stage 4 (ICD)")
	(presence TRUE))

([KB_261275_Class1] of  N_ary_Criterion

	(criteria
		[KB_261275_Class0]
		[library_Class50008])
	(label "Presence of CKD Stage 4 or 5")
	(operator OR))

([KB_261275_Class10] of  Presence_Criterion

	(domain_term Beta_blocker_not_StageC_HF)
	(entry_type Medication)
	(label "Presence of BB not Stage C HF")
	(presence TRUE)
	(status "active"))

([KB_261275_Class11] of  Action_Choice

	(actions
		[KB_261275_Class13]
		[KB_261275_Class12])
	(label "Presence of BB not Stage C HF, substitute")
	(strict_rule_in_condition [ATHENA_HF_Class400000]))

([KB_261275_Class12] of  Evaluate_Substitution_Activity

	(activity_class "Medication")
	(activity_spec Drug_Usage)
	(activity_spec_key [Drug_Class_Name])
	(activity_to_stop [ATHENA_HF_Class450000])
	(alternatives [ATHENA_HF_Class340000])
	(domain_term Beta_blocker_not_StageC_HF)
	(label "Evaluate substitute BB not stage C for Stage C recommended"))

([KB_261275_Class13] of  On_Screen_Message

	(label "BB substitution")
	(message "Patient is taking a beta blocker that is not one of the recommeded beta blockers for heart failure patients. Evaluate susbtitution with carvedilol, bisoprolol or sustained release metoprolol succinate.")
	(message_type Recommendation))

([KB_261275_Class14] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [KB_261275_Class11]))

([KB_261275_Class2] of  N_ary_Criterion

	(criteria
		[KB_261275_Class1]
		[ATHENA_HF_Class110374])
	(label "Presence of CKD Stage 4 OR 5 OR eGFR<30")
	(operator OR))

([KB_261275_Class3] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[KB_056864_Class7]
		[KB_261275_Class7]
		[ATHENA_HF_Class220005])
	(label "LVEF<=40 and NYHA Class IIi or IV and (Absence ACE or ARB and (CKD Stage4/5 eGFR<30) or (ADR to ACE or ARB))")
	(operator AND))

([KB_261275_Class4] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class210007]
		[KB_261275_Class2])
	(label "Absence of ACE or ARB and (CKD Stage 4/5 or eGFR<30)")
	(operator AND))

([KB_261275_Class5] of  N_ary_Criterion

	(criteria
		[athena_hypertension_203766]
		[ATHENA_HF_Class140014])
	(label "ADR to ACE-I or ADR to ARB")
	(operator OR))

([KB_261275_Class6] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class210007]
		[KB_261275_Class5])
	(label "Absence to ACE or ARB and (ADR to ACE or ARB)")
	(operator AND))

([KB_261275_Class7] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class470000]
		[ATHENA_HF_Class470001]
		[ATHENA_HF_Class470002])
	(label "Absence of ACE AND ARB AND ((CKD stage 4/5 or eGFR<30) OR (ADR to ACE or ARB) OR SBP<110)")
	(operator OR))

([KB_261275_Class8] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class210007]
		[library_Class30002])
	(label "Absence of ACE or ARB and SBP<110")
	(operator AND))

([KB_261747_Class0] of  Evaluate_Start_Activity

	(alternatives
		[ATHENA_HF_Class70000]
		[ATHENA_HF_Class90000]
		[ATHENA_HF_Class10000]
		[ATHENA_HF_Class70157]
		[ATHENA_HF_Class70183])
	(label "Stage C drug recs"))

([KB_304655_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_304655_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_304655_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_306762_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_306762_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_306762_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_313397_Class0] of  Collateral_Action

	(actions [KB_313397_Class2])
	(mood Recommend_Add))

([KB_313397_Class1] of  On_Screen_Message

	(description "PM: rec add ACEi")
	(message "Patient has a diagnosis of chronic kidney disease stage 3 or 4, or eGFR between 15 and 60); evaluate clinical significance and impact of prescription for ACEi and frequency of monitoring labs")
	(message_type Primary_Recommendation))

([KB_313397_Class10] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50024]
		[library_Class70013])
	(label "on ace and ckd stage 5 or eGFR<15")
	(operator AND))

([KB_313397_Class11] of  Conditional_On_Screen_Message

	(description "On ACEi and renal artery stenosis")
	(label "PM On ACEi and renal artery stenosis")
	(message "Patient has a diagnosis of renal artery stenosis; evaluate clinical significance and impact of prescription for ACE Inhibitor.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_313397_Class12]))

([KB_313397_Class12] of  N_ary_Criterion

	(criteria
		[library_Class50004]
		[ATHENA_HF_Class50024])
	(label "On ACEi and renal artery stenosis")
	(operator AND))

([KB_313397_Class13] of  Collateral_Action

	(actions [KB_313397_Class14])
	(mood Recommend_Add))

([KB_313397_Class14] of  Conditional_On_Screen_Message

	(description "PM rec add ACEi CKD stage5 or eGFR>15")
	(label "PM rec add ACEi CKD stage5 or eGFR>15")
	(message "Patient has a diagnosis of chronic kidney disease stage 5 (or eGFR less than 15), evaluate clinical significance and impact of prescription for ACE inhibitor.")
	(message_type Recommendation)
	(rule_in_condition [library_Class70013]))

([KB_313397_Class15] of  Collateral_Action

	(actions [KB_313397_Class16]))

([KB_313397_Class16] of  Conditional_On_Screen_Message

	(description "PM Rec add ACEi and renal artery stenosis")
	(label "PM Rec add ACEi and renal artery stenosis")
	(message "Patient has a diagnosis of renal artery stenosis; evaluate clinical significance and impact of prescription for ACE Inhibitor. Use caution if prescribing.")
	(message_type Primary_Recommendation)
	(rule_in_condition [library_Class50004]))

([KB_313397_Class17] of  Collateral_Action
)

([KB_313397_Class18] of  Conditional_On_Screen_Message

	(description "PM add ACEi and 20 percent increase creatinine after starting ACEi")
	(label "PM add ACEi and 20 percent increase creatinine after starting ACEi")
	(message "Patient had 20% increase in creatinine after initiation of ACE inhibitor or ARB; evaluate clinical significance and impact of prescription for ACE inhibitor.")
	(message_type Primary_Recommendation)
	(rule_in_condition [library_Class70000]))

([KB_313397_Class19] of  Conditional_On_Screen_Message

	(description "PM on ACEi and 20 percent increase in creatinine after starting ACEi or ARB")
	(label "PM on ACEi and 20 percent increase in creatinine after starting ACEi or ARB")
	(message "Patient had 20% increase in creatinine after initiation of ACE inhibitor or ARB; evaluate clinical significance and impact of prescription for ACE inhibitor.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_486502_Class14]))

([KB_313397_Class2] of  Conditional_On_Screen_Message

	(description "PM rec add ACEi CKD stage3 or 4 15<=eGFR<60")
	(label "PM rec add ACEi CKD stage3 or 4 15<=eGFR<60")
	(message "Patient has a diagnosis of chronic kidney disease stage 3 or 4, or eGFR between 15 and 60); evaluate clinical significance and impact of prescription for ACEi and frequency of monitoring labs.")
	(message_type Primary_Recommendation)
	(rule_in_condition [library_Class70009]))

([KB_313397_Class20] of  Conditional_On_Screen_Message

	(description "PM on ACE and prescription for Aliskiren (current)")
	(label "PM on ACE and prescription for Aliskiren (current)")
	(message "Patient has a prescription for aliskiren; evaluate clinical significance and impact of prescription for ACE inhibitor.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_313397_Class21]))

([KB_313397_Class21] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50024]
		[library_Class70016])
	(label "active prescriptions for ACE and Aliskiren")
	(operator AND))

([KB_313397_Class22] of  Conditional_On_Screen_Message

	(label "PM Rec add ACEi and active prescription for Aliskerin")
	(message "Patient has a prescription for aliskerin; evaluate clinical significance and impact of prescription for ACE inhibitor")
	(message_type Recommendation)
	(rule_in_condition [library_Class70016]))

([KB_313397_Class23] of  Conditional_On_Screen_Message

	(label "PM Rec add ACE and presence K sparing diuretic")
	(message "Patient has an active prescription for potassium sparing diuretics; evaluate clinical significance and impact of prescription for ACE inhibitor.")
	(message_type Primary_Recommendation)
	(rule_in_condition [library_Class70018]))

([KB_313397_Class24] of  Conditional_On_Screen_Message

	(description "PM On ACEi and K sparing diuretic")
	(label "PM On ACEi and K sparing diuretic")
	(message "Patient has an active prescription for potassium sparing diuretics; evaluate clinical significance and impact of prescription for ACE inhibitor.")
	(message_type Primary_Recommendation)
	(rule_in_condition [library_Class70018]))

([KB_313397_Class3] of  Consultation_Action_Step

	(actions
		[KB_313397_Class7]
		[KB_313397_Class9]
		[KB_313397_Class11]
		[KB_313397_Class19]
		[KB_313397_Class20]
		[KB_313397_Class24]
		[KB_486502_Class5]
		[KB_486502_Class8]
		[KB_486502_Class10]
		[KB_486502_Class12]
		[KB_486502_Class15]
		[KB_486502_Class17]
		[ATHENA_HF_Class380817]
		[ATHENA_HF_Class440002]
		[ATHENA_HF_Class440004])
	(label "Messages")
	(rule_in [criterion_INSTANCE_00001]))

([KB_313397_Class4] of  Followed_By

	(%3AFROM [ATHENA_HF_Class170006])
	(%3ATO [KB_313397_Class3]))

([KB_313397_Class5] of  Supporting_Material

	(label "on ace CKD stage 3 or 4 15<=eGFR<60"))

([KB_313397_Class6] of  Supporting_Material
)

([KB_313397_Class7] of  Conditional_On_Screen_Message

	(description "PM on ACEi and CKD stage 3 or 4 or 15<=eGFR<60")
	(label "PM on ACEi and CKD stage 3 or 4 or 15<=eGFR<60")
	(message "Patient has a diagnosis of chronic kidney disease stage 3 or 4, or eGFR between 15 and 60); evaluate clinical significance and impact of prescription for ACEi and frequency of monitoring labs.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_313397_Class8]))

([KB_313397_Class8] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50024]
		[library_Class70009])
	(label "on ACEi and CKD stage 3 or 4 or 15<=eGFR<60")
	(operator AND))

([KB_313397_Class9] of  Conditional_On_Screen_Message

	(description "on ACEi and ckd stage 5 or eGFR<15")
	(label "PM on ace and ckd stage 5 or eGFR<15")
	(message "Patient has a diagnosis of chronic kidney disease stage 5 (or eGFR less than 15), evaluate clinical significance and impact of prescription for ACE inhibitor.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_313397_Class10]))

([KB_315111_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_315111_Class318] of  Qualitative_Constant

	(value "Male"))

([KB_315111_Class320] of  Qualitative_Constant

	(value "Female"))

([KB_335875_Class0] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00016]
		[KB_502940_Class9])
	(label "women <=50 years and on ACE")
	(operator AND))

([KB_335875_Class1] of  Scenario

	(followed_by [ATHENA_HF_Class360004])
	(label "PMs after generating recommendations")
	(new_encounter FALSE)
	(precondition [criterion_INSTANCE_00001]))

([KB_335875_Class10] of  N_ary_Criterion

	(criteria
		[KB_155357_Class71]
		[KB_335875_Class11])
	(label "rec ADD BB or rec ADD AA")
	(operator OR))

([KB_335875_Class11] of  Presence_Criterion

	(domain_term aldosterone+antagonist)
	(entry_type Medication)
	(label "rec ADD AA")
	(mood Recommend_Add)
	(presence TRUE)
	(status "active"))

([KB_335875_Class12] of  Parameterized_Message

	(label "Most recent eGFR<30 and on ACE")
	(message_type Primary_Recommendation)
	(parameterized_message [KB_335875_Class14])
	(rule_in_condition [KB_335875_Class13]))

([KB_335875_Class13] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00016]
		[ATHENA_HF_Class110374])
	(label "most recent eGFR<30 and on ACE")
	(operator AND))

([KB_335875_Class14] of  Parameterized_String

	(label "Most recent eGFR<30 and on ACE")
	(value "Patient has active prescription for ACE inhibitor and most recent eGFR (date ?date) is less than 30.  Evaluate clinically.")
	(variables [KB_335875_Class15]))

([KB_335875_Class15] of  Variable

	(derivation_expression [KB_335875_Class16])
	(label "date for most recent eGFR")
	(string_name "?date"))

([KB_335875_Class16] of  Structured_Query

	(aggregation_operator most_recent)
	(attribute [valid_time])
	(label "most recent date eGFR")
	(type Numeric_Entry)
	(where_restriction [KB_335875_Class17]))

([KB_335875_Class17] of  Comparison_Filter

	(attribute [domain_term])
	(label "domain term eq eGFR")
	(operator eq)
	(value_expression [eGFR]))

([KB_335875_Class19] of  Parameterized_Message

	(label "Most recent eGFR<30 and on ARB")
	(message_type Primary_Recommendation)
	(parameterized_message [KB_335875_Class21])
	(rule_in_condition [KB_335875_Class20]))

([KB_335875_Class2] of  Followed_By

	(%3AFROM [ATHENA_HF_Class270000])
	(%3ATO [KB_335875_Class1]))

([KB_335875_Class20] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class110374]
		[athena_hypertension_141022])
	(label "most recnet eGFR<30 and on ARB")
	(operator AND))

([KB_335875_Class21] of  Parameterized_String

	(label "Most recent eGFR<30 and on ARB")
	(value "Patient has active prescription for an angiotensin receptor blocker and most recent eGFR (date ?date) is less than 30.  Evaluate clinically.")
	(variables [KB_335875_Class15]))

([KB_335875_Class22] of  Conditional_On_Screen_Message

	(description "PM CKD stage 5 ICD")
	(label "PM CKD stage 5 ICD")
	(message "Patient has a diagnosis of CKD stage 5. Evaluate clinical significance.")
	(message_type Primary_Recommendation)
	(rule_in_condition [library_Class50008]))

([KB_335875_Class23] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class300002]
		[KB_335875_Class24])
	(label "eGFR >=30 OR (creatinine <2.5 (men) OR creatinine<2.3 (women)")
	(operator OR))

([KB_335875_Class24] of  Numeric_Term_Criterion

	(aggregation_operator most_recent)
	(entry_type Numeric_Entry)
	(label "most recent eGFR>=30")
	(numeric_domain_term eGFR)
	(operator %3E%3D)
	(status "active")
	(value 30.0))

([KB_335875_Class25] of  Conditional_On_Screen_Message

	(label "Delete")
	(message "Patient has a diagnosis of chronic kidney disease stage 3 or 4, or eGFR between 15 and 60); evaluate clinical significance and impact of prescription for ACEi and frequency of monitoring labs.")
	(message_type Recommendation))

([KB_335875_Class3] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130004])
	(%3ATO [KB_335875_Class1]))

([KB_335875_Class4] of  Followed_By

	(%3AFROM [KB_486502_Class1])
	(%3ATO [KB_335875_Class1]))

([KB_335875_Class5] of  Followed_By

	(%3AFROM [KB_335875_Class1])
	(%3ATO [ATHENA_HF_Class360004]))

([KB_335875_Class6] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[KB_335875_Class7])
	(label "DELETE    LVEF<=40 AND (SPB<110 OR angioedema ACE or Angioedema ARB or high creatinine )")
	(operator AND))

([KB_335875_Class7] of  N_ary_Criterion

	(label "DELETE"))

([KB_335875_Class8] of  Conditional_On_Screen_Message

	(description "PM SBP<110 and (rec add BB or rec add AA)")
	(label "PM SBP<110 and (rec add BB or rec add AA)")
	(message "Most recent SBP less than 110mmHg. Evaluate clinical significance and therapeutic implications.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_335875_Class9]))

([KB_335875_Class9] of  N_ary_Criterion

	(criteria
		[library_Class30020]
		[KB_335875_Class10])
	(label "PM SBP<110 and (rec add BB or rec add AA)")
	(operator AND))

([KB_341641_Class0] of  Presence_Criterion

	(domain_term Diabetes-Mellitus-Type1)
	(entry_type Note_Entry)
	(label "Presence of DM-1")
	(presence TRUE)
	(status "active"))

([KB_341641_Class1] of  Presence_Criterion

	(domain_term DM-Type2)
	(entry_type Note_Entry)
	(label "Presence of DM-2")
	(presence TRUE)
	(status "active"))

([KB_341641_Class2] of  N_ary_Criterion

	(criteria
		[KB_341641_Class0]
		[KB_341641_Class1])
	(label "Presence of DM-1 or DM-2")
	(operator OR))

([KB_376528_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_376528_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_376528_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_377636_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_377636_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_377636_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_390380_Class81] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_407858_Class0] of  %3APAL-CONSTRAINT

	(%3APAL-DESCRIPTION "This criterion restricts the Drug_Usage instances used to check for strong or relative contraindications to those that are in the drug_usages slot of the \"ATHENA HF Astronaut\" guideline.")
	(%3APAL-NAME "There exists strong or relative contraindicated drug, with guideline drug_usages")
	(%3APAL-RANGE "(defrange ?current_med :FRAME Medication)\n(defrange ?problem :FRAME Note_Entry)\n(defrange ?med_class :FRAME Drug_Usage)\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_contraindication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)")
	(%3APAL-STATEMENT "(exists ?current_med \n        (and (or (not (own-slot-not-null mood ?current_med ))\n                 (mood ?current_med Authorized)) \n             (patient_id ?current_med $patient_id)\n             (is-class (drug_name ?current_med))\n             (exists ?med_class\n                     (and (subclass-of (coerce-to-class (drug_name ?current_med)) (Drug_Class_Name ?med_class ))\n                          (exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")\n                                                  (drug_usages ?guideline ?med_class)))\n                          (or (exists ?contraindication \n                                      (and  (or (Absolute_Contraindications ?med_class ?contraindication)\n                                                (Relative_Contraindications ?med_class ?contraindication))\n                                            (exists ?problem \n                                                    (and (patient_id ?problem $patient_id)\n                                                         (is-class (domain_term ?problem) )\n                                                         (equal-or-subclass-of  (coerce-to-class (domain_term ?problem))\n                                                                                ?contraindication)))\n                                      ))\n                              (exists ?derived_contraindication\n                                      (and (or (Absolute_Contraindications ?med_class ?derived_contraindication)\n                                               (Relative_Contraindications ?med_class ?derived_contraindication))\n                                           (is-derivable ?derived_contraindication)\n                                               \n                                      ))\n                          ))))\n)"))

([KB_407858_Class1] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "there exists a strong or relative contraindicated current med according to Astronaut guideline drug_usages")
	(PAL_constraint [KB_407858_Class0]))

([KB_407858_Class2] of  PAL_Query

	(case_variable "$patient_id")
	(key_slot [drug_name])
	(label "query for strong or relative contraindicated current med in guideline drug_usage class")
	(PAL_query [KB_407858_Class3]))

([KB_407858_Class3] of  PAL-QUERY

	(%3APAL-NAME "query for strong or relative contraindicated current med in guideline drug usage class")
	(%3APAL-RANGE "(defrange ?current_med :FRAME Medication)\n(defrange ?problem :FRAME Note_Entry)\n(defrange ?med_class :FRAME Drug_Usage)\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_contraindication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)\n")
	(%3APAL-STATEMENT "(findall ?current_med\n         (and (or (not (own-slot-not-null mood ?current_med ))\n                  (mood ?current_med Authorized))\n              (patient_id ?current_med $patient_id)\n              (is-class (drug_name ?current_med))\n              (exists ?med_class\n                      (and (equal-or-subclass-of (coerce-to-class (drug_name ?current_med)) (Drug_Class_Name ?med_class ))\n                           (exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")(drug_usages ?guideline ?med_class)))\n                           (or (exists ?contraindication\n                                       (and (or  (Absolute_Contraindications ?med_class ?contraindication)\n                                                 (Relative_Contraindications ?med_class ?contraindication))\n                                            (exists ?problem\n                                                    (and (patient_id ?problem $patient_id)\n                                                         (is-class (domain_term ?problem) )\n                                                         (equal-or-subclass-of  (coerce-to-class (domain_term ?problem))\n                                                                                ?contraindication)\n                                                    ))))\n                               (exists ?derived_contraindication                           \n                                       (and (or (Absolute_Contraindications ?med_class ?derived_contraindication)\n                                                (Relative_Contraindications ?med_class ?derived_contraindication))\n                                            		(is-derivable ?derived_contraindication)\n                                       )))))))\n"))

([KB_407858_Class4] of  Variable

	(derivation_expression [KB_407858_Class5])
	(label "There exists strong or relative contraindicated drug")
	(string_name "?relcontra"))

([KB_407858_Class5] of  Conditional_Expression

	(label "There exists strong or relative contraindicated drug")
	(precondition [KB_407858_Class1])
	(value [KB_407858_Class2]))

([KB_408923_Class217] of  Qualitative_Constant

	(value "Female"))

([KB_408923_Class220] of  Qualitative_Constant

	(value "Male"))

([KB_408923_Class81] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_412386_Class0] of  Presence_Criterion

	(domain_term Heart_failure_N)
	(entry_type Note_Entry)
	(label "Absence HF_N")
	(presence FALSE))

([KB_412386_Class1] of  N_ary_Criterion

	(criteria
		[KB_412386_Class0]
		[ATHENA_HF_Class60088])
	(label "Absence of HF and HF_N")
	(operator AND))

([KB_412386_Class2] of  Presence_Criterion

	(domain_term TRANSPLANT002)
	(entry_type Procedure)
	(label "Absence of heart transplant ICD")
	(presence FALSE))

([KB_412386_Class3] of  Presence_Criterion

	(domain_term heart_transplant_CPT)
	(entry_type Note_Entry)
	(label "Absence of heart transplant CPT")
	(presence FALSE))

([KB_412386_Class5] of  Drug_Usage

	(Absolute_Contraindications Lupus_ADR_hydralazine)
	(collateral_actions
		[KB_899077_Class9]
		[ATHENA_HF_Class401990])
	(Compelling_Indications
		African_American_and_NYHA_III_IV_symptoms_ACE_or_ARB_and_BB
		LVEF%3C%3D40_and_NYHA_Class_IIi_or_IV_and_ACE_intolerance)
	(Drug_Class_Name hydralazine)
	(label "hydralazine Astronaut II")
	(Relative_Contraindications Lupus))

([KB_412386_Class6] of  Drug_Usage

	(Absolute_Contraindications Presence_phosphodiesterase_inhibitor)
	(collateral_actions
		[KB_899077_Class9]
		[ATHENA_HF_Class401988])
	(Compelling_Indications
		African_American_and_NYHA_III_IV_symptoms_ACE_or_ARB_and_BB
		LVEF%3C%3D40_and_NYHA_Class_IIi_or_IV_and_ACE_intolerance)
	(Drug_Class_Name Isosorbide_dinitrate)
	(label "isosorbide dinitrate Astronaut II"))

([KB_412412_Class0] of  Guideline_Drug

	(generic_drug spironolactone)
	(label "spironolactone")
	(starting_dose 12.5))

([KB_421296_Class0] of  Qualitative_Constant

	(value "BLACK OR AFRICAN AMERICAN, HISPANIC OR LATINO"))

([KB_421296_Class1] of  Qualitative_Constant

	(value "BLACK OR AFRICAN AMERICAN, NOT HISPANIC OR LATINO"))

([KB_421296_Class10] of  N_ary_Criterion

	(criteria
		[KB_247253_Class2]
		[KB_421296_Class15])
	(label "Hydralazine and nitrates or contra AND African American OR cannot tolerate ACE/ARB")
	(operator OR))

([KB_421296_Class11] of  N_ary_Criterion

	(criteria
		[KB_261275_Class3]
		[KB_149589_Class15])
	(label "hydralazine and cannot tolerate ACEI or ARB")
	(operator AND))

([KB_421296_Class12] of  N_ary_Criterion

	(criteria
		[KB_261275_Class3]
		[KB_149589_Class16])
	(label "isosorbide dinitrate and cannot tolerate ACEI or ARB")
	(operator AND))

([KB_421296_Class13] of  N_ary_Criterion

	(criteria
		[KB_421296_Class11]
		[ATHENA_HF_Class460022])
	(label "hydralazine and cannot tolerate ACEI or ARB or contra")
	(operator OR))

([KB_421296_Class14] of  N_ary_Criterion

	(criteria
		[KB_421296_Class12]
		[ATHENA_HF_Class460018])
	(label "isosorbide dinitrate and cannot tolerate ACEI or ARB or contra")
	(operator OR))

([KB_421296_Class15] of  N_ary_Criterion

	(criteria
		[KB_421296_Class13]
		[KB_421296_Class14])
	(label "hydralazine and cannot tolerate ACE/ARB or contra AND isosorbide dinitrate and cannot tolerate ACE/ARB or contra")
	(operator AND))

([KB_421296_Class2] of  Qualitative_Constant

	(value "HISPANIC, BLACK, HISPANIC OR LATINO"))

([KB_421296_Class3] of  Qualitative_Constant

	(value "HISPANIC, BLACK, NOT HISPANIC OR LATINO"))

([KB_421296_Class4] of  General_Comparison_Criterion

	(domain_term Race)
	(entry_type Patient)
	(label "BLACK OR AFRICAN AMERICAN, HISPANIC OR LATINO")
	(operator eq)
	(value [KB_421296_Class0]))

([KB_421296_Class5] of  General_Comparison_Criterion

	(domain_term Race)
	(entry_type Patient)
	(label "BLACK OR AFRICAN AMERICAN, NOT HISPANIC OR LATINO")
	(operator eq)
	(value [KB_421296_Class1]))

([KB_421296_Class6] of  General_Comparison_Criterion

	(domain_term Race)
	(entry_type Patient)
	(label "HISPANIC, BLACK, HISPANIC OR LATINO")
	(operator eq)
	(value [KB_421296_Class2]))

([KB_421296_Class7] of  General_Comparison_Criterion

	(domain_term Race)
	(entry_type Patient)
	(label "HISPANIC, BLACK, NOT HISPANIC OR LATINO")
	(operator eq)
	(value [KB_421296_Class3]))

([KB_421296_Class8] of  N_ary_Criterion

	(criteria
		[ATHENA_CKD_Instance_70020]
		[ATHENA_CKD_Instance_70022]
		[KB_421296_Class4]
		[KB_421296_Class5]
		[KB_421296_Class6]
		[KB_421296_Class7])
	(label "African American too")
	(operator OR))

([KB_421296_Class9] of  N_ary_Criterion

	(criteria [KB_421296_Class8])
	(label "not African American too")
	(operator NOT))

([KB_421688_Class89] of  N_ary_Criterion

	(label "Eligibility criteria")
	(operator AND))

([KB_423334_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_423334_Class318] of  Qualitative_Constant

	(value "Male"))

([KB_423334_Class320] of  Qualitative_Constant

	(value "Female"))

([KB_433271_Class0] of  Drug_Usage

	(collateral_actions [KB_899077_Class8])
	(Compelling_Indications LVEF%3C%3D40+and+MI)
	(Drug_Class_Name Beta_Blocker+Stage+C+Heart+Failure)
	(Drug_Partners_To_Avoid sotalol)
	(formulary_preferred_drug_in_class [KB_433271_Class1])
	(label "DO NOT USE Beta Blocker MI  Astronaut II")
	(Relative_Contraindications
		Aortic_stenosis
		Asthma
		Prescription_verapamil))

([KB_433271_Class1] of  Guideline_Drug

	(generic_drug carvedilol)
	(label "Carvedilol MI")
	(rule_in [ATHENA_HF_Class50011])
	(starting_dose 6.25))

([KB_433271_Class2] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50018])
	(label "LVEF<=40 and absence of MI")
	(operator AND))

([KB_433271_Class4] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[ATHENA_HF_Class50011])
	(label "LVEF<=40 and MI")
	(operator AND))

([KB_433271_Class6] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "ACE Inhibitor in guideline has relative or absolute contraindication")
	(%3APAL-RANGE "(defrange ?current_med :FRAME Medication)\n(defrange ?problem :FRAME Medical_Conditions_Metaclass))\n(defrange ?med_class :FRAME Drug_Usage)\n(defrange ?derived_contraindication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)\n(defrange ?condition :FRAME Note_Entry)\n(defrange ?derived_problem :FRAME Diagnostic_Term_Metaclass)\n(defrange ?drug_usage :FRAME Drug_Usage)")
	(%3APAL-STATEMENT "(exists ?drug_usage\n        (and (Drug_Class_Name ?drug_usage ACE_Inhibitors)\n             		(exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")\n                                       (drug_usages ?guideline ?drug_usage)))           \n             (or (exists ?condition\n                         (and (patient_id ?condition $patient_id)\n                                  (is-class (domain_term ?condition))\n                             (exists ?problem\n                                      (and (or (Absolute_Contraindications ?drug_usage ?problem)\n                                               (Relative_Contraindications ?drug_usage ?problem))\n                                           (or (= (coerce-to-class (domain_term ?condition)) ?problem )\n                                               (subclass-of (coerce-to-class (domain_term ?condition)) ?problem ))\n                                      ))))\n                 (exists  ?derived_problem\n                          (and (or (Absolute_Contraindications ?drug_usage ?derived_problem)\n                                   (Relative_Contraindications ?drug_usage ?derived_problem))\n                               (is-derivable ?derived_problem))))\n        )\n)\n"))

([KB_436714_Class462] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_436714_Class490] of  Qualitative_Constant

	(value "Male"))

([KB_436714_Class492] of  Qualitative_Constant

	(value "Female"))

([KB_438400_Class1] of  %3APAL-CONSTRAINT

	(%3APAL-DESCRIPTION "This criterion restricts the Drug_Usage instances used to check for contraindications to those that are in the drug_usages slot of the \"ATHENA HF Astronaut\" guideline.")
	(%3APAL-NAME "There exists contraindicated drug, with guideline drug_usages")
	(%3APAL-RANGE "(defrange ?current_med :FRAME Medication)\n(defrange ?problem :FRAME Note_Entry)\n(defrange ?med_class :FRAME Drug_Usage)\n(defrange ?contraindication :FRAME Medical_Conditions_Metaclass)\n(defrange ?derived_contraindication :FRAME Diagnostic_Term_Metaclass)\n(defrange ?guideline :FRAME Management_Guideline)")
	(%3APAL-STATEMENT "(exists ?current_med \n        (and (or (not (own-slot-not-null mood ?current_med ))\n                 (mood ?current_med Authorized)) \n             (patient_id ?current_med $patient_id)\n             (is-class (drug_name ?current_med))\n             (exists ?med_class\n                     (and (subclass-of (coerce-to-class (drug_name ?current_med)) (Drug_Class_Name ?med_class ))\n                          (exists ?guideline (and (label ?guideline \"ATHENA HF Astronaut\")\n                                                  (drug_usages ?guideline ?med_class)))\n                          (or (exists ?contraindication \n                                      (and  (Absolute_Contraindications ?med_class ?contraindication)\n                                            (exists ?problem \n                                                    (and (patient_id ?problem $patient_id)\n                                                         (is-class (domain_term ?problem) )\n                                                         (equal-or-subclass-of  (coerce-to-class (domain_term ?problem))\n                                                                                ?contraindication)))\n                                      ))\n                              (exists ?derived_contraindication\n                                      (and (Absolute_Contraindications ?med_class ?derived_contraindication)\n                                           (is-derivable ?derived_contraindication)\n                                               \n                                      ))\n                          ))))\n)"))

([KB_438400_Class4] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "there exists a contraindicated current med according to Astronaut guideline drug_usages")
	(PAL_constraint [KB_438400_Class1]))

([KB_442092_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_442092_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_442092_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_443299_Class0] of  Guideline_Drug

	(dose_level_ranges [ATHENA_HF_Class10002])
	(dose_strength_unit mg_per_mL)
	(generic_drug captopril)
	(label "Captopril")
	(max_recommended_dose_level Low_Dose%28high%2Flow%29)
	(rule_in [ATHENA_HF_Class50043])
	(starting_dose 18.75))

([KB_443299_Class1] of  Guideline_Drug

	(collateral_actions
		[ATHENA_HF_Class110354]
		[ATHENA_HF_Class110359])
	(dose_level_ranges [ATHENA_HF_Class50041])
	(drug_usage [ATHENA_HF_Class10000])
	(generic_drug lisinopril)
	(label "Lisinopril")
	(max_recommended_dose_level High_Dose%28high%2Flow%29)
	(rule_in [ATHENA_HF_Class50043])
	(starting_dose 2.5))

([KB_444257_Class110] of  Qualitative_Constant

	(value "Male"))

([KB_444257_Class112] of  Qualitative_Constant

	(value "Female"))

([KB_444257_Class209] of  Qualitative_Constant

	(value "Female"))

([KB_444257_Class84] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_451095_Class81] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_459737_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_459737_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_459737_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_469476_Class216] of  Qualitative_Constant

	(value "Female"))

([KB_469476_Class219] of  Qualitative_Constant

	(value "Male"))

([KB_469476_Class81] of  N_ary_Criterion

	(label "Eligibility criteria")
	(operator AND))

([KB_479685_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_479685_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_479685_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_482846_Class0] of  Qualitative_Constant

	(value "UNKNOWN BY PATIENT"))

([KB_482846_Class1] of  Qualitative_Constant

	(value "UNKNOWN BY PATIENT, DECLINED TO ANSWER"))

([KB_482846_Class2] of  Qualitative_Constant

	(value "DECLINED TO ANSWER, DECLINED TO ANSWER"))

([KB_482846_Class3] of  General_Comparison_Criterion

	(domain_term Race)
	(entry_type Patient)
	(label "DECLINED TO ANSWER, DECLINED TO ANSWER")
	(operator eq)
	(value [KB_482846_Class2]))

([KB_482846_Class4] of  General_Comparison_Criterion

	(domain_term Race)
	(entry_type Patient)
	(label "UNKNOWN BY PATIENT")
	(operator eq)
	(value [KB_482846_Class0]))

([KB_482846_Class5] of  General_Comparison_Criterion

	(domain_term Race)
	(entry_type Patient)
	(label "UNKNOWN BY PATIENT, DECLINED TO ANSWER")
	(operator eq)
	(value [KB_482846_Class1]))

([KB_482846_Class6] of  N_ary_Criterion

	(criteria
		[KB_482846_Class4]
		[KB_482846_Class5]
		[KB_482846_Class3])
	(label "unknown race in deId data")
	(operator OR))

([KB_485757_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_485757_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_485757_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_486502_Class0] of  Conditional_On_Screen_Message

	(label "PM 20% increase of creatinine after starting ACE inhibitor")
	(message "Patient had an increase of more than 20% of creatinine (comparing pre ACE inhibitor value with peak value within 3m after starting ACE inhibitor) after starting ACE inhibitor.")
	(message_type Recommendation)
	(rule_in_condition [library_Class70000]))

([KB_486502_Class1] of  Action_Choice

	(actions
		[KB_810954_Class12]
		[KB_155357_Class2]
		[KB_155357_Class14]
		[ATHENA_HF_Class440006])
	(followed_by [KB_335875_Class1])
	(label "LVEF<=40 and  SBP<110")
	(strict_rule_in_condition [KB_810954_Class11]))

([KB_486502_Class10] of  Conditional_On_Screen_Message

	(description "PM On ARB and renal artery stenosis")
	(label "PM On ARB and renal artery stenosis")
	(message "Patient has a diagnosis of renal artery stenosis; evaluate clinical significance and impact of prescription for angiotensin receptor blocker.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_486502_Class11]))

([KB_486502_Class11] of  N_ary_Criterion

	(criteria
		[library_Class50004]
		[athena_hypertension_141022])
	(label "On ARB and renal artery stenosis")
	(operator AND))

([KB_486502_Class12] of  Conditional_On_Screen_Message

	(description "PM on ARB and 20 percent increase in creatinine after starting ARB or ACE inhibitor")
	(label "PM on ARB and 20 percent increase in creatinine after starting ARB or ACE inhibitor")
	(message "Patient had 20% increase in creatinine after initiation of ACE inhibitor or ARB; evaluate clinical significance and impact of prescription for aldosterone antagonist blocker.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_486502_Class13]))

([KB_486502_Class13] of  N_ary_Criterion

	(criteria
		[athena_hypertension_141022]
		[library_Class70000])
	(label "on ARB and 20 percent increase in creatinine after starting ARB or ACE inhibitor")
	(operator AND))

([KB_486502_Class14] of  N_ary_Criterion

	(criteria
		[library_Class70000]
		[athena_hypertension_INSTANCE_00016])
	(label "PM on ACEi and 20 percent increase in creatinine after starting ACEi or ARB")
	(operator AND))

([KB_486502_Class15] of  Conditional_On_Screen_Message

	(description "PM on ARB and prescription for Aliskiren (current)")
	(label "PM on ARB and prescription for Aliskiren (current)")
	(message "Patient has a prescription for aliskiren; evaluate clinical significance and impact of prescription for angiotensin receptor blocker.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_486502_Class16]))

([KB_486502_Class16] of  N_ary_Criterion

	(criteria
		[library_Class70016]
		[athena_hypertension_141022])
	(label "on ARB and prescription for Aliskiren (current)")
	(operator AND))

([KB_486502_Class17] of  Conditional_On_Screen_Message

	(description "PM On ARB and K sparing diuretic")
	(label "PM On ARB and K sparing diuretic")
	(message "Patient has an active prescription for potassium sparing diuretics; evaluate clinical significance and impact of prescription for angiotensin receptor blocker.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_486502_Class18]))

([KB_486502_Class18] of  N_ary_Criterion

	(criteria
		[athena_hypertension_141022]
		[library_Class70018])
	(label "active prescrition for ARB and K sparing diuretics")
	(operator AND))

([KB_486502_Class19] of  Conditional_On_Screen_Message

	(description "PM rec ADD ACE inhibitor and renal artery stenosis")
	(label "DELETE  PM rec ADD ACE inhibitor and renal artery stenosis")
	(message_type Primary_Recommendation))

([KB_486502_Class2] of  Conditional_On_Screen_Message

	(description "PM Rec ADD ARB and CKD stage 3/4 or most recent 15<=eGFR<60")
	(label "PM Rec ADD ARB and CKD stage 3/4 or most recent 15<=eGFR<60")
	(message "Patient has a diagnosis of chronic kidney disease stage 3 or 4, or most recent eGFR between 15 and 59; evaluate clinical significance and impact of prescription for ARB and frequency of monitoring labs.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_486502_Class4]))

([KB_486502_Class20] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130001])
	(%3ATO [ATHENA_HF_Class130002]))

([KB_486502_Class3] of  Conditional_On_Screen_Message

	(description "PM  hydralazine and nitrates together are beneficial")
	(label "PM  hydralazine and nitrates together are beneficial")
	(message "Hydralazine and nitrates TOGETHER are beneficial to patients with HF.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_048666_Class1]))

([KB_486502_Class4] of  N_ary_Criterion

	(criteria
		[athena_hypertension_305979]
		[library_Class50000])
	(label "ADD ARB AND (CKD stage 3/4 OR eGFR btw 15 and 60)")
	(operator AND))

([KB_486502_Class5] of  Conditional_On_Screen_Message

	(description "PM On ARB and CKD stage 3/4 OR 15<=eGFR<60")
	(label "PM On ARB and CKD stage 3/4 OR 15<=eGFR<60")
	(message "Patient has a diagnosis of chronic kidney disease stage 3 or 4, or most recent eGFR between 15 and 59); evaluate clinical significance and impact of prescription for ARB and frequency of monitoring labs.")
	(message_type Primary_Recommendation)
	(rule_in_condition [athena_hypertension_141022]))

([KB_486502_Class6] of  Conditional_On_Screen_Message

	(description "PM Rec ADD ACEi and CKD stage 3/4 or most recent 15<=eGFR<60")
	(label "PM Rec ADD ACEi and CKD stage 3/4 or most recent 15<=eGFR<60")
	(message "Patient has a diagnosis of chronic kidney disease stage 3 or 4, or most recent eGFR between 15 and 59); evaluate clinical significance and impact of prescription for ACE inhibitor and frequency of monitoring labs.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_486502_Class7]))

([KB_486502_Class7] of  N_ary_Criterion

	(criteria
		[athena_hypertension_00154]
		[library_Class50000])
	(label "Rec ADD ACEi AND (CKD stage 3/4 OR 15<=eGFR<60)")
	(operator AND))

([KB_486502_Class8] of  Conditional_On_Screen_Message

	(description "PM on ARB and (CKD stage 5 OR most recent  eGFR<15)")
	(label "PM on ARB and (CKD stage 5 OR most recent  eGFR<15)")
	(message "Patient has a diagnosis of chronic kidney disease stage 5 (or eGFR less than 15), evaluate clinical significance and impact of prescription for angiotensin receptor blocker.")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_486502_Class9]))

([KB_486502_Class9] of  N_ary_Criterion

	(criteria
		[athena_hypertension_141022]
		[library_Class70013])
	(label "ON ARB AND (CKD stage 5 OR most recent eGFR<15)")
	(operator AND))

([KB_490421_Class0] of  General_Comparison_Criterion

	(domain_term Race)
	(entry_type Note_Entry)
	(label "Black")
	(operator subclass_of)
	(status "active")
	(value [Black]))

([KB_490421_Class1] of  Qualitative_Constant

	(label "Black")
	(value "Black"))

([KB_494836_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_494836_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_494836_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_502940_Class0] of  Conditional_On_Screen_Message

	(description "PM Pregnancy message")
	(label "PM Pregnancy message")
	(message "ACE inhibitor is contraindicated in pregnant women; assess pregnancy status.")
	(message_type Primary_Recommendation)
	(rule_in_condition [athena_hypertension_238799]))

([KB_502940_Class10] of  Numeric_Term_Criterion

	(entry_type Numeric_Entry)
	(label "age<=50")
	(numeric_domain_term Age)
	(operator %3C%3D)
	(value 50.0))

([KB_502940_Class2] of  Consultation_Guideline

	(first_step [KB_502940_Class3])
	(label "PM after generating recs")
	(steps
		[KB_502940_Class3]
		[KB_502940_Class4])
	(transitions [KB_502940_Class5]))

([KB_502940_Class3] of  Consultation_Branch_Step

	(label "PM after generating recs")
	(selection_method all_of))

([KB_502940_Class4] of  Consultation_Action_Step

	(actions [KB_502940_Class6])
	(label "PM after generating recs"))

([KB_502940_Class5] of  Followed_By

	(%3AFROM [KB_502940_Class3])
	(%3ATO [KB_502940_Class4]))

([KB_502940_Class6] of  Conditional_On_Screen_Message

	(description "PM ACE Pregnancy warning")
	(label "PM Pregancy warning (add ACEi or on ACEi)")
	(message "ACE inhibitor is contraindicated in pregnant women; assess pregnancy status")
	(message_type Primary_Recommendation)
	(rule_in_condition [KB_502940_Class7]))

([KB_502940_Class7] of  N_ary_Criterion

	(criteria
		[KB_502940_Class8]
		[KB_335875_Class0])
	(label "(women <=50 years and add ACE) OR (women <=50 and ON ACEI)")
	(operator OR))

([KB_502940_Class8] of  N_ary_Criterion

	(criteria
		[KB_502940_Class9]
		[athena_hypertension_00154])
	(label "women <=50 and add ACEI")
	(operator AND))

([KB_502940_Class9] of  N_ary_Criterion

	(criteria
		[athena_hypertension_INSTANCE_00100]
		[KB_502940_Class10])
	(label "Women <= 50 years")
	(operator AND))

([KB_503818_Class81] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_564278_Class0] of  N_ary_Criterion

	(criteria [KB_810954_Class10])
	(label "NOT angioedema ACE or ARB")
	(operator NOT))

([KB_567743_Class0] of  N_ary_Criterion

	(criteria
		[library_Class110013]
		[library_Class50008]
		[KB_261275_Class0])
	(label "Decision 1st eGFR<=30 or creat>=2.5 male, 2.3 female) OR ICD CKD stage 4 OR ICD stage 5")
	(operator OR))

([KB_579166_Class133] of  Qualitative_Constant

	(value "Female"))

([KB_579166_Class135] of  Qualitative_Constant

	(value "Male"))

([KB_579166_Class89] of  N_ary_Criterion

	(label "Eligibility criteria")
	(operator AND))

([KB_606662_Class0] of  Collateral_Action

	(mood Recommend_Add))

([KB_606662_Class10] of  PAL-QUERY

	(%3APAL-NAME "find guideline med with 0.0 < MPR < 0.9")
	(%3APAL-RANGE "(defrange ?med :FRAME Medication)\n(defrange ?drugUsage :FRAME Drug_Usage)\n(defrange ?guideline :FRAME Management_Guideline)")
	(%3APAL-STATEMENT "(findall ?med \n         (and (= (patient_id ?med) $patient_id) \n              (isa-classname (drug_name ?med))\n              (< (medication_possession_ratio ?med) 0.9)\n              (< 0.0 (medication_possession_ratio ?med))             \n              (or  (not (own-slot-not-null mood ?med))(= (mood ?med) Authorized))\n              (exists ?drugUsage (and \n                                      (exists ?guideline (and (drug_usages ?guideline ?drugUsage)\n                                                              (= (label ?guideline) \"ATHENA HF Astronaut\")))\n                                      (subclass-of (coerce-to-class (drug_name ?med))(Drug_Class_Name ?drugUsage))))\n         ))"))

([KB_606662_Class2] of  PAL_Criterion

	(case_variable "$patient_id")
	(label "Presence of guideline med with 0.0>MPR<0.9")
	(PAL_constraint [KB_606662_Class3]))

([KB_606662_Class3] of  %3APAL-CONSTRAINT

	(%3APAL-NAME "Presence of guideline med with 0.0 < MPR < 0.9")
	(%3APAL-RANGE "(defrange ?med :FRAME Medication)\n(defrange ?drugUsage :FRAME Drug_Usage)\n(defrange ?guideline :FRAME Management_Guideline)")
	(%3APAL-STATEMENT "(exists ?med \n        (and (= (patient_id ?med) $patient_id) \n             (isa-classname (drug_name ?med))\n             (< (medication_possession_ratio ?med) 0.9)\n             (< 0.0 (medication_possession_ratio ?med))             \n             (or  (not (own-slot-not-null mood ?med))(= (mood ?med) Authorized))\n             (exists ?drugUsage (and \n                                     (exists ?guideline (and (drug_usages ?guideline ?drugUsage)\n                                                             (= (label ?guideline) \"ATHENA HF Astronaut\")))\n                                     (subclass-of (coerce-to-class (drug_name ?med))(Drug_Class_Name ?drugUsage))))\n        ))"))

([KB_606662_Class4] of  Parameterized_String

	(label "Lisinopril MPR < 0.7 message")
	(multivalued_variables [KB_606662_Class6])
	(value "Patient appears not to be adhering to lisinopril prescription (MPR =?mpr, present release time = ?prt). Confirm and evaluate clinical strategy."))

([KB_606662_Class6] of  Variable_ValueSet

	(derivation_expression [KB_606662_Class9])
	(label "Query for ?mpr, ?prt")
	(property_values_to_get
		[KB_606662_Class7]
		[KB_606662_Class8]))

([KB_606662_Class7] of  Property_Value

	(slot [medication_possession_ratio])
	(string_name "?mpr"))

([KB_606662_Class8] of  Property_Value

	(slot [present_release_time])
	(string_name "?prt"))

([KB_606662_Class9] of  PAL_Query

	(case_variable "$patient_id")
	(label "find guideline med with 0.0<MPR<0.9")
	(PAL_query [KB_606662_Class10]))

([KB_618647_Class0] of  Evaluate_Substitution_Activity

	(activity_class "Medication")
	(activity_spec Drug_Usage)
	(activity_spec_key [Drug_Class_Name])
	(activity_to_stop [ATHENA_HF_Class450004])
	(alternatives
		[ATHENA_HF_Class260000]
		[ATHENA_HF_Class240006]
		[ATHENA_HF_Class180005]
		[ATHENA_HF_Class340000]
		[KB_412386_Class5]
		[KB_412386_Class6]
		[KB_433271_Class0])
	(label "Presence of contraindication, eval substituion Astronaut"))

([KB_618647_Class1] of  Action_Choice

	(actions
		[KB_618647_Class0]
		[ATHENA_HF_Class160000]
		[ATHENA_HF_Class230001]
		[ATHENA_HF_Class230003]
		[ATHENA_HF_Class230005])
	(label "Presence of contraindication, Substitute")
	(strict_rule_in_condition [ATHENA_HF_Class430002]))

([KB_618647_Class2] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [KB_618647_Class1]))

([KB_632464_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_632464_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_632464_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_637536_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_637536_Class318] of  Qualitative_Constant

	(value "Male"))

([KB_637536_Class320] of  Qualitative_Constant

	(value "Female"))

([KB_645796_Class216] of  Qualitative_Constant

	(value "Female"))

([KB_645796_Class219] of  Qualitative_Constant

	(value "Male"))

([KB_645796_Class81] of  N_ary_Criterion

	(label "Eligibility criteria")
	(operator AND))

([KB_660669_Class0] of  Qualitative_Constant

	(label "NYHA_ClassI")
	(value "NYHA_ClassI"))

([KB_660669_Class1] of  Qualitative_Constant

	(label "NYHA_ClassII")
	(value "NYHA_ClassII"))

([KB_660669_Class2] of  Qualitative_Constant

	(label "NYHA_ClassIII")
	(value "NYHA_ClassIII"))

([KB_660669_Class3] of  Qualitative_Constant

	(label "NYHA_ClassIV")
	(value "NYHA_ClassIV"))

([KB_660669_Class4] of  Qualitative_Constant

	(label "NYHA_ClassIV_ambulatory")
	(value "NYHA_ClassIV_ambulatory"))

([KB_671524_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_671524_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_671524_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_697720_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_697720_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_697720_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_699901_Class214] of  Qualitative_Constant

	(value "Female"))

([KB_699901_Class217] of  Qualitative_Constant

	(value "Male"))

([KB_707214_Class0] of  N_ary_Criterion

	(criteria [ATHENA_HF_Class100013])
	(label "Not Stage D HF (refractory end stage HF)")
	(operator NOT))

([KB_753810_Class213] of  Qualitative_Constant

	(value "Female"))

([KB_753810_Class216] of  Qualitative_Constant

	(value "Male"))

([KB_753810_Class79] of  N_ary_Criterion

	(label "Eligibility criteria")
	(operator AND))

([KB_768321_Class0] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class270266]
		[athena_hypertension_INSTANCE_00054]
		[ATHENA_HF_Class60054])
	(label "Absence of NYHA or DM AND absence of AA")
	(operator AND))

([KB_768321_Class1] of  N_ary_Criterion

	(criteria
		[KB_240498_Class14]
		[KB_240498_Class15])
	(label "Absence of hydralazine or isosorbide dinitrates")
	(operator OR))

([KB_768321_Class2] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class60054]
		[KB_768321_Class1])
	(label "Absence of HF symptoms and Absence of hydralazine or nitrates")
	(operator AND))

([KB_778916_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_778916_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_778916_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_783525_Class0] of  PAL-QUERY

	(%3APAL-NAME "Patient taking drug harmful to HF")
	(%3APAL-RANGE "(defrange ?med :FRAME Medication)")
	(%3APAL-STATEMENT "(findall ?med (and (patient_id ?med $patient_id)\n                   (is-class (drug_name ?med))\n                   (or (not (own-slot-not-null mood ?med))\n                       (mood ?med Authorized))\n                   (subclass-of (coerce-to-class (drug_name ?med))(coerce-to-class \"Harmful_to_HF\")))\n)"))

([KB_783525_Class1] of  PAL_Query

	(case_variable "$patient_id")
	(key_slot [drug_name])
	(label "patient taking drug harmful to HF")
	(PAL_query [KB_783525_Class0]))

([KB_783525_Class2] of  Variable

	(derivation_expression [ATHENA_HF_Class450002])
	(label "?harmful_HF_drug")
	(string_name "?harmful_HF_drug"))

([KB_783525_Class3] of  Parameterized_String

	(value "Patient is taking ?harmful_HF_drug that may be harmful to those with HF.")
	(variables [KB_783525_Class2]))

([KB_783525_Class4] of  Parameterized_Message

	(label "Patient is taking $harmful_HF_drug")
	(message_type Primary_Recommendation)
	(parameterized_message [KB_783525_Class3])
	(rule_in_condition [KB_783525_Class5]))

([KB_783525_Class5] of  Presence_Criterion

	(domain_term Harmful_to_HF)
	(entry_type Medication)
	(label "Presence of harmful HF drug")
	(presence TRUE)
	(status "active"))

([KB_794216_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_794216_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_794216_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_810954_Class0] of  N_ary_Criterion

	(criteria [library_Class70000])
	(label "NOT increase 20% creat after start ACEi/ARB")
	(operator NOT))

([KB_810954_Class1] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130002])
	(%3ATO [KB_486502_Class1]))

([KB_810954_Class10] of  N_ary_Criterion

	(criteria
		[library_Class120000]
		[library_Class140004])
	(label "angioedema ARB or ACE inhibitor")
	(operator OR))

([KB_810954_Class11] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50019]
		[library_Class30020])
	(label "LVEF<=40 and SBP<110")
	(operator AND))

([KB_810954_Class12] of  Evaluate_Start_Activity

	(alternatives
		[ATHENA_HF_Class180005]
		[ATHENA_HF_Class340000])
	(label "Evaluate start BB stage C HF and AA"))

([KB_810954_Class14] of  Conditional_On_Screen_Message

	(description "PM Angioedema as a reaction to ACEi")
	(label "PM Angioedema as a reaction to ACEi")
	(message "Patient has angioedema as a recorded allergy to ACE inhibitor. Evaluate clinical significance.")
	(message_type Recommendation)
	(rule_in_condition [library_Class120000]))

([KB_810954_Class15] of  N_ary_Criterion

	(operator NOT))

([KB_810954_Class16] of  N_ary_Criterion

	(operator OR))

([KB_810954_Class2] of  N_ary_Criterion

	(criteria
		[KB_810954_Class3]
		[KB_810954_Class4]
		[ATHENA_HF_Class50019]
		[KB_810954_Class5]
		[library_Class120000])
	(label "LVEF<=40 and Angioedema ACEi (not kidney failure and NOT SBP<110 and not 20%increase creat)")
	(operator AND))

([KB_810954_Class3] of  N_ary_Criterion

	(criteria [library_Class30020])
	(label "NOT SBP<110")
	(operator NOT))

([KB_810954_Class4] of  N_ary_Criterion

	(criteria [KB_155357_Class38])
	(label "NOT CKD stage4/5 or eGFR<30 or high creatinine")
	(operator NOT))

([KB_810954_Class5] of  N_ary_Criterion

	(criteria [library_Class70000])
	(label "NOT 20%increase creatinine post ARB/ACEi")
	(operator NOT))

([KB_810954_Class6] of  Evaluate_Start_Activity

	(alternatives
		[KB_412386_Class5]
		[ATHENA_HF_Class150001]
		[KB_412386_Class6]
		[ATHENA_HF_Class240002])
	(label "LVEF<=40, angioedema ACE, NOT SPB<110, NOT kidney failure, NOT 20%increase creat after ACEi/ARB"))

([KB_814969_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_814969_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_814969_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_866213_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_866213_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_866213_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_874985_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_874985_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_874985_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_881797_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_881797_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_881797_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_883703_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_883703_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_883703_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_886846_Class0] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class50043]
		[KB_886846_Class1])
	(label "Presence of HF or HF_N")
	(operator OR))

([KB_886846_Class1] of  Presence_Criterion

	(domain_term Heart_failure_N)
	(entry_type Note_Entry)
	(label "Presence of HF_N")
	(presence TRUE))

([KB_899077_Class0] of  N_ary_Criterion

	(criteria
		[ATHENA_HF_Class70142]
		[ATHENA_HF_Class220017]
		[KB_104117_Class7]
		[KB_247253_Class1])
	(label "LVEF<=35 & NYHA functional class II or III or ambulatory class IV symptoms & GDMT")
	(operator AND)
	(%3ADOCUMENTATION "Removed criteria for CRT\n& QRS >=0.15 & sinus rhythm & LBBB"))

([KB_899077_Class1] of  Collateral_Action

	(actions
		[ATHENA_HF_Class110380]
		[KB_899077_Class2])
	(mood Recommend_Add))

([KB_899077_Class2] of  On_Screen_Message

	(label "rec add ACE-I dose based on 2013 ACCF/AHA Guideline")
	(message "Refer to 2013 ACCF/AHA Guideline for specific ACE-I starting dose and maximum dose.  In this application, we do not know what particular dosage can be tolerated by the patient.")
	(message_type Recommendation))

([KB_899077_Class3] of  Collateral_Action

	(actions [KB_899077_Class4])
	(mood Recommend_Add))

([KB_899077_Class4] of  On_Screen_Message

	(label "rec add ARB based on 2013 ACCF/AHA guidelines")
	(message "Refer to 2013 ACCF/AHA Guideline (reproduced below)  for specific ARB starting dose and maximum dose.  In this application, we do not know what particular dosage can be tolerated by the patient.\ncandesartan starting dose 4-8 mg/once; max dose 32 mg once\nlosartan starting dose 25-50 once; max dose 50-150 mg once\nvalsartan 20-40 mg twice; max dose 160 mg twice")
	(message_type Recommendation))

([KB_899077_Class5] of  On_Screen_Message

	(description "rec add AA based on 2013 ACCF/AHA guidelines")
	(label "rec add AA based on 2013 ACCF/AHA guidelines")
	(message "Refer to 2013 ACCF/AHA Guideline (reproduced below) for specific AA starting dose and maximum dose.  In this application, we do not know what particular dosage can be tolerated by the patient.\nspironolactone starting dose 12.5 0 25.0 once; max dose 25 mg once or twice\neplerenone starting dose 25 mg once; max dose 50 mg once")
	(message_type Recommendation))

([KB_899077_Class6] of  On_Screen_Message

	(description "rec add BB based on 2013 ACCF/AHA guidelines")
	(label "rec add BB based on 2013 ACCF/AHA guidelines")
	(message "Refer to 2013 ACCF/AHA Guideline (reproduced below) for specific BB starting dose and maximum dose.  In this application, we do not know what particular dosage can be tolerated by the patient.\nbisoprolol starting dose 1.25 mg once; max dose 10 mg once\ncarvedilol starting dose 3.125 mg twice; max dose 50 mg twice\ncarvedilol CR starting dose 10 mg once; max dose 80 mg once\nmetoprolol succinate ER starting dose 12.5 - 25 mg once; 200 mg once")
	(message_type Recommendation))

([KB_899077_Class7] of  On_Screen_Message

	(label "rec add hydralazine and nitrates based on 2013 ACCF/AHA guideline")
	(message "Refer to 2013 ACCF/AHA Guideline for specific hydraline and nitrates starting dose and maximum dose.  In this application, we do not know what particular dosage can be tolerated by the patient.\nfixed dose combination starting dose 37.5 mg hydralazine + 20 mg isosorbide dintrate/ 3x; max dose 75 mg hydralazine + 40 mg isosorbide dinitrate 3x dialy\nhydralazine and isosorbide dinitrate sstarting dose hydralazine 25-50 mg 3 or 4 x daily and isosorbide dintrate 20 to 30 mg 3 or 4 x dialy; max dose hydralazine 300 mg daily in divided doses and isosorbide dintrate 120 mg daily in divided doses")
	(message_type Recommendation))

([KB_899077_Class8] of  Collateral_Action

	(actions [KB_899077_Class6])
	(mood Recommend_Add))

([KB_899077_Class9] of  Collateral_Action

	(actions
		[KB_899077_Class7]
		[ATHENA_HF_Class240016])
	(mood Recommend_Add))

([KB_911127_Class0] of  Presence_Criterion

	(domain_term Beta_Blocker+Stage+C+Heart+Failure)
	(entry_type Medication)
	(label "Absence of Stage C BB")
	(presence FALSE)
	(status "active"))

([KB_911127_Class1] of  N_ary_Criterion

	(criteria
		[KB_261275_Class10]
		[KB_911127_Class0])
	(label "Presence of BB not Stage C and Absence of Stage C BB")
	(operator AND))

([KB_918681_Class0] of  Case_Selection

	(%3AFROM [KB_048666_Class0])
	(%3ATO [KB_048666_Class4]))

([KB_918681_Class2] of  Scenario

	(followed_by [ATHENA_HF_Class350000])
	(label "Presence of hydralazine or nitrates rec")
	(new_encounter FALSE)
	(precondition [KB_048666_Class1]))

([KB_918681_Class3] of  Followed_By

	(%3AFROM [ATHENA_HF_Class130004])
	(%3ATO [KB_918681_Class2]))

([KB_918681_Class4] of  Followed_By

	(%3AFROM [ATHENA_HF_Class270000])
	(%3ATO [KB_918681_Class2]))

([KB_923519_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_923519_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_923519_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_929760_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_929760_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_929760_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_931688_Class216] of  Qualitative_Constant

	(value "Female"))

([KB_931688_Class219] of  Qualitative_Constant

	(value "Male"))

([KB_931688_Class81] of  N_ary_Criterion

	(label "Eligibility criteria")
	(operator AND))

([KB_950991_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_950991_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_950991_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_952347_Class654] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_952347_Class681] of  Qualitative_Constant

	(value "Male"))

([KB_952347_Class683] of  Qualitative_Constant

	(value "Female"))

([KB_963063_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_963063_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_963063_Class319] of  Qualitative_Constant

	(value "Female"))

([KB_978532_Class0] of  N_ary_Criterion

	(criteria [library_Class140004])
	(label "NOT angioedema ARB")
	(operator NOT))

([KB_978532_Class1] of  N_ary_Criterion

	(criteria [library_Class120000])
	(label "NOT angioedema ACEi")
	(operator NOT))

([KB_982939_Class0] of  Conditional_On_Screen_Message

	(description "Angioedema as a reaction to ARB")
	(label "PM Angioedema as a reaction to ARB")
	(message "Patient has angioedema as a recorded allergy to angiotensin receptor blocker. Evaluate clinical significance.")
	(message_type Primary_Recommendation)
	(rule_in_condition [library_Class70004]))

([KB_987641_Class0] of  Variable

	(derivation_expression [ATHENA_HF_Class460018])
	(label "Drug usage Isosorbide contraindicated")
	(string_name "Isosorbide_contraindicated"))

([KB_987641_Class1] of  Variable

	(derivation_expression [KB_987641_Class2])
	(label "most recent Systolic_BP"))

([KB_987641_Class2] of  Structured_Query

	(aggregation_operator most_recent)
	(attribute [valid_time])
	(label "most recent SBP (mapped to Systolic_BP)")
	(type Numeric_Entry)
	(where_restriction [KB_987641_Class3]))

([KB_987641_Class3] of  Comparison_Filter

	(attribute [domain_term])
	(label "domain term eq Systolic_BP")
	(operator eq)
	(value_expression [Systolic_BP]))

([KB_994402_Class1131] of  N_ary_Criterion

	(label "Eligibility criteria")
	(operator AND))

([KB_994402_Class1212] of  Qualitative_Constant

	(value "Female"))

([KB_994402_Class1304] of  Qualitative_Constant

	(value "Male"))

([KB_998060_Class290] of  N_ary_Criterion

	(criteria [KB_707214_Class0])
	(label "Eligibility criteria")
	(operator AND))

([KB_998060_Class317] of  Qualitative_Constant

	(value "Male"))

([KB_998060_Class319] of  Qualitative_Constant

	(value "Female"))

([Low_Ejection_Fraction] of  Diagnostic_Term_Metaclass

	(data_source VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class20004])
	(PrettyName "Low ejection fraction (<40)"))

([Low_LVEF_High_Creatinine] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_055251_Class2])
	(PrettyName "Low LVEF and High Creatinine"))

([Low_LVEF_Low_SBC] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_055251_Class3])
	(PrettyName "Low LVEF and Low SBC"))

([Lupus] of  Medical_Conditions_Metaclass
)

([Lupus_ADR_hydralazine] of  Diagnostic_Term_Metaclass

	(controllable FALSE)
	(DiagnosticCriteria [ATHENA_HF_Class460000]))

([LVEF%3C%3D40] of  Diagnostic_Term_Metaclass

	(data_source VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class50019])
	(PrettyName "LV Ejection Fraction <= 40"))

([LVEF%3C%3D40+%26+using+ACE+%26+using+BB+%26+HF+symptoms] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element clinical_assessment VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class102530])
	(PrettyName "HF with low EF and persistent symptoms, using ACE and BB"))

([LVEF%3C%3D40+and+contraindications+to+ACE%2FARB+%28hypotension%2C+renal+insufficiency+or+drug+intolerance%29] of  Diagnostic_Term_Metaclass

	(data_source VISTA_freetext VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class100224])
	(PrettyName "HF with low EF,  intolerance to ACE/ARB"))

([LVEF%3C%3D40+and+intolerant+ACE] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class50039]))

([LVEF%3C%3D40+and+MI] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_433271_Class4]))

([LVEF%3C%3D40+and+MI+or+ACS+Stage+B] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class270003]))

([LVEF%3C%3D40+and+no+HF+and+no+MI] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class90002])
	(PrettyName "LVEF<=40 and no HF and no MI"))

([LVEF%3C%3D40+and+no+HF+symptoms] of  Diagnostic_Term_Metaclass

	(data_source clinical_assessment VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class80356]))

([LVEF%3C%3D40+and+no+MI] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_433271_Class2]))

([LVEF%3C%3D40+and+sinus+rhythm+and+Stage+B+and+absence+HF+symptoms] of  Diagnostic_Term_Metaclass

	(data_source clinical_assessment VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class50048]))

([LVEF%3C%3D40+and+using+ACE+and+BB+and+HF+and+symptomatic] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element clinical_assessment VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class70185]))

([LVEF%3C%3D40_and_NYHA_Class_IIi_or_IV_and_ACE_intolerance] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_261275_Class3])
	(PrettyName "LVEF ltn 40 and NYHA Class IIi or IV and ACE-I intolerance"))

([Male+and+most+recent+creatinine%3E2.5] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class70161]))

([MI+no+HF] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class90005])
	(PrettyName "MI no HF"))

([Mild+HF+signs+and+symptoms] of  Medical_Conditions_Metaclass

	(data_source clinical_assessment))

([Mild-moderate+HF+symptoms+and+LVEF%3C%3D+40+and+ACE+intolerant] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element VISTA_freetext clinical_assessment)
	(DiagnosticCriteria [ATHENA_HF_Class70179]))

([Moderate+HF+signs+and+symptoms] of  Medical_Conditions_Metaclass

	(data_source clinical_assessment))

([moricizine] of  Medications_Metaclass

	(data_source VISTA_data_element))

([Most+recent+SBP%3C110] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [library_Class30002])
	(PrettyName "Most recent SBP<110mmHg"))

([No+HF%2C+MI%2C++LVEF%3C%3D40+and+ADR+ACE] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class50035]))

([Non+steroidal+anti+inflammatory+drugs] of  Medications_Metaclass

	(data_source VISTA_data_element))

([non-ischemic+dilated+cardiomyopathy] of  Medical_Conditions_Metaclass

	(data_source VISTA_data_element))

([NYHA_functional_class_IV] of  Medical_Conditions_Metaclass

	(PrettyName "NYHA functional class IV"))

([NYHA_functional_class_IV_ambulatory] of  Medical_Conditions_Metaclass

	(PrettyName "NYHA functional class IV ambulatory"))

([On_Potassium+supplements] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_155357_Class47]))

([Palliative_care] of  Canonical_Terms_Metaclass
)

([PalliativeCare] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_155357_Class77]))

([Persistent+HF+signs+and+symptoms] of  Medical_Conditions_Metaclass

	(data_source clinical_assessment))

([Potassium_supplements] of  Medications_Metaclass
)

([Prescription++for+ACE+Inhibitor] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class50024]))

([Prescription_betablocker_notstageC_HF] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_155357_Class67])
	(PrettyName "Prescription of beta blocker that is not Stage C BB"))

([Prescription_cholestyramine] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_155357_Class51]))

([Prescription_diltiazem] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class430000])
	(PrettyName "Active prescription for diltiazem"))

([Prescription_heparin] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_155357_Class49]))

([prescription_sotalol] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [athena_hypertension_299947]))

([Prescription_verapamil] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class430001])
	(PrettyName "active prescription for verapamil"))

([Prescription_verapamil_OR_diltiazem] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_155357_Class64]))

([Presence+of+adverse+reaction+to+ACE] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class50036]))

([Presence+of+adverse+reaction+to+ARB] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element)
	(DiagnosticCriteria [ATHENA_HF_Class60012]))

([Presence_phosphodiesterase_inhibitor] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [athena_hypertension_504685])
	(PrettyName "Presence of phosphodiesterase-5 inhibitor"))

([prior_cardiovascular_hospitalization] of  Medical_Conditions_Metaclass

	(PrettyName "prior cardiovascular hospitalization"))

([Prior_Myocardial_Infarction] of  Canonical_Terms_Metaclass

	(data_source VISTA_data_element)
	(PrettyName "Prior Myocardial Infarction"))

([procainamide] of  Medications_Metaclass

	(data_source VISTA_data_element))

([Pulse_lt_60] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [KB_155357_Class62]))

([quinidine] of  Medications_Metaclass

	(data_source VISTA_data_element))

([RelativeIndHF+symptoms%2FHF+and+LVEF%3C%3D40digoxin] of  Drug_Indication_Relation

	(degree relative)
	(indication HF+and+LVEF%3C%3D35+%26+HF+%26+moderate%2Fsevere+symptoms+%26+low+creatinine+%26+K%3C5))

([RelativeIndHTN+and+LVHACE_Inhibitors] of  Drug_Indication_Relation

	(degree relative)
	(indication HTN+and+LVH))

([RelativeIndHTN+and+LVHAngiotensin_II_receptor_blockers] of  Drug_Indication_Relation

	(degree relative)
	(indication HTN+and+LVH))

([RelativeIndMild-moderate+HF+symptoms+and+LVEF%3C%3D+40Angiotensin_II_receptor_blockers] of  Drug_Indication_Relation

	(degree relative)
	(indication Mild-moderate+HF+symptoms+and+LVEF%3C%3D+40+and+ACE+intolerant))

([RelativeIndStage+B+and+LVEF%3C%3D40+and+ADR+ACEAngiotensin_II_receptor_blockers] of  Drug_Indication_Relation

	(degree relative)
	(indication Stage+B+and+LVEF%3C%3D40+and+ADR+ACE))

([Severe+HF+signs+and+symptoms] of  Medical_Conditions_Metaclass

	(data_source clinical_assessment))

([Severe_LVH] of  Canonical_Terms_Metaclass

	(data_source clinical_assessment)
	(PrettyName "Severe LVH"))

([Stage+A+Heart+Failure] of  Medical_Conditions_Metaclass

	(data_source clinical_assessment VISTA_data_element))

([Stage+B+and+LVEF%3C%3D40+and+ADR+ACE] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class70138]))

([Stage+B+Heart+Failure] of  Medical_Conditions_Metaclass

	(data_source clinical_assessment VISTA_data_element VISTA_freetext))

([Stage+C+and+LVEF%3C%3D40+and+ADR+ACE] of  Diagnostic_Term_Metaclass

	(data_source VISTA_data_element VISTA_freetext)
	(DiagnosticCriteria [ATHENA_HF_Class50067]))

([Stage+C+and+LVEF%3C%3D40+and+symptoms+and+ADR+ACE] of  Diagnostic_Term_Metaclass

	(DiagnosticCriteria [ATHENA_HF_Class240004]))

([Stage+C+Heart+Failure] of  Medical_Conditions_Metaclass

	(data_source clinical_assessment VISTA_data_element))

([Stage+D+Heart+Failure] of  Medical_Conditions_Metaclass

	(data_source clinical_assessment VISTA_data_element))

([UNKNOWN+BY+PATIENT] of  Canonical_Terms_Metaclass
)

([UNKNOWN+BY+PATIENT%2C+DECLINED+TO+ANSWER] of  Canonical_Terms_Metaclass
)

([Valvular+heart+disease] of  Medical_Conditions_Metaclass

	(data_source VISTA_data_element)
	(PrettyName "Valvular heart disease"))
